# EDGAR Filing Document

**Accession Number:** 0001374310
**File Stem:** 0001628280-26-022939
**Filing Date:** 2026-4
**Character Count:** 390412
**Document Hash:** 07d7c1b23bbd6b18d4fe4e928a393b97
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-022939.hdr.sgml**: 20260402

**ACCESSION NUMBER**: 0001628280-26-022939

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 81

**CONFORMED PERIOD OF REPORT**: 20260514

**FILED AS OF DATE**: 20260402

**DATE AS OF CHANGE**: 20260402

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cboe Global Markets, Inc.
- **CENTRAL INDEX KEY:** 0001374310
- **STANDARD INDUSTRIAL CLASSIFICATION:** SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200]
- **ORGANIZATION NAME:** 09 Crypto Assets
- **EIN:** 205446972
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34774
- **FILM NUMBER:** 26830736

**BUSINESS ADDRESS:**
- **STREET 1:** 433 WEST VAN BUREN STREET
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60607
- **BUSINESS PHONE:** 312 786 7200

**MAIL ADDRESS:**
- **STREET 1:** 433 WEST VAN BUREN STREET
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60607

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CBOE Holdings, Inc.
- **DATE OF NAME CHANGE:** 20060831

?xml version='1.0' encoding='ASCII'? cboe-20260401

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 14A**

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No.)

---

| | |
|:---|:---|
| Filed by the Registrant [x] | Filed by the Registrant [x] |
| Filed by a party other than the Registrant [ ] | Filed by a party other than the Registrant [ ] |
| Check the appropriate box: | Check the appropriate box: |
| [ ] | Preliminary Proxy Statement |
| [ ] | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| [x] | Definitive Proxy Statement |
| [ ] | Definitive Additional Materials |
| [ ] | Soliciting Material under §240.14a-12 |

---

---

| | |
|:---|:---|
| **Cboe Global Markets, Inc.** | **Cboe Global Markets, Inc.** |
| (Name of Registrant as Specified In Its Charter) | (Name of Registrant as Specified In Its Charter) |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
| Payment of Filing Fee (Check all boxes that apply): | Payment of Filing Fee (Check all boxes that apply): |
| [x] | No fee required |
| [ ] | Fee paid previously with preliminary materials |
| [ ] | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

![New-CboeLogo-RGB.jpg](cboe-20260401_g1.jpg)

**2026**

Notice of Annual Meeting of Stockholders

and Proxy Statement

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

![New-CboeLogo-RGB.jpg](cboe-20260401_g1.jpg)

April 2, 2026

Dear Cboe Stockholder:

We cordially invite you to attend the 2026 Annual Meeting of Stockholders (the "Annual Meeting") of Cboe

Global Markets, Inc. to be held on Thursday, May 14, 2026, at 8:00 a.m., Central time.

The Annual Meeting will be a completely virtual meeting of stockholders and there will be no physical meeting

location. You will be able to attend the Annual Meeting, vote your shares and submit questions during the

meeting via live audio webcast by visiting www.virtualshareholdermeeting.com/CBOE2026 and entering the 16-

digit control number included in your proxy materials or on your proxy card. The live audio webcast of the

Annual Meeting will also be available for listening to the general public.

At the Annual Meeting, you will be asked to do the following:

Elect 12 directors to the Board of Directors to hold office until the next Annual Meeting of Stockholders

![cboe-20240516xdef14a_a016.jpg](cboe-20260401_g2.jpg)

or until their respective successors have been elected and qualified;

Approve, in a non-binding resolution, the compensation paid to our executive officers;

![cboe-20240516xdef14a_a016.jpg](cboe-20260401_g2.jpg)

Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the 2026

![cboe-20240516xdef14a_a016.jpg](cboe-20260401_g2.jpg)

fiscal year;

Consider one stockholder proposal, if properly presented at the Annual Meeting; and

![cboe-20240516xdef14a_a016.jpg](cboe-20260401_g2.jpg)

Transact any other business that may properly come before the meeting and any adjournments and

![cboe-20240516xdef14a_a016.jpg](cboe-20260401_g2.jpg)

postponements of the meeting.

Enclosed with this letter are a formal notice of the Annual Meeting, a proxy statement, and a form of proxy.

***Please carefully review the form of proxy that you receive to confirm that it reflects all of your shares of***

***our stock. If you hold stock in different accounts, you may need to complete multiple proxy cards to***

***vote all of your shares.***

Whether or not you plan to attend the Annual Meeting via live audio webcast, it is important that your shares be

represented and voted. Please submit your proxy by Internet or telephone, or complete, sign, date and return

the enclosed proxy using the enclosed postage-paid envelope. The enclosed proxy, when returned properly

executed, will be voted in the manner directed in the proxy.

We hope that you will participate in the Annual Meeting, either via live audio webcast or by proxy.

---

| |
|:---|
| Sincerely, |
| ![2026 Back-up - WF Signature.jpg](cboe-20260401_g3.jpg) |
| William M. Farrow, III<br>*Chairman*<br>|

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**CBOE GLOBAL MARKETS, INC.**

**NOTICE OF ANNUAL MEETING OF STOCKHOLDERS**

The 2026 Annual Meeting of Stockholders (the "Annual Meeting") of Cboe Global Markets, Inc. will be held on

Thursday, May 14, 2026, at 8:00 a.m., Central time.

The Annual Meeting will be a completely virtual meeting of stockholders. You will be able to attend the Annual

Meeting, vote your shares and submit questions during the meeting via live audio webcast by visiting

www.virtualshareholdermeeting.com/CBOE2026 and entering the 16-digit control number included in your proxy

materials or on your proxy card. Online check-in to the Annual Meeting live audio webcast will begin at 7:45

a.m., Central time, and you are encouraged to allow ample time to log in to the meeting webcast and test your

computer audio system. There will be no physical meeting location.

The purpose of the Annual meeting is to:

1. Consider and act upon a proposal to elect 12 directors named in the proxy statement to the Board of

Directors to hold office until the next Annual Meeting of Stockholders or until their respective successors

have been elected and qualified;

2. Consider and act upon a non-binding resolution to approve the compensation paid to our executive

officers;

3. Consider and act upon the ratification of the appointment of KPMG LLP as our independent registered

public accounting firm for the 2026 fiscal year;

4. Consider one stockholder proposal, if properly presented at the Annual Meeting; and

5. Transact any other business that may properly come before the meeting and any adjournments or

postponements of the meeting.

You are entitled to vote online during the Annual Meeting and any adjournments or postponements of the

meeting if you were a stockholder of record at the close of business on March 19, 2026. A list of stockholders of

record will be open for examination by any stockholder for any purpose germane to the Annual Meeting for a

period of 10 days prior to the Annual Meeting at our principal executive offices at 433 West Van Buren Street,

Chicago, Illinois 60607.

**Your vote is important. Whether or not you plan to attend, please vote as soon as possible. For** 

**additional details, please see the information under "How do I vote?" in the proxy statement.**

---

| | | | |
|:---|:---|:---|:---|
| **Internet**<br>**Before the Meeting**<br>![cboe-20240516xdef14a_a011.jpg](cboe-20260401_g4.jpg)<br>Go to <br>www.proxyvote.com<br>| **Internet**<br>**During the Meeting**<br>![cboe-20240516xdef14a_a011.jpg](cboe-20260401_g4.jpg)<br>Go to<br>www.virtualshareholdermeeting<br>.com/CBOE2026<br>| **Telephone**<br>![cboe-20240516xdef14a_a013.jpg](cboe-20260401_g5.jpg)<br>Call toll free<br>1-800-690-6903<br>| **Mail**<br>![cboe-20240516xdef14a_a014.jpg](cboe-20260401_g6.jpg)<br>Complete, sign, date and return <br>the enclosed proxy using the <br>enclosed <br>postage-paid envelope |
|  |  | By Order of the Board of Directors, | By Order of the Board of Directors, |
|  |  | ![2026 Back-up - PS Signature.jpg](cboe-20260401_g7.jpg) | ![2026 Back-up - PS Signature.jpg](cboe-20260401_g7.jpg) |
| April 2, 2026 | April 2, 2026 | Patrick Sexton<br>*Corporate Secretary* | Patrick Sexton<br>*Corporate Secretary* |

---

**IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS**

**FOR THE STOCKHOLDER MEETING TO BE HELD ON MAY 14, 2026:**

Notice of Annual Meeting and Proxy Statement are on our Investor Relations website at http://ir.Cboe.com.

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**<u>**TABLE OF CONTENTS**</u>**

---

| | |
|:---|:---|
| **[Proxy Statement Summary](#i6fe99c16e7ba4527ada2d89600dfba88_19)** | **[1](#i6fe99c16e7ba4527ada2d89600dfba88_19)** |
| **[Corporate Governance](#i6fe99c16e7ba4527ada2d89600dfba88_22)** | **[5](#i6fe99c16e7ba4527ada2d89600dfba88_22)** |
| [Proposal 1—Election of Directors](#i6fe99c16e7ba4527ada2d89600dfba88_25) | [5](#i6fe99c16e7ba4527ada2d89600dfba88_25) |
| [Board Structure](#i6fe99c16e7ba4527ada2d89600dfba88_28) | [14](#i6fe99c16e7ba4527ada2d89600dfba88_28) |
| [Committees of the Board](#i6fe99c16e7ba4527ada2d89600dfba88_31) | [18](#i6fe99c16e7ba4527ada2d89600dfba88_31) |
| [Stockholder Engagement](#i6fe99c16e7ba4527ada2d89600dfba88_34) | [23](#i6fe99c16e7ba4527ada2d89600dfba88_34) |
| [Communications with Directors](#i6fe99c16e7ba4527ada2d89600dfba88_37) | [24](#i6fe99c16e7ba4527ada2d89600dfba88_37) |
| [Insider Trading Policy](#i6fe99c16e7ba4527ada2d89600dfba88_40) | [24](#i6fe99c16e7ba4527ada2d89600dfba88_40) |
| **[Non-Employee Director Compensation](#i6fe99c16e7ba4527ada2d89600dfba88_43)** | **[26](#i6fe99c16e7ba4527ada2d89600dfba88_43)** |
| **[Executive Compensation](#i6fe99c16e7ba4527ada2d89600dfba88_46)** | **[29](#i6fe99c16e7ba4527ada2d89600dfba88_46)** |
| [Proposal 2—Advisory Vote to Approve Executive Compensation](#i6fe99c16e7ba4527ada2d89600dfba88_49) | [29](#i6fe99c16e7ba4527ada2d89600dfba88_49) |
| [Compensation Discussion and Analysis](#i6fe99c16e7ba4527ada2d89600dfba88_52) | [30](#i6fe99c16e7ba4527ada2d89600dfba88_52) |
| [Compensation and Human Capital Committee Report](#i6fe99c16e7ba4527ada2d89600dfba88_163) | [59](#i6fe99c16e7ba4527ada2d89600dfba88_163) |
| [Risk Assessment](#i6fe99c16e7ba4527ada2d89600dfba88_166) | [59](#i6fe99c16e7ba4527ada2d89600dfba88_166) |
| [Summary Compensation](#i6fe99c16e7ba4527ada2d89600dfba88_169) | [61](#i6fe99c16e7ba4527ada2d89600dfba88_169) |
| [Severance, Change in Control, and Employment-Related Agreements](#i6fe99c16e7ba4527ada2d89600dfba88_172) | [71](#i6fe99c16e7ba4527ada2d89600dfba88_172) |
| [Pay Ratio](#i6fe99c16e7ba4527ada2d89600dfba88_175) | [75](#i6fe99c16e7ba4527ada2d89600dfba88_175) |
| [Pay Versus Performance](#i6fe99c16e7ba4527ada2d89600dfba88_178) | [76](#i6fe99c16e7ba4527ada2d89600dfba88_178) |
| [Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to](#i6fe99c16e7ba4527ada2d89600dfba88_181)<br>[the Release of Material Nonpublic Information](#i6fe99c16e7ba4527ada2d89600dfba88_181)<br>| [81](#i6fe99c16e7ba4527ada2d89600dfba88_181) |
| [Equity Compensation Plan Information](#i6fe99c16e7ba4527ada2d89600dfba88_184) | [81](#i6fe99c16e7ba4527ada2d89600dfba88_184) |
| **[Audit Matters](#i6fe99c16e7ba4527ada2d89600dfba88_187)** | **[82](#i6fe99c16e7ba4527ada2d89600dfba88_187)** |
| [Proposal 3—Ratification of Appointment of Independent Registered Public Accounting](#i6fe99c16e7ba4527ada2d89600dfba88_190)<br>[Firm](#i6fe99c16e7ba4527ada2d89600dfba88_190)<br>| [82](#i6fe99c16e7ba4527ada2d89600dfba88_190) |
| [Report of the Audit Committee](#i6fe99c16e7ba4527ada2d89600dfba88_193) | [83](#i6fe99c16e7ba4527ada2d89600dfba88_193) |
| **[Stockholder Proposal](#i6fe99c16e7ba4527ada2d89600dfba88_202)** | **[84](#i6fe99c16e7ba4527ada2d89600dfba88_202)** |
| [Proposal 4—Stockholder Proposal—Shareholder Right to Act by Written Consent](#i6fe99c16e7ba4527ada2d89600dfba88_205) | [84](#i6fe99c16e7ba4527ada2d89600dfba88_205) |
| **[Other Items](#i6fe99c16e7ba4527ada2d89600dfba88_208)** | **[88](#i6fe99c16e7ba4527ada2d89600dfba88_208)** |
| [Beneficial Ownership of Management and Directors](#i6fe99c16e7ba4527ada2d89600dfba88_211) | [88](#i6fe99c16e7ba4527ada2d89600dfba88_211) |
| [Relationships and Related Party Transactions](#i6fe99c16e7ba4527ada2d89600dfba88_214) | [89](#i6fe99c16e7ba4527ada2d89600dfba88_214) |
| [Incorporation by Reference](#i6fe99c16e7ba4527ada2d89600dfba88_217) | [90](#i6fe99c16e7ba4527ada2d89600dfba88_217) |
| [Stockholder Proposals](#i6fe99c16e7ba4527ada2d89600dfba88_220) | [90](#i6fe99c16e7ba4527ada2d89600dfba88_220) |
| [Voting Instructions](#i6fe99c16e7ba4527ada2d89600dfba88_223) | [91](#i6fe99c16e7ba4527ada2d89600dfba88_223) |
| **[Appendix A—Reconciliation of Non-GAAP Financial Measures to GAAP Measures](#i6fe99c16e7ba4527ada2d89600dfba88_226)** | **[96](#i6fe99c16e7ba4527ada2d89600dfba88_226)** |

---

We are furnishing this Proxy Statement to you in connection with a solicitation of proxies by the Board of

Directors of Cboe Global Markets, Inc., a Delaware corporation, for use at the Cboe Global Markets, Inc. 2026

Annual Meeting of Stockholders on Thursday, May 14, 2026 at 8:00 a.m., Central time, and at any

adjournments or postponements thereof. The approximate date on which this Proxy Statement and the

accompanying form of proxy are first being sent to stockholders is April 2, 2026.

Except as otherwise indicated, the terms "the Company", "Cboe Global Markets", "we", "us", and "our" refer to

Cboe Global Markets, Inc. When we use the term "Cboe Options" or "C1" we are referring to Cboe Exchange,

Inc., a wholly owned subsidiary and predecessor entity of Cboe Global Markets.

**Trademark Information**

Cboe®, Cboe Global Markets®, Cboe Titanium®, and VIX® are registered trademarks of Cboe Global Markets,

Inc. or its subsidiaries. All other trademarks are property of their respective owners.

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Note About Forward-Looking Statements**

This Proxy Statement contains historical and forward-looking statements within the meaning of the Private

Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. You can identify these

statements by forward-looking words such as "may", "might", "should", "expect", "plan", "anticipate", "believe",

"estimate", "predict", "potential", or "continue", and the negative of these terms and other comparable

terminology. All statements that reflect our expectations, assumptions or projections about the future other than

statements of historical fact are forward-looking statements. These forward-looking statements, which are

subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our

future financial performance based on our growth strategies and anticipated trends in our business. These

statements are only predictions based on our current expectations and projections about future events. There

are important factors that could cause our actual results, level of activity, performance or achievements to differ

materially from those expressed or implied by the forward-looking statements. In particular, you should consider

the risks and uncertainties described in Part 1 of our Annual Report on Form 10-K for the fiscal year ended

December 31, 2025 under Item 1A., "Risk Factors", and our other filings with the Securities and Exchange

Commission ("SEC"). While we believe we have identified material risks, these risks and uncertainties are not

exhaustive. Moreover, we operate in a very competitive and rapidly changing environment. New risks and

uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor can we

assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may

cause actual results to differ materially from those contained in any forward-looking statements.

![](cboe-20260401_g8.gif)

**Cboe Global Markets 2026 Proxy Statement**<sub>1</sub>

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**<u>PROXY STATEMENT SUMMARY</u>**

This summary highlights information contained elsewhere in this Proxy Statement for the Cboe Global Markets,

Inc. 2026 Annual Meeting of Stockholders (the "Annual Meeting"). It does not contain all of the information that

you should consider in voting your shares of our common stock. Before voting, you should carefully read this

entire Proxy Statement, as well as our 2025 Annual Report to Stockholders included in this mailing, which

includes a copy of our Annual Report on Form 10-K for the year ended December 31, 2025.

---

| | |
|:---|:---|
| **Annual Meeting Date:** | May 14, 2026 |
| **Annual Meeting Time:** | 8:00 a.m. (Central time) |
| **Virtual Meeting Website Address:** | www.virtualshareholdermeeting.com/CBOE2026 |
| **Record Date:** | March 19, 2026 |

---

**Stockholder Actions and Board of Directors Voting Recommendations**

---

| | | |
|:---|:---|:---|
| **Proposal**  | **Board Voting**<br>**Recommendation**<br>| **Page**<br>**Reference**<br>|
| [1 - Elect 12 directors to the Board of Directors](#i6fe99c16e7ba4527ada2d89600dfba88_25) | FOR | [5](#i6fe99c16e7ba4527ada2d89600dfba88_25) |
| [2 - Approve, in a non-binding resolution, the compensation paid to our](#i6fe99c16e7ba4527ada2d89600dfba88_49)<br>[executive officers](#i6fe99c16e7ba4527ada2d89600dfba88_49)<br>| FOR | [29](#i6fe99c16e7ba4527ada2d89600dfba88_49) |
| [3 - Ratify the appointment of KPMG LLP ("KPMG") as our independent](#i6fe99c16e7ba4527ada2d89600dfba88_190)<br>[registered public accounting firm for the 202](#i6fe99c16e7ba4527ada2d89600dfba88_190)6[fiscal year](#i6fe99c16e7ba4527ada2d89600dfba88_190)<br>| FOR | [82](#i6fe99c16e7ba4527ada2d89600dfba88_190) |
| 4[- Stockholder proposal regarding shareholder right to act by written](#i6fe99c16e7ba4527ada2d89600dfba88_205)<br>[consent](#i6fe99c16e7ba4527ada2d89600dfba88_205)<br>| AGAINST | [84](#i6fe99c16e7ba4527ada2d89600dfba88_205) |

---

**Business Highlights**

Achieved record options volume activity levels

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Launched new products and added new indices

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Conducted a comprehensive strategic review of the Company's global business operations, resulting in a

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

strategic realignment of the Company's business portfolio and an enhanced focus on core strengths and

emerging growth opportunities

Expanded retail access with the launch of a Pan-European Best Bid and Offer trading solution

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Began enhancing our governance, risk, and compliance framework

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Advanced cloud-based data access with launch of index datasets

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Successfully navigated key executive transitions

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Completed key migrations

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

For more highlights, see "Executive Compensation—Compensation Discussion and Analysis"

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

![](cboe-20260401_g8.gif)

---

| | |
|:---|:---|
| 2 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Returns to Stockholders**

Cboe Global Markets and its Board of Directors ("Board") have demonstrated an ongoing commitment to

creating long-term stockholder value and produced the following notable returns to stockholders in 2025.

![1424](cboe-20260401_g10.gif)

**Total Stockholder Return (2)**

![1456](cboe-20260401_g11.gif)

![1458](cboe-20260401_g12.gif)

![1460](cboe-20260401_g13.gif)

![1462](cboe-20260401_g14.gif)

________________________________________________

(1)$ in millions. Numbers may not foot due to rounding.

(2)As of December 31, 2025. Includes reinvestment of all dividends.

![](cboe-20260401_g8.gif)

**Cboe Global Markets 2026 Proxy Statement**<sub>3</sub>

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Director Nominee Highlights**

The nominees for our Board exhibit an effective mix of qualifications, experiences, and tenure. For additional

information, see "Corporate Governance—Proposal 1—Election of Directors".

![1846](cboe-20260401_g15.gif)

100%

100%

100%

83%

75%

83%

50%

42%

42%

![1850](cboe-20260401_g16.gif)

9 years average tenure

33%

25%

42%

![](cboe-20260401_g8.gif)

---

| | |
|:---|:---|
| 4 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Corporate Governance Highlights**

We are committed to good corporate governance, which promotes the long-term interests of stockholders by

providing for effective oversight and management of the Company. The following are highlights of our corporate

governance framework. For additional information, see "Corporate Governance".

---

| | |
|:---|:---|
| 10 of the 12 Nominees are Independent;![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>| Split Chairman and CEO roles; ![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>|
| Directors are Elected Annually;![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>| Majority Voting Standard in Director Elections;![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>|
| Majority Voting Standard for Bylaw and ![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>Charter Amendments;<br>| Risk Oversight by Board and Committees, including a ![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>Risk Committee;<br>|
| Proxy Access Bylaw Provision for Director ![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>Nominations;<br>| Human Capital and Succession Oversight by Board and ![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>Compensation and Human Capital Committee;<br>|
| Stockholders can Call Special Meetings;![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>| Executive Sessions of Board and Committees; and![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>|
| Robust Annual Board and Committees Self-![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>Evaluation process;<br>| Anti-Hedging, Anti-Pledging, and Clawback Policies for ![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>Executive Officers.<br>|
| Independent Audit, Compensation and ![cboe-20240516xdef14a_a037.jpg](cboe-20260401_g17.jpg)<br>Human Capital, and Nominating and <br>Governance Committees;<br>|  |

---

**Stockholder Engagement Highlights**

We are committed to fostering long-term and institution-wide relationships with stockholders and maintaining

their trust and goodwill. Through a variety of engagement activities, our discussions with stockholders cover a

variety of topics, including our performance, strategy, and executive compensation. See also "Corporate

Governance—Stockholder Engagement".

**Executive Compensation Highlights**

The design of our executive compensation program, including compensation practices and independent

oversight, is intended to align management's interests with those of our stockholders. The following are

highlights of our 2025 executive compensation program. See also "Executive Compensation".

Annual cash incentives were based on corporate performance (weighted 70%) and individual

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

performance (weighted 30%);

Long-term incentives in the form of equity awards were comprised of 50% time-based restricted stock

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

units ("RSUs") and 50% performance-based RSUs ("PSUs"), other than a special one-time grant to Ms.

Clay and the grant of RSUs to Mr. Tomczyk;

Performance-based compensation with limits on all incentive award payouts;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

No excessive perquisites;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Mandatory and supplemental clawback policies applicable to cash incentives and equity awards; and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Mandatory stock ownership and holding guidelines.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

**Additional Information**

Please see the information under "Other Items" for important information about this Proxy Statement, voting, the

Annual Meeting, Cboe Global Markets documents available to stockholders, communications, and the deadlines

to submit stockholder proposals for the 2027 Annual Meeting of Stockholders. Additional questions may be

directed to Investor Relations at investorrelations@Cboe.com or (312) 786-7559.

**Cboe Global Markets 2026 Proxy Statement**<sub>5</sub>

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**<u>CORPORATE GOVERNANCE</u>**

**PROPOSAL 1—ELECTION OF DIRECTORS**

**Board Composition**

Our Third Amended and Restated Certificate of Incorporation provides that our Board will consist of not less

than 11 and not more than 23 directors. Our Board currently has 13 directors. Each director is elected annually

to serve until the next Annual Meeting of Stockholders and until his or her successor is elected or appointed and

qualified, except in the event of earlier death, resignation or removal. Subject to retirement, there is no limit on

the number of terms a director may serve on our Board.

**General**

At the Annual Meeting, our stockholders will be asked to elect the 12 director nominees set forth below, each to

serve until the 2027 Annual Meeting of Stockholders. All of the director nominees have been recommended for

election by our Nominating and Governance Committee and approved and nominated for election by our Board.

In addition, with respect to Mr. Donohue, his employment agreement provides that the Company will nominate

him as a director for stockholder approval at each annual meeting during his employment with us. All of the

director nominees were elected as directors by stockholders at the 2025 Annual Meeting of Stockholders, other

than Mr. Donohue, who was appointed in May 2025.

Mr. Matturri is not standing for reelection as a director at the Annual Meeting. We thank him for his dedicated

service to the Company. The Board intends to decrease the total number of directors constituting our entire

Board to 12.

All of the nominees have indicated their willingness to serve if elected. If any nominee is unable or unwilling to

serve as a director at the time of the Annual Meeting, then shares represented by properly executed proxies will

be voted at the discretion of the persons named in those proxies for such other person as the Board may

designate. We do not presently expect that any of the nominees will be unavailable. Your proxy for the Annual

Meeting cannot be voted for more than 12 nominees.

**Qualifications and Experience**

The Board believes that the skills, qualifications and experiences of the director nominees make them all highly

qualified to serve on our Board, both individually and as providing complementary skills on our Board. In

addition, our Board's composition represents a balanced approach to director tenure: 5 of the 12 nominees

have tenures equal to or less than 5 years, with an average tenure of approximately 9 years, allowing the Board

to benefit from the experience of longer-serving directors combined with fresh perspectives from newer

---

| | |
|:---|:---|
| 6 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

directors. The following table shows the specific qualifications and experiences the Board and the Nominating

and Governance Committee considered for each nominee.

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Director Qualifications and Experiences** | **Farrow** | **Donohue** | **Fitzpatrick** | **Fong** | **Froetscher** | **Goodman** | **Mansfield** | **Mao** | **McPeek** | **Palmore** | **Parisi** | **Tomczyk** |
| **Strategy** |  |  |  |  |  |  |  |  |  |  |  |  |
| Experience developing and executing upon long-term <br>strategic plans, growth strategies, and capital <br>allocation plans<br>| ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  |
| **Management** |  |  |  |  |  |  |  |  |  |  |  |  |
| Experience managing large and complex <br>organizations at a senior level<br>| ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  |
| **Financial Markets, Clearing, and our Products** |  |  |  |  |  |  |  |  |  |  |  |  |
| Experience with the trading or clearing of derivatives, <br>equities, or FX and/or with our markets and products<br>| ●  | ●  |  |  |  |  | ●  |  | ●  |  | ●  | ●  |
| **Government Relations and Regulatory** |  |  |  |  |  |  |  |  |  |  |  |  |
| Experience and understanding of the complex <br>regulatory environment in which our businesses <br>operate and/or working in or with the government and <br>regulators<br>| ●  | ●  | ●  | ●  | ●  |  | ●  |  | ●  | ●  | ●  | ●  |
| **Corporate Governance** |  |  |  |  |  |  |  |  |  |  |  |  |
| Knowledge of corporate governance matters, primarily <br>through service on other public company boards, to <br>help support our goals of strong Board and <br>management accountability, transparency, effective <br>oversight, and good governance<br>| ●  | ●  |  | ●  | ●  | ●  |  |  | ●  | ●  | ●  | ●  |
| **International** |  |  |  |  |  |  |  |  |  |  |  |  |
| Experience in a senior leadership role in an <br>organization with significant international operations or <br>expansion into new international markets<br>| ●  | ●  | ●  | ●  | ●  |  | ●  | ●  | ●  | ●  |  | ●  |
| **Risk Management** |  |  |  |  |  |  |  |  |  |  |  |  |
| Skills and experience in assessment, oversight, and/or <br>management of risks<br>| ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  | ●  |
| **Technology** |  |  |  |  |  |  |  |  |  |  |  |  |
| Experience or expertise in assessing opportunities and <br>risks of new technologies and/or assessing <br>cybersecurity risks and vulnerabilities<br>| ●  | ●  |  | ●  |  |  |  | ●  |  |  |  | ●  |
| **Fresh Perspective** |  |  |  |  |  |  |  |  |  |  |  |  |
| Board tenure is equal to or less than five years |  | ●  |  | ●  |  |  | ●  | ●  | ●  |  |  |  |

---

**Cboe Global Markets 2026 Proxy Statement**<sub>7</sub>

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Nominees**

Set forth below is biographical information, as of March 19, 2026, for each of the directors nominated to serve

on our Board for a one-year term until the 2027 Annual Meeting of Stockholders, as well as the reasons why the

Board believes each candidate is well suited to serve as a director. Additionally, based on the characteristics of

our directors as reported in their respective directors and officers questionnaires, 5 of the nominees are women

and 4 of the nominees are racially or ethnically diverse. The terms indicated for service include the service on

the board of Cboe Options prior to our demutualization and our initial public offering in 2010.

In addition, as indicated below, certain director nominees also have served on certain boards of directors and

committees of Cboe Futures Exchange, LLC ("CFE"), Cboe SEF, LLC ("SEF") and our U.S. securities

exchanges, which include Cboe Options, Cboe C2 Exchange, Inc. ("C2"), Cboe BZX Exchange, Inc. ("BZX"),

Cboe BYX Exchange, Inc., Cboe EDGA Exchange, Inc., and Cboe EDGX Exchange, Inc. (collectively, the

"securities exchanges").

---

| | |
|:---|:---|
| 8 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **William M. Farrow, III**<br>Chairman<br>**Independent**<br> **Age: 71**<br>**Committees:**<br>Audit Committee![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Executive (Chair)![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Compensation and Human ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Capital<br>&nbsp;&nbsp;&nbsp;&nbsp;Nominating and ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Governance<br>| *Background*<br>Mr. Farrow has served as non-executive Chairman of the Board since <br>September 2023, as our independent Lead Director from May 2023 to <br>September 2023 and as a member of our Board since 2016. Mr. Farrow is the <br>retired President and CEO of Urban Partnership Bank, a position he held from <br>2010 through 2017. Prior to that, he was the Managing Partner and CEO of <br>FC Partners Group, LLC from 2007 to 2009, the Executive Vice President and <br>Chief Information Officer of The Chicago Board of Trade from 2001 to 2007 <br>and held various senior positions at Bank One Corporation. Mr. Farrow <br>currently serves on the board of directors of publicly traded company WEC <br>Energy Group, Inc. and on the boards of directors of CoBank, Inc. and <br>Endeavor Health. Mr. Farrow previously was the owner of Winston and Wolfe <br>LLC, a privately held technology development and advisory company, and <br>served on the boards of directors of the Federal Reserve Bank of Chicago, <br>Urban Partnership Bank, and Echo Global Logistics, Inc., formerly a publicly <br>traded company. Mr. Farrow holds a B.A. degree from Augustana College and <br>a Masters of Management from Northwestern University's Kellogg School of <br>Management. <br>*Qualifications*<br>Mr. Farrow brings his experience as the retired President and CEO of a <br>mission based community development financial institution to our Board. He <br>has a strong understanding of information technology systems, including <br>cybersecurity, and the financial services and banking industry. He also has <br>knowledge of the corporate governance issues facing boards from his <br>experience serving on them. We believe that these experiences give Mr. <br>Farrow an important skill set that makes him well suited to serve on our Board <br>and as our Chairman.<br>|
| **Craig S. Donohue**<br>CEO and President<br> **Age: 64**<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Executive![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| *Background*<br>Mr. Donohue has served as our Chief Executive Officer ("CEO") and director <br>since May 2025 and as our President since August 2025. Prior to joining <br>Cboe, Mr. Donohue served as Chairman of the board of directors of the <br>Options Clearing Corporation ("OCC") from January 2024 to May 2025, as <br>Executive Chairman of OCC from January 2014 to January 2024, and as <br>Chief Executive Officer of OCC from September 2016 to January 2019. Prior <br>to joining OCC, Mr. Donohue spent more than two decades in global financial <br>markets, most recently as Chief Executive Officer of CME Group, Inc. from <br>January 2004 to May 2012. Mr. Donohue holds a Master of Management from <br>Northwestern University's Kellogg Graduate School of Management, a Master <br>of Law in Financial Services Regulation from IIT Chicago-Kent College of <br>Law, a J.D. from The John Marshall Law School and a bachelor's degree in <br>political science and history from Drake University.<br>*Qualifications*<br>Mr. Donohue's extensive experience in global financial markets provides him <br>with valuable insight into our business. His prior leadership roles as Chief <br>Executive Officer of CME Group, Inc. and as Chairman and Chief Executive <br>Officer of OCC provide him with significant experience in corporate <br>governance, regulatory engagement, strategic transformation and risk <br>management. We believe that these experiences, along with his role as our <br>CEO, make Mr. Donohue well suited to serve on our Board.<br>|

---

**Cboe Global Markets 2026 Proxy Statement**<sub>9</sub>

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **Edward J. Fitzpatrick**<br>Independent<br> **Age:** 59<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Finance and Strategy![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Risk![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| *Background*<br>Mr. Fitzpatrick has served on our Board since 2013. Mr. Fitzpatrick is currently <br>Senior Vice President and Senior Client Advisor of Genpact Limited, a <br>position he has held since August 2021, and prior to that was its Chief <br>Financial Officer from July 2014 to August 2021. Prior to joining Genpact <br>Limited, Mr. Fitzpatrick worked at Motorola Solutions, Inc. and its <br>predecessors from 1998 through 2014 in various financial positions, including <br>as its Chief Financial Officer from 2009 to 2013. Before joining Motorola, Mr. <br>Fitzpatrick was an auditor at PricewaterhouseCoopers, LLP from 1988 to <br>1998. Mr. Fitzpatrick holds a B.S. degree in Accounting from Pennsylvania <br>State University and an M.B.A. degree from The Wharton School at the <br>University of Pennsylvania and earned his CPA (inactive) certification in 1990.<br>*Qualifications*<br>Mr. Fitzpatrick brings his experience as the former Chief Financial Officer of <br>publicly traded companies to our Board. He has extensive experience with <br>finance, public company responsibilities and strategic transactions. We <br>believe that these experiences give Mr. Fitzpatrick an important skill set that <br>makes him well suited to serve on our Board. <br>|
| **Ivan K. Fong**<br>Independent<br> **Age:** 64<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Nominating and ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Governance<br>&nbsp;&nbsp;&nbsp;&nbsp;Risk![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| *Background*<br>Mr. Fong has served on our Board since December 2020. Mr. Fong is the <br>retired Executive Vice President, General Counsel and Secretary of Medtronic <br>plc, a position he held from February 2022 to July 2025. Mr. Fong also served <br>as Strategic Advisor of Medtronic plc from July 2025 to November 2025. Prior <br>to his roles at Medtronic, he served as Senior Vice President, Chief Legal and <br>Policy Officer and Secretary of 3M Company from 2019 to January 2022 and <br>as its Senior Vice President, Legal Affairs and General Counsel from 2012 to <br>2019. Prior to joining 3M Company, Mr. Fong was General Counsel of the <br>U.S. Department of Homeland Security from 2009 to 2012 and Chief Legal <br>Officer and Secretary of Cardinal Health, Inc. from 2005 to 2009. He has <br>previously served as Deputy Associate Attorney General with the U.S. <br>Department of Justice and was a partner with the law firm of Covington & <br>Burling LLP. Mr. Fong holds an S.B. degree in Chemical Engineering and an <br>S.M. degree in Chemical Engineering Practice from Massachusetts Institute <br>of Technology, a J.D. degree from Stanford University, and a Bachelor of Civil <br>Law from Oxford University.<br>*Qualifications*<br>Mr. Fong brings his experience as the former general counsel of public <br>companies, in private practice and as the former general counsel of a <br>government department. He has extensive experience in corporate <br>governance, government relations and the types of legal issues that public <br>companies face, which we believe makes him well suited to serve on our <br>Board. <br>|

---

---

| | |
|:---|:---|
| 10 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **Janet P. Froetscher**<br>Independent<br> **Age:** 66<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Compensation and Human ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Capital (Chair)<br>&nbsp;&nbsp;&nbsp;&nbsp;Executive![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Risk![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| *Background*<br>Ms. Froetscher is currently Senior Advisor, since September 2023, of The J.B. <br>and M.K. Pritzker Family Foundation, and was its Chair from September 2023 <br>until March 2026 and its President from April 2016 until September 2023. She <br>has served on the Board of Cboe Global Markets since our initial public <br>offering in 2010 and of Cboe Options from 2005 to 2017. Previously, she <br>served as President and Chief Executive Officer of Special Olympics <br>International from October 2013 until October 2015, President and CEO of the <br>National Safety Council from 2008 until October 2013, President and CEO of <br>the United Way of Metropolitan Chicago and in a variety of roles at the Aspen <br>Institute, most recently as Chief Operating Officer. From 1992 to 2000, Ms. <br>Froetscher was the executive director of the Finance Research and Advisory <br>Committee of the Commercial Club of Chicago. Ms. Froetscher currently <br>serves on the board of directors of SouthState Corporation, a publicly traded <br>company. She has also previously served on the board of directors of <br>Independent Bank Group, Inc., formerly a publicly traded company that was <br>acquired by SouthState Corporation, and the board of trustees of National <br>Louis University. Ms. Froetscher holds a B.A. degree from the University of <br>Virginia and a Masters of Management from Northwestern University's <br>Kellogg School of Management. Ms. Froetscher is also a Henry Crown Fellow <br>of the Aspen Institute. <br>*Qualifications*<br>Ms. Froetscher brings her experiences as the former President of a family <br>foundation and former Chief Executive Officer of public service entities to our <br>Board. In addition, her service on another public company board also gives <br>Ms. Froetscher experience with corporate governance and leadership skills. <br>We believe that these experiences give her leadership, operational and <br>community engagement skills that make her well suited to serve on our <br>Board.<br>|
| **Jill R. Goodman**<br>Independent<br> **Age:** 59<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Executive![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Finance and Strategy ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>(Chair)<br>&nbsp;&nbsp;&nbsp;&nbsp;Nominating and ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Governance<br>| *Background*<br>Ms. Goodman has served on our Board since 2012. Ms. Goodman is <br>currently Managing Director of Foros, a strategic financial and mergers and <br>acquisitions advisory firm, a position she has held since November 2013. <br>Previously, she served as a Managing Director and Head, Special Committee <br>and Fiduciary Practice—U.S. at Rothschild from 2010 to October 2013. From <br>1998 to 2010, Ms. Goodman was with Lazard in the Mergers & Acquisitions <br>and Strategic Advisory Group, most recently as Managing Director. Ms. <br>Goodman advises companies and special committees with regard to mergers <br>and acquisitions. Ms. Goodman currently serves on the boards of directors of <br>Cover Genius, a global insurance technology company, and publicly traded <br>company Genworth Financial, Inc. Ms. Goodman graduated *magna cum* <br>*laude* from Rice University with a B.A. degree. She received her J.D. degree, <br>with honors, from the University of Chicago Law School.<br>*Qualifications*<br>Ms. Goodman brings extensive experience in the boardroom to the Company. <br>Her experiences, both as an investment banker and her corporate and <br>securities legal background, bring a unique insight with which to consider our <br>opportunities. In addition, her service on another company board also gives <br>Ms. Goodman experience with corporate governance and leadership skills. <br>We believe that these experiences give her knowledge and skills that make <br>her well suited to serve on our Board.<br>|

---

**Cboe Global Markets 2026 Proxy Statement**<sub>11</sub>

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **Erin A. Mansfield**<br>Independent<br> **Age:** 66<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Compensation and Human ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Capital <br>&nbsp;&nbsp;&nbsp;&nbsp;Executive![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Risk (Chair)![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| *Background*<br>Ms. Mansfield has served on our Board since 2024. Ms. Mansfield is a retired <br>Managing Director from Barclays PLC, a position she held from 2003 to 2023, <br>where she served in multiple roles, including Global Head of Regulatory <br>Relations & Policy, Global Head of Investment Banking Compliance and Chief <br>Compliance Officer Americas. Prior to her time with Barclays, Ms. Mansfield <br>was a Vice President at Goldman Sachs & Co. LLC in their Fixed Income, <br>Currencies & Commodities group. Ms. Mansfield holds a B.A. degree from <br>Vassar College.<br>*Qualifications*<br>Ms. Mansfield has a strong understanding of our business, financial markets, <br>products, compliance and the regulation of the financial and derivatives <br>industries from her leadership positions at key financial institutions. We <br>believe that her experience makes her well suited to serve on our Board.<br>|
| **Cecilia H. Mao**<br>Independent<br>**Age:** 51<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Finance and Strategy ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Risk![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| *Background*<br>Ms. Mao has served on our Board since 2024. Ms. Mao is currently Global <br>Chief Product Officer at Equifax, having served in this position since 2020. <br>Previously, Ms. Mao was with Oracle Corp. from 2014 to 2020, holding <br>multiple positions including Director, Senior Director, and Vice President of <br>Oracle Data Cloud. Prior to her time at Oracle Corp., Ms. Mao held <br>management positions at Verisk Analytics, FICO, and other technology <br>companies. Ms. Mao graduated from the University of California, Berkeley <br>with a B.A. degree.<br>*Qualifications*<br>As an experienced leader, Ms. Mao's positions at Equifax and Oracle give her <br>unique insights into all aspects of corporate growth, enterprise management, <br>and technology. Ms. Mao has a deep understanding of revenue acceleration <br>and adapting to new strategic opportunities. We believe that her experience <br>makes her well suited to serve on our Board.<br>|

---

---

| | |
|:---|:---|
| 12 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **Jennifer J. McPeek**<br>Independent<br>**Age:** 56<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Audit![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| *Background*<br>Ms. McPeek has served on our Board since August 2020. Ms. McPeek is an <br>independent advisor to companies on value-based management and <br>incentive design. Previously, she has served as the Chief Financial Officer of <br>Russell Investments from 2018 to 2019. From 2009 to 2017, Ms. McPeek was <br>with Janus Henderson Investors plc and its predecessor company Janus <br>Capital Group Inc., serving as the Chief Financial Officer from 2013 to 2017, <br>and as the Chief Operating and Strategy Officer post-merger in 2017. Prior to <br>that, Ms. McPeek was with ING Investment Management, Americas from <br>2005 to 2009, where she was a member of the management committee and <br>led the strategy function. Ms. McPeek currently serves on the boards of <br>directors of First American Funds Trust, overseeing six money market funds, <br>and Cushman & Wakefield plc, a publicly traded company. She graduated <br>magna cum laude from Duke University with an A.B. degree in Mathematics <br>and Economics and received her M.S. degree in Financial Engineering from <br>the MIT Sloan School of Management. Ms. McPeek holds the Chartered <br>Financial Analyst designation. <br>*Qualifications*<br>As the former Chief Financial Officer of privately held and publicly traded <br>asset management companies, Ms. McPeek has extensive experience with <br>finance, public company responsibilities, strategic transactions and <br>knowledge of our industry. In addition, her service on another company board <br>also gives Ms. McPeek experience with corporate governance and leadership <br>skills. We believe that her experience makes her well suited to serve on our <br>Board.<br>|

---

---

| | |
|:---|:---|
| **Roderick A. Palmore** <br>Independent<br>**Age:** 74<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Executive![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Finance and Strategy![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Nominating and ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Governance (Chair)<br>| *Background*<br>Mr. Palmore is Senior Counsel at Dentons where he advises public and <br>private corporations and their leadership suites on risk management and <br>governance issues across practices and industry sectors. Mr. Palmore retired <br>from his position as Executive Vice President, General Counsel and Chief <br>Compliance and Risk Management Officer of General Mills, Inc. in February <br>2015 and has served on the Board of Cboe Global Markets since our initial <br>public offering in 2010 and of Cboe Options from 2000 to 2017. Prior to <br>joining General Mills in February 2008, he served as Executive Vice President <br>and General Counsel of Sara Lee Corporation. Before joining Sara Lee, Mr. <br>Palmore served in the U.S. Attorney's Office in Chicago and in private <br>practice. Mr. Palmore has previously served as a member of the boards of <br>directors of The Goodyear Tire & Rubber Company, a publicly traded <br>company, Express Scripts Holding Company, formerly a publicly traded <br>company, Nuveen Investments, Inc. and the United Way of Metropolitan <br>Chicago. Mr. Palmore holds a B.A. degree in Economics from Yale University <br>and a J.D. degree from the University of Chicago Law School.<br>*Qualifications*<br>Through his experience as general counsel of public companies, in private <br>practice and as an Assistant U.S. Attorney, Mr. Palmore has extensive <br>experience in corporate governance and the legal issues facing the Company. <br>In addition, his experience provides him with strong risk management skills. <br>We believe that his experience makes him well suited to serve on our Board.<br>|

---

**Cboe Global Markets 2026 Proxy Statement**<sub>13</sub>

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **James E. Parisi**<br>Independent<br>**Age:** 61<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Audit (Chair)![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Compensation and Human ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Capital<br>&nbsp;&nbsp;&nbsp;&nbsp;Executive![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| *Background*<br>Mr. Parisi has served on our Board since 2018. Mr. Parisi most recently <br>served as the Chief Financial Officer of CME Group Inc. from November 2004 <br>to August 2014, prior to which he held positions of increasing responsibility <br>and leadership within CME Group Inc. from 1988, including as Managing <br>Director & Treasurer and Director, Planning & Finance. He has previously <br>served as the Chairman of the Illinois Special Olympics Foundation Board <br>and as a member of the boards of directors of CFE, SEF and Pursuant Health <br>Inc., as well as ATI Physical Therapy, Inc. and Cotiviti Holdings, Inc., both <br>formerly publicly traded companies. Mr. Parisi holds a B.S. degree in Finance <br>from the University of Illinois and an M.B.A. degree from the University of <br>Chicago.<br>*Qualifications*<br>As the retired Chief Financial Officer of a publicly traded company offering a <br>diverse derivatives marketplace and as a former member of the boards of <br>directors of CFE and SEF, Mr. Parisi has extensive knowledge of our industry. <br>His service on other company boards also gives Mr. Parisi experience with <br>corporate governance and leadership skills. We believe that his experience <br>makes him well suited to serve on our Board.<br>|
| **Fredric J. Tomczyk**<br>Former CEO<br>**Age:** 70<br>**Committees:**<br>&nbsp;&nbsp;&nbsp;&nbsp;Finance and Strategy![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;Risk![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| *Background*<br>Mr. Tomczyk has served on our Board since 2019. He served as our CEO <br>from September 2023 to May 2025. Previously, he was President and Chief <br>Executive Officer of TD Ameritrade Holding Corporation, a position he held <br>from October 2008 to October 2016. Prior to this position, he held positions of <br>increasing responsibility and leadership with the TD organization from 1999. <br>Mr. Tomczyk was also a member of the TD Ameritrade board of directors from <br>2006 to 2007 and 2008 to 2016. Prior to joining the TD organization in 1999, <br>Mr. Tomczyk was President and Chief Executive Officer of London Life. He <br>currently serves on the board of Willis Towers Watson PLC, a publicly traded <br>company, and is a member of the Cornell University Athletic Alumni Advisory <br>Council. Mr. Tomczyk also previously served as the lead independent director <br>of Sagen MI Canada Inc., a publicly traded company, and of its operating <br>subsidiary Sagen Mortgage Insurance Company Canada, as a director of <br>Knight Capital Group, Inc. and as a trustee of Liberty Property Trust, both <br>formerly publicly traded companies, and as a director of the Securities <br>Industry and Financial Markets Association. Mr. Tomczyk holds a B.S. degree <br>in Applied Economics & Business Management from Cornell University and is <br>a Fellow of the Institute of Chartered Accountants of Ontario. <br>*Qualifications*<br>Mr. Tomczyk's extensive knowledge of the financial markets, technology and <br>the financial services and banking industries gives him unique insights into <br>our business. His prior service as our CEO and as TD Ameritrade's President <br>and Chief Executive Officer also gives Mr. Tomczyk experience with corporate <br>governance and leadership skills, working with the government and <br>regulators, successfully developing and executing corporate strategic <br>initiatives and overseeing risk management programs. We believe that these <br>experiences, make him well suited to serve on our Board.<br>|

---

The Board recommends that the stockholders vote **FOR** each of the director nominees.

---

| | |
|:---|:---|
| 14 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**BOARD STRUCTURE**

**Independence**

Our Bylaws require that, at all times, no less than two-thirds of our directors will be independent. The

Nominating and Governance Committee has affirmatively determined that all of our directors serving in 2025,

except Messrs. Donohue and Tomczyk, are independent under BZX listing standards for independence.

All of the directors then serving on each of the Audit, Compensation and Human Capital, and Nominating and

Governance Committees are independent. Each of these Committees (as defined below) reports to the Board

as they deem appropriate, and as the Board may request.

**Non-Executive Chairman**

The Board has an independent Non-Executive Chairman, Mr. Farrow. Our Corporate Governance Guidelines

require that an independent director serve as our Non-Executive Chairman or Lead Director, as applicable. The

position is annually elected by the Board, upon the recommendation of the Nominating and Governance

Committee, however, it is expected that the elected director will serve 4 years, which may be extended in

extraordinary circumstances. Under our Bylaws, the Chairman shall be the presiding officer at all meetings of

the Board and stockholders and shall exercise such other powers and perform such other duties as are

delegated to the Chairman by the Board. Additionally, the Charter of the Non-Executive Chairman/Lead Director,

Appendix A to our Corporate Governance Guidelines, provides for the following responsibilities, among other

items:

Chair all meetings of the non-employee and independent directors of the Board, including the executive

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

sessions;

Approve agendas for Board meetings and consult with the CEO on other matters pertinent to us and the

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Board;

Serve as a liaison between the CEO and the independent Directors;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Approve meeting schedules to assure that there is sufficient time for discussion of all agenda items;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Advise and consult with the CEO on the general scope and type of information to be provided in

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

advance of Board meetings;

In collaboration with the CEO, consult with the appropriate members of senior management about what

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

information pertaining to our finances, operations, strategic alternatives, and compliance is to be sent to

the Board; and

To perform other duties as the Board may determine.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

**Chairman and CEO Roles**

The Board carefully considers its Board leadership structure and the benefits of continuity in leadership roles

and believes having Mr. Farrow serve in the role of Non-Executive Chairman enhances the Company's strategic

alignment and supports Cboe Global Markets' ability to deliver stockholder value.

The Board periodically reviews the leadership structure and may make changes in the future based upon what

the Board believes to be in the best interests of the Company and stockholders at the time. At certain points in

our history, the Chairman and CEO roles have been held by the same person, and at other times the roles have

been held by different individuals. Under our Bylaws, the Chairman may, but need not be, our CEO, and the

Board believes it is important to retain its flexibility to allocate the responsibilities of the offices of the Chairman

and CEO in any way that is in the best interests of the Company and stockholders at a given point in time based

upon then-prevailing circumstances. The Board believes that the decision as to who should serve in those roles,

and whether the offices should be combined or separate, should be assessed periodically by the Board and that

the Board should not be constrained by a rigid policy mandate when making these determinations.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 15 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

In addition, our Board has implemented the following elements to help ensure independent oversight for us and

for our Board:

Requiring the Board to consist of at least two-thirds independent directors who meet regularly without

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

management and solely with non-employee and independent directors;

Establishing independent Audit, Compensation and Human Capital, and Nominating and Governance

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Committees; and

Appointing an independent Non-Executive Chairman or Lead Director, as applicable.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

**Board Oversight of Strategy**

With oversight and direction from the Board and the Finance and Strategy Committee, our CEO develops the

Company's business strategy in conjunction with management. This process is collaborative and evolving. The

Finance and Strategy Committee meets quarterly with management to approve or make recommendations, as

necessary, to the Board regarding the Company's budget, capital allocation, strategic plans, and acquisition,

investment or divestment opportunities. Further, summaries of the proceedings from prior Finance and Strategy

Committee meetings are provided to the Board on a quarterly basis.

In particular, in the second half of 2025, Mr. Donohue and management conducted a comprehensive strategic

review of the Company's global business operations, resulting in a strategic realignment of the Company's

business portfolio and an enhanced focus on core strengths and emerging growth opportunities. Following this

comprehensive strategic review, the Company initiated the wind-down of its Japanese equities business,

including the cessation of operations of its Cboe Japan proprietary trading system and Cboe BIDS Japan block

trading platform, initiated a sales process for its Cboe Australia and Cboe Canada businesses, discontinued its

U.S. and European Corporate Listings efforts, and reduced costs associated with its U.S. and European

exchange-traded products ("ETPs") Listings businesses, Cboe Europe Derivatives ("CEDX"), and several of the

Company's smaller Risk and Market Analytics businesses. Subsequent to December 31, 2025, after further

review of its global business operations, the Company initiated the wind-down of CEDX. For more information

on the Company's sharpened strategy, see "Executive Compensation—Compensation Discussion and Analysis

—Executive Summary—2025 Business Highlights".

**Board Oversight of Human Capital and Succession Planning**

The Board recognizes that our business depends on employee productivity, development, and engagement.

The Compensation and Human Capital Committee has been delegated the responsibility to oversee the policies

and strategies relating to talent, leadership, and culture, including inclusion. The Compensation and Human

Capital Committee receives presentations throughout the year on human resources matters, including

succession planning, inclusion initiatives, employee metrics, attrition and retention metrics, compensation and

benefits, and employee engagement survey results. Further, summaries of the proceedings from prior

Compensation and Human Capital Committee meetings are provided to the Board on a routine basis, including

on a quarterly basis.

The Board further believes that providing for effective continuity of leadership is central to our long-term growth

strategy. The succession planning process includes consideration of ordinary course succession and planning

for situations where executives unexpectedly become unable to perform their duties. Executive succession

planning is an ongoing process, reviewed and discussed on at least an annual basis by the Compensation and

Human Capital Committee. The Compensation and Human Capital Committee reviews the Company's

organizational chart for potential successors. Summaries of these proceedings from prior Compensation and

Human Capital Committee meetings are provided to the Board on a routine basis. The Board also reviews

reports about executive succession and undergoes other relevant evaluations on an as needed basis.

In addition, Board succession planning is evaluated regularly within the Nominating and Governance

Committee, whose reports and other necessary action items are discussed and acted upon by the Board as a

whole. For more information see "Committees of the Board—Nominating and Governance Committee" below.

Further, as a result of recent executive transitions, in particular the appointments of Mr. Donohue as Chief

Executive Officer and President, Scott Johnston as Executive Vice President, Chief Operating Officer, Robert A.

Hocking as Executive Vice President, Global Head of Derivatives, Prashant Bhatia as Executive Vice President,

Head of Enterprise Strategy and Corporate Development, and Timothy Lipscomb as Executive Vice President,

Chief Technology Officer, effective succession planning and the effective transfer of knowledge has been one of

the Company's top priorities, including expanding succession planning deeper into the organization.

---

| | |
|:---|:---|
| 16 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Board Oversight of Governance, Social, and Environmental Matters**

The Board stays apprised of particular governance, social, and environmental matters in accordance with its

general oversight responsibilities. The Board has delegated to the Committees oversight over specific areas

relevant to the Committees and all Committees report to the full Board on a routine basis, including on a

quarterly basis, and when a matter rises to a material or enterprise level. For more information about Committee

responsibilities, see also "Committees of the Board" below.

**Board Oversight of Risk** 

The Board is responsible for overseeing our risk management processes. The Board is responsible for

overseeing our general risk management strategy, the risk mitigation strategies employed by management,

including adequacy of resources, and the significant risks facing us, including, for example, competition,

reputation, compliance, operational, and technology risks. The Board stays informed of particular risk

management matters in accordance with its general oversight responsibilities. The Board has delegated to the

Committees oversight over the following specific areas and all Committees report to the full Board on a routine

basis, including on a quarterly basis, and when a matter rises to a material or enterprise level risk. For more

information about Committee responsibilities, see "Committees of the Board" below.

---

| | |
|:---|:---|
| **Committee** | **Primary Areas of Risk Oversight** |
| **Audit**  | Adequacy and effectiveness of internal controls and procedures![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Financial reporting and taxation![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| **Compensation and** <br>**Human Capital** <br>| Compensation policies and procedures![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| **Finance and Strategy** | Credit and capital structure![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Strategy with business partners![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| **Nominating and** <br>**Governance**<br>| Corporate governance practices![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| **Risk**  | Enterprise risk management![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Information security![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Operational risks relating to internal processes, people or systems, ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>including information technology<br>Compliance, environmental, legal and regulatory risks ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Artificial Intelligence ("AI") related risks ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|

---

In addition to our Board, our management is responsible for daily risk management. To help achieve this goal,

we have adopted an enterprise risk management framework that is supported by a three lines of defense

approach, which involve the Business, Risk Management and Information Security Department, Compliance

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 17 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

Department, Internal Audit Department, and the Board and Committees. We believe the following division of risk

management responsibilities is an effective approach for addressing the enterprise risks that we face.

---

| | |
|:---|:---|
| **Line of Defense** | **Description** |
| **First**  | Our Business managers and employees, who are responsible for ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>identification and assessment of risks in their day-to-day activities, design <br>and operation of policies, procedures, and controls, and remediation of <br>issues when they arise<br>|
| **Second**  | Compliance and Risk Management and Information Security Departments, ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>which provide oversight, expertise, and constructive challenge<br>Compliance Department governs policies, advises on regulatory ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>requirements, and performs monitoring and testing<br>Risk Management and Information Security Department oversees ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>enterprise risks and risk frameworks<br>|
| **Third**  | Internal Audit Department, which provides additional independent ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>assurance that significant risks are being managed effectively and that <br>controls are reasonably designed and operating effectively<br>|

---

**Board Oversight of Information Security**

The Board recognizes that our business depends on the confidentiality, integrity, availability, performance,

security, and reliability of our data and technology systems and devotes time and attention to the oversight of

cybersecurity and information security risk. In particular, the Board and Risk Committee each, as applicable,

receives updates and reports on information security from senior management, including from the Company's

Chief Compliance Officer, Chief Risk Officer, and Chief Information Security Officer. More specifically, the Risk

Committee receives presentations from senior management throughout the year on cybersecurity, including

architecture and resiliency, incident management, business continuity and disaster recovery, significant

information technology changes, data privacy, insider threat, physical security, information related to third-party

assessments conducted by leading information security providers of the Company's information security

program, and risks associated with the use of third party service providers. The Risk Committee also receives

periodic reports regarding the overall status of the Company's information security strategy and program,

including adequacy of staffing and resources, and reviews and approves any changes to the related information

security charter. Further, summaries of the proceedings from prior Risk Committee meetings are provided to the

Board on a routine basis, including on a quarterly basis.

In addition, our 2025 Annual Report to Stockholders included in this mailing, which includes a copy of our

Annual Report on Form 10-K for the year ended December 31, 2025, also contains relevant additional

information under "Part I–Item 1C. Cybersecurity".

**Board Oversight of AI**

The Board has delegated oversight of AI-related risks to the Risk Committee, which is informed of such risks on

a routine basis as applicable and which then informs the Board of such risks as applicable. Additionally, the

Committees are expected to oversee use of AI by the specific areas relevant to the Committees and all

Committees report to the full Board on a routine basis, including on a quarterly basis, and when a matter rises to

a material or enterprise level. As discussed in more detail below, in furtherance of director education, prior

Board meetings have also included presentations on AI.

Further, to assist with oversight of AI, including with respect to governance, strategy, adoption, and risks, the

Company established an AI Steering Committee, an AI Governance Subgroup, and an AI Center of Excellence.

The Company also maintains AI-specific policies and procedures and a risk assessment methodology to help

evaluate risks associated with AI applications.

**Board and Committee Meeting Attendance**

There were 11 meetings of the Board during 2025. Each director attended at least 75% of the aggregate

number of meetings of the Board and meetings of Committees of which the director was a member during 2025.

---

| | |
|:---|:---|
| 18 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Independent Directors Meetings**

Periodically, the independent directors meet separately without management. The Non-Executive Chairman or

Lead Director, as applicable, presides over these meetings. The independent directors met separately without

management 4 times during 2025.

**Annual Meeting Attendance**

We encourage members of the Board to attend our annual meeting of stockholders. All of our current directors,

who were then-serving on the Board, attended the 2025 Annual Meeting of Stockholders. Meetings of the Board

and its Committees are being held in conjunction with the Annual Meeting. We expect all director nominees will

attend the Annual Meeting.

**COMMITTEES OF THE BOARD**

**Overview**

Our Board has the following standing committees (each, a "Committee" and collectively, the "Committees"):

The Audit Committee,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The Compensation and Human Capital Committee,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The Executive Committee,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The Finance and Strategy Committee,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The Nominating and Governance Committee, and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The Risk Committee.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Other than the members of the Executive Committee required to be on such Committee pursuant to our Bylaws,

each of the members of the Committees was recommended by the Nominating and Governance Committee for

approval by the Board for service on that Committee. Each of the Committees has a charter and the Audit

Committee, Compensation and Human Capital Committee, and Nominating and Governance Committee

charters are available on the Governance Documents page of our Investor Relations section of our website at:

http://ir.Cboe.com. The ATS Oversight Committee was dissolved on December 16, 2025.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 19 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

The following table is a listing of the composition of our standing Committees during 2025 and as of March 19,

2026, including the number of meetings of each Committee during 2025.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Director** | **Audit** | &nbsp;&nbsp;&nbsp;&nbsp;**Compensation** <br>**and Human Capital** <br>| **Executive** | **Finance and** <br>**Strategy**<br>| **Nominating and** <br>**Governance**<br>| **Risk** |
| **Number of meetings** | **14** | **16** | **1** | **6** | **9** | **11** |
| William M. Farrow, III (1) | (2)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>| (3)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>| ![cboe-20240516xdef14a_a127.jpg](cboe-20260401_g20.jpg) | (4)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>| (3)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>|  |
| Craig S. Donohue (5) |  |  | (6)![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg)<br>|  |  |  |
| Edward J. Fitzpatrick |  | (4)(7)![cboe-20240516xdef14a_a127.jpg](cboe-20260401_g20.jpg)<br>| (4)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>| (3)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>|  | ![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg) |
| Ivan K. Fong |  |  |  |  | ![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg) | ![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg) |
| Janet P. Froetscher |  | (7)![cboe-20240516xdef14a_a127.jpg](cboe-20260401_g20.jpg)<br>| ![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg) |  |  | (8)![cboe-20240516xdef14a_a127.jpg](cboe-20260401_g20.jpg)<br>|
| Jill R. Goodman |  |  | ![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg) | ![cboe-20240516xdef14a_a164.jpg](cboe-20260401_g22.jpg) | ![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg) |  |
| Erin A. Mansfield |  | (3)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>| (3)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>|  |  | (8)![cboe-20240516xdef14a_a127.jpg](cboe-20260401_g20.jpg)<br>|
| Cecilia H. Mao |  |  |  | ![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg) |  | ![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg) |
| Alexander J. Matturri, Jr. | ![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg) | (3)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>| (9) ![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>|  |  |  |
| Jennifer J. McPeek | ![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg) |  |  |  |  |  |
| Roderick A. Palmore |  |  | ![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg) | ![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg) | ![cboe-20240516xdef14a_a127.jpg](cboe-20260401_g20.jpg) |  |
| James E. Parisi | ![cboe-20240516xdef14a_a164.jpg](cboe-20260401_g22.jpg) | ![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg) | ![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg) |  |  |  |
| Fredric J. Tomczyk |  |  | (4)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>| (3)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>|  | (3)![cboe-20240516xdef14a_a126.jpg](cboe-20260401_g19.jpg)<br>|

---

________________________________________________

= Chair = Member

![cboe-20240516xdef14a_a164.jpg](cboe-20260401_g22.jpg)

![cboe-20240516xdef14a_a165.jpg](cboe-20260401_g21.jpg)

(1)The Non-Executive Chairman, Mr. Farrow, and the Chief Executive Officer, Mr. Donohue, are both members

of the Executive Committee. Mr. Farrow is an invited guest to the meetings of each of the other standing

Committees that he is not already a member of.

(2)Joined as a member of the Committee on February 13, 2026.

(3)Joined as a member of the Committee on May 6, 2025.

(4)Stepped down as a member of the Committee on May 6, 2025.

(5)Mr. Donohue is an invited guest to the meetings of each of the other standing Committees, other than the

ATS Oversight Committee (for the portion of 2025 during which that Committee existed).

(6)Joined as a member of the Committee on May 7, 2025.

(7)Effective May 6, 2025, Ms. Froetscher became Chair and Mr. Fitzpatrick stepped down as Chair of the

Compensation and Human Capital Committee.

(8)Effective May 6, 2025, Ms. Mansfield became Chair and Ms. Froetscher stepped down as Chair of the Risk

Committee.

(9)Stepped down as a member of the Committee on December 16, 2025.

**Audit Committee**

The Audit Committee consists of 4 directors, all of whom are independent under BZX listing rules, as well as

under Rule 10A-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Audit

Committee consists exclusively of directors who are financially literate. In addition, Mr. Parisi has been

designated as our audit committee financial expert and meets the SEC definition of that position.

The Audit Committee's responsibilities include:

Engaging our independent auditor and overseeing its compensation, work, and performance,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

---

| | |
|:---|:---|
| 20 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

Reviewing and discussing the annual and quarterly financial statements and related press releases with

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

management and the independent auditor,

Overseeing the internal audit function and reviewing the adequacy of internal controls and procedures,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

and

Reviewing transactions with related persons for potential conflict of interest situations.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The Audit Committee also meets, as needed, with our independent auditor, Chief Executive Officer, Chief

Financial Officer, Chief Audit Executive, and other management in executive session without management

present and our independent auditor, Chief Audit Executive, and other management may communicate directly,

as needed, with members of the Audit Committee and the Board at large.

**Compensation and Human Capital Committee**

The Compensation and Human Capital Committee consists of 5 directors, all of whom are independent under

BZX listing rules. The Compensation and Human Capital Committee has primary responsibility to approve or

make recommendations to the Board for:

All elements and amounts of compensation for the executive officers, including any performance goals,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Reviewing succession plans relating to the CEO and our other executive officers,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Adopting, amending, and terminating cash and equity-based incentive compensation plans,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Approving any employment agreements, severance agreements, or change in control agreements with

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

executive officers,

Adopting, periodically reviewing, and overseeing any clawback policy governing the recoupment of

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

incentive-based compensation,

Overseeing the policies and strategies relating to talent, leadership, and culture, including inclusion, and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The level and form of non-employee director compensation and benefits.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

For additional information, see "Corporate Governance—Board Structure—Board Oversight of Human Capital

and Succession Planning".

**Nominating and Governance Committee** 

***Overview***

The Nominating and Governance Committee consists of 4 directors, all of whom are independent under BZX

listing rules. The Nominating and Governance Committee's responsibilities include making recommendations to

the Board on:

Persons for election as director,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

An independent director to serve as Non-Executive Chairman of the Board (or, if applicable, a director

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

to serve as Chairman of the Board and an independent director to serve as Lead Director),

Any stockholder proposals and nominations for director,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The appropriate structure, operations, and composition of the Board and its Committees,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The Board and Committee annual self-evaluation process, and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The contents of the Corporate Governance Guidelines, Code of Business Conduct and Ethics, and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

other corporate governance policies and programs.

The Nominating and Governance Committee shall receive, direct and supervise any investigations into any

matter brought to its attention within the scope of its duties, in the Company's Corporate Governance Guidelines

or as directed by the Board. In addition, the Committee shall review and may investigate matters pertaining to

the integrity of management, including conflicts of interest and adherence to codes of ethics or business

conduct.

The Nominating and Governance Committee also receives periodic reports from the Company regarding its

political activities and related expenditures and is also responsible for general oversight of the Cboe impact

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 21 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

reports and program. For additional information, see "Corporate Governance—Board Structure—Board

Oversight of Governance, Social, and Environmental Matters".

***Selection Process and Criteria for Directors***

The Nominating and Governance Committee is responsible for considering and recommending to the Board

nominees for election as director, including considering each incumbent director's continued service on the

Board. The Committee annually reviews the skills and characteristics required of all directors in the context of

the current composition of the Board, our operating requirements, targeted skills and experiences, and the long-

term interests of our stockholders. In addition, the Committee may consider such other factors it deems

appropriate when conducting its assessment of director candidates.

We believe that each of the individuals serving on our Board has the necessary qualifications to be a member of

the Board and that each director brings skills and experiences that collectively allow the Board to address the

challenges and opportunities we face. In evaluating incumbent and new prospective director candidates, the

Committee takes into consideration many factors, including the individual's educational and professional

background, potential retirement plans, whether the individual has any special experience in a relevant area,

personal accomplishments, and cultural experiences. Among other attributes, our selection process prioritizes

individuals with integrity, substantial business experience, a track record of sound professional judgment, and a

commitment to the long-term growth of the company. As one of the world's largest derivatives exchanges, our

selection process seeks to create a Board with a deep understanding of the derivatives industry and the

knowledge and experience to execute on our strategic derivatives goals. Moreover, as needed, we look for a

mix of financial and accounting expertise and technological expertise in our Board that will help us to oversee

the Company and to identify and adapt to opportunities in the global financial industry. In addition, the

Committee may consider such other factors it deems appropriate when conducting its assessment of director

candidates. For more information on each Directors' background and individual skills, see "Corporate

Governance—Proposal 1—Election of Directors".

Additionally, while we do not currently have a formal diversity policy, our Corporate Governance Guidelines

provide that the Nominating and Governance Committee will seek to recommend to the Board candidates for

director with a diverse range of experiences, qualifications, and skills to provide varied insights and competent

guidance regarding our operations, with a goal of having a Board that reflects diverse backgrounds, gender,

race, experience, and viewpoints. We believe that we benefit from having directors with a diversity of skills,

characteristics, backgrounds, and cultural experiences.

***Identifying and Evaluating New Directors***

The Nominating and Governance Committee utilizes a variety of methods to identify, recruit, and evaluate

potential new director candidates. The Committee considers various potential candidates for director,

considering the criteria discussed above and qualifications of the individual candidate. Board nominees can be

identified by current directors, management, third-party professional search firms, stockholders, or other

persons. Prior to a prospective new director's nomination, the director candidate is asked to meet separately

with the Chairman of the Board, the Chair of the Nominating and Governance Committee, and the independent

Non-Executive Chairman or Lead Director, as applicable, who will each consider the prospective director's

candidacy. New director candidates may also meet separately with other members of the Board. In addition, a

background check is completed before a final recommendation is made to the Board. After a review and

evaluation of a prospective new director based on the criteria discussed above, the Nominating and

Governance Committee will decide whether to recommend to the Board the candidate's appointment as a

director or nominee for election as a director, and the Board will decide whether to approve the candidate's

appointment as a director or a nominee.

***Onboarding New Directors***

New directors participate in a robust multi-session orientation program to familiarize themselves with the

company and management. Our orientation program for new directors includes a discussion of a broad range of

topics, including the background of the company, the Board and its governance model, subsidiary governance,

regulatory oversight, strategy and business operations, financial statements and capital structure, the

management team, key industry and competitive factors, the legal and ethical responsibilities of the Board, and

other matters crucial to the ability of a new director to fulfill his or her responsibilities.

---

| | |
|:---|:---|
| 22 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***Continuing Education for Directors***

Directors are encouraged to attend conferences, seminars, trainings and/or courses and take other actions as

they deem necessary to enhance their effectiveness as directors. Appropriate areas of director education need

not be confined to corporate governance but may include broader topics related to our businesses. In

furtherance of director education, Board meetings and dinners may include guest speakers, client

presentations, and our employees presenting on a variety of topics, including on emerging technologies, such

as AI, and Cboe's potential utilization and adoption thereof. Cboe will reimburse directors, up to a certain

amount, for the reasonable costs of attending relevant education programs.

***Retirement***

Our Corporate Governance Guidelines provide that the Board expects that no director shall be elected or

reelected as a director once he or she reaches age 75. Any director who turns 75 while serving as a director

may continue to serve for the remainder of their current term. The Board undertakes ongoing evaluation of its

members' performance with respect to their capacity to serve and keeps note of director age for director

planning purposes.

***Annual Board, Committee, and Director Self-Evaluations***

The Board believes that a robust annual evaluation process is a critical part of its governance practices. The

Nominating and Governance Committee is responsible for establishing and overseeing the Board's,

Committees', and directors' annual self-evaluations to determine whether the Board, the Committees, and the

directors are functioning effectively and to identify potential areas of improvement. The annual self-evaluation

process includes the following:

---

| | | |
|:---|:---|:---|
| **Stage in Process** | **Board of Directors** | **Committees** |
| **Determine** <br>**Discussion Topics**<br>**↓**<br>| Nominating and Governance ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Committee determines specific <br>topics and subject areas to <br>discuss with each director, such <br>as roles, responsibilities, <br>structure, skills, experience, <br>background, composition, and <br>effectiveness<br>| Nominating and Governance ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Committee determines and <br>distributes to each Committee a <br>list of specific topics and subject <br>areas to facilitate discussion <br>about each Committee's roles <br>and responsibilities, structure, <br>charter, policies, composition, <br>and effectiveness<br>|
| **Discussions**<br>**↓**<br>| Chair of Nominating and ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Governance Committee and <br>Non-Executive Chairman or Lead <br>Director, as applicable, interview <br>each director in one-on-ones to <br>discuss Board's and directors' <br>performances<br>| Chair of each Committee ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>facilitates discussion of <br>Committee's performance in <br>executive session and in one-on-<br>ones<br>|
| **Feedback**<br>**↓**<br>| Chair of Nominating and ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Governance Committee and <br>Non-Executive Chairman or Lead <br>Director, as applicable, report <br>results of discussions and <br>recommendations to Nominating <br>and Governance Committee for <br>its consideration<br>| Chair of each Committee reports ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>results of Committee self-<br>evaluation and recommendations <br>to Nominating and Governance <br>Committee for its consideration<br>|
| **Reviews**<br>**↓**<br>| Nominating and Governance Committee reviews results from Board, ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Committee, and director self-evaluations and provides summary of <br>assessments and recommendations to full Board and each director, as <br>applicable<br>Board discusses results and, if necessary, provides additional ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>recommendations | Nominating and Governance Committee reviews results from Board, ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>Committee, and director self-evaluations and provides summary of <br>assessments and recommendations to full Board and each director, as <br>applicable<br>Board discusses results and, if necessary, provides additional ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>recommendations |
| **Feedback** <br>**Incorporated**<br>| Changes and enhancements, if any, are implemented to governance policies ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>and practices | Changes and enhancements, if any, are implemented to governance policies ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>and practices |

---

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 23 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

In addition to the annual evaluation process, the Board and Committees meet in regular executive sessions,

which provides the directors with opportunities to reflect and provide feedback on an ongoing basis to determine

whether the Board and the Committees are functioning effectively and to identify potential areas of

improvement.

***Stockholder Nominations***

The Nominating and Governance Committee will consider stockholder recommendations for candidates for our

Board and will consider those candidates using the same criteria applied to candidates suggested by

management. Stockholders may recommend candidates for our Board by contacting the Corporate Secretary of

Cboe Global Markets, Inc. at 433 West Van Buren Street, Chicago, Illinois 60607.

In addition, stockholders may formally nominate candidates for our Board to be considered at an annual

meeting of stockholders through the process described below under the heading "Other Items—Stockholder

Proposals".

**ATS Oversight Committee**

The ATS Oversight Committee, which met 5 times in 2025 and was dissolved on December 16, 2025, was

responsible for, among other things, overseeing the business and operations of BIDS Trading's U.S. equities

businesses, overseeing the adequacy and effectiveness of the information and other barriers established to

maintain the separation of BIDS Trading's U.S. equities businesses from Cboe Global Markets' registered

national exchange businesses, and helping to ensure that specified functions of those BIDS Trading's U.S.

equities businesses were independent of and not integrated with or otherwise linked to Cboe Global Markets'

registered national exchange businesses. The Committee was composed of Alexander Matturri (Chair), Erin

Mansfield, and Jennifer McPeek. It was determined in late 2025 that BIDS Trading could operate under the

Company's ownership without a requirement for oversight by such Committee.

**Executive Committee**

The Executive Committee has the authority to exercise the powers and authority of the Board when the

convening of the Board is not practicable, except as limited by its charter, the Company's Bylaws and applicable

law.

**Finance and Strategy Committee**

The Finance and Strategy Committee's responsibilities include approving or making recommendations to the

Board regarding the budget, capital allocation, strategic plans, and acquisition, investment, or divestment

opportunities.

**Risk Committee**

The Risk Committee is generally responsible for, among other things, overseeing the risk assessment and risk

management of the Company, including risk related to cybersecurity, clearing, information technology, AI,

environment, and the Company's compliance with laws, regulations, and its policies.

**Compensation and Human Capital Committee Interlocks and Insider Participation**

Messrs. Farrow, Fitzpatrick, Matturri, and Parisi and Mses. Froetscher and Mansfield served as members of our

Compensation and Human Capital Committee during 2025. No member of the Compensation and Human

Capital Committee is a current or former officer or employee of the Company. In addition, there are no

compensation committee interlocks with other entities with respect to any member of the Compensation and

Human Capital Committee.

**STOCKHOLDER ENGAGEMENT**

Cboe Global Markets and its Board are committed to fostering long-term and institution-wide relationships with

stockholders and maintaining their trust and goodwill. As a result, each year we interact with stockholders

through a variety of engagement activities. These engagements routinely cover strategy and performance,

corporate governance, executive compensation, and other current and emerging issues to help ensure that our

Board and management understand and address the issues that are important to our stockholders.

Our key stockholder engagement activities in 2025 included attending investor and industry conferences,

participating in informational fireside chats, and hosting meetings at our corporate headquarters. Some of these

---

| | |
|:---|:---|
| 24 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

conferences also featured webcasts and replays of the presentations so that our stockholders could listen

remotely. In addition, our quarterly earnings calls are open to the general public and feature a live webcast.

Further, in 2025, we also conducted an outreach specifically focused on corporate governance, executive

compensation, and proxy season trends and issues, targeting our top stockholders that represented

approximately 40% of our common stock outstanding. Through corporate governance outreach and investor

and industry conferences, we engaged in meetings with holders of approximately 47% of our common stock

outstanding. Through these discussions we gained valuable feedback, and this feedback was shared with the

Board and its relevant Committees.

For the 2025 Annual Meeting of Stockholders, we received a stockholder proposal regarding the disclosure of

political contributions. In response to the proposal we published an annual report on political contributions prior

to the proxy distribution date, including our policy for making contributions with corporate funds to participate in

political campaigns or influence public opinion, confirmation that no corporate funds are used for federal political

activities or contributed to 501(c)(4) organizations, acknowledgment of potential corporate contributions to state

and local candidates or political entities (without disclosing specific amounts or recipients), disclosure of

payments to trade associations receiving over $50,000 annually that may engage in U.S. federal lobbying on

the Company's behalf, the title of the individual responsible for decision-making regarding political contributions,

and presentation of the report to the Board and relevant Committees. Notwithstanding these actions, the

stockholder proposal received the support of approximately 56.1% of our stockholders at the 2025 Annual

Meeting of Stockholders. Based on this support, we expanded the disclosures in our annual report on political

contributions by including, in addition to the items described previously, all contributions to state and local

candidates and political entities (including specific amounts and recipients), contributions to certain entities

directly affiliated with political parties, such as the Democratic and Republican National Conventions,

contributions to 501(c)(6) industry associations exceeding $25,000, regardless of lobbying activity, confirmation

that the Company does not make non-monetary contributions, such as the use of facilities for political purposes,

and confirmation that the Company does not earmark or direct the use of contributions to industry associations.

We also reached out to our top stockholders that represented approximately 47% of our common stock

outstanding for any additional feedback related to such enhancements.

**COMMUNICATIONS WITH DIRECTORS**

As provided in our Corporate Governance Guidelines, stockholders and other interested parties may

communicate directly with our independent directors or the entire Board. Our policy and procedures regarding

these communications are located in the Investor Relations section of our website at http://ir.Cboe.com.

**INSIDER TRADING POLICY**

Our Insider Trading Policy prohibits directors, officers and employees worldwide from trading in Company

securities while in possession of material, non-public information about the Company. The Insider Trading Policy

is designed to promote compliance with insider trading laws, rules and regulations, as well as the rules and

regulations of BZX. The policy also applies to transactions in the securities of other entities to the extent

covered persons are in possession of any material, non-public information relating to those securities. Under the

policy, certain individuals are prohibited from trading in Company securities during various times throughout the

year known as "blackout periods", and certain individuals must receive preclearance from the General Counsel

before trading in Company securities.

Our Insider Trading Policy prohibits our executive officers and all employees, except as set forth below, from

entering into transactions involving options to purchase or sell our common stock or other derivatives related to

our common stock.

Employees, other than our executive officers, may enter covered calls and collars for hedging purposes through

the purchase or sale of exchange-traded options, provided that they otherwise comply with the remainder of our

Insider Trading Policy. See "Executive Compensation—Compensation Discussion and Analysis—Other

Executive Compensation Program Considerations—Hedging Policy".

Under the Insider Trading Policy, employees are prohibited from entering into pledges or margin loans of

Company securities.

Our policy on insider trading was filed as Exhibit 19.1 to our Annual Report on Form 10-K for the fiscal year

ended December 31, 2025.

Additionally, in 2011, the Board of Directors approved an initial authorization for the Company to repurchase

shares of its outstanding common stock of $100 million and subsequently approved additional authorizations for

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 25 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

a total authorization of $2.3 billion, as of December 31, 2025. The Company expects to fund repurchases

primarily through the use of existing cash balances. The program permits the Company to purchase shares,

through a variety of methods, including in the open market or through privately negotiated transactions, in

accordance with applicable securities laws. It does not obligate the Company to make any repurchases at any

specific time or situation.

---

| | |
|:---|:---|
| 26 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**<u>NON-EMPLOYEE DIRECTOR COMPENSATION</u>**

**Compensation Philosophy and Summary**

Our non-employee director compensation program provides director fees that are generally designed to be paid

at competitive levels that are near the median of director fees of our compensation peer group, which is

discussed in further detail below in the "Executive Compensation—Compensation Discussion and Analysis"

section. This allows us to attract and retain individuals with the skills, qualifications, and experiences required to

sit on our Board.

Annually, the Compensation and Human Capital Committee reviews a competitive market data analysis for non-

employee director compensation produced by Meridian Compensation Partners, LLC ("Meridian"), our

independent compensation consultant, and recommends changes to our director compensation program, if any,

to the Board for approval.

For 2025, our non-employee director compensation program remained unchanged from 2024 and consisted of

a mix of: cash and stock retainers, committee member cash retainers, committee chair cash retainers,

committee meeting attendance fees, if applicable, and a non-executive Chairman retainer. Committee chairs

receive both the applicable committee chair, committee member cash retainers, and committee meeting

attendance fees, if applicable.

**2025 Elements of Director Compensation Program**

The compensation of our non-employee directors is based upon a compensation year beginning and ending in

May coinciding with the holding of our Annual Meeting of Stockholders. The following table reflects the base

amount payable (i.e., not prorated) with respect to each component of our director compensation program for

the Board term ending with the 2025 Annual Meeting of Stockholders and for the Board term ending with the

Annual Meeting in 2026:

---

| | |
|:---|:---|
| **Annual Fees** | **May 2025 —**<br>**May 2026**<br>|
| Cash retainer | $90000 |
| Stock retainer, value based on closing price on date of grant | $170000 |
| Committee chair cash retainer |  |
| ATS Oversight (1) | $20000 |
| Audit | $25000 |
| Compensation and Human Capital  | $15000 |
| Finance and Strategy | $15000 |
| Nominating and Governance | $15000 |
| Risk | $20000 |
| Committee member cash retainer (2) |  |
| ATS Oversight (1) | $7500 |
| Audit | $16500 |
| Compensation | $12000 |
| Finance and Strategy | $12000 |
| Nominating and Governance | $12000 |
| Risk | $12000 |
| Non-Executive Chairman cash retainer fee | $150000 |
| **Meeting Fees** |  |
| Committee meeting attendance fee per meeting attended (only if in excess <br>of each committee's baseline meeting number plus two) (2)(3)<br>| $1500 |

---

_____________________________________

(1)The ATS Oversight Committee was dissolved on December 16, 2025.

(2)In lieu of a cash retainer, non-employee directors serving on the Executive Committee are paid an

attendance fee of $1,500 for each meeting of the Executive Committee attended.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 27 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

(3)The baseline meeting number plus two for each committee is ATS Oversight (7), Audit (13), Compensation

(10), Finance and Strategy (10), Nominating and Governance (10), and Risk (7).

**2025 Director Compensation**

The compensation of our non-employee directors (other than Mr. Tomczyk, whose compensation is included

under the heading "Executive Compensation") for their service for the year ended December 31, 2025 is shown

in the following table.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name** | **Fees Earned or**<br>**Paid in Cash (1)**<br>| **Stock**<br>**Awards (2)**<br>| **All other** <br>**Compensation (3)**<br>| **Total** |
| William M. Farrow, III (4)(5)(6)(7) | $283126 | $170090 | $10000 | $463216 |
| Edward J. Fitzpatrick (6)(7) | $126313 | $170090 | $10000 | $306403 |
| Ivan K. Fong (7) | $118500 | $170090 | $15000 | $303590 |
| Janet P. Froetscher (6)(7) | $138266 | $170090 | $15000 | $323356 |
| Jill R. Goodman (6)(7) | $130500 | $170090 | $— | $300590 |
| Erin A. Mansfield (7) | $133335 | $170090 | $10000 | $313425 |
| Cecilia H. Mao (6)(7) | $118500 | $170090 | $10000 | $298590 |
| Alexander J. Matturri, Jr. (5)(7) | $163313 | $170090 | $— | $333403 |
| Jennifer J. McPeek  | $114000 | $170090 | $— | $284090 |
| Roderick A. Palmore (5)(7)  | $150500 | $170090 | $5000 | $325590 |
| James E. Parisi (5)(6)(7) | $165000 | $170090 | $20000 | $355090 |

---

____________________________________

(1)The amounts shown in the Fees Earned or Paid in Cash column include the Board cash retainer and the

Committee chair and member cash retainers and may also include certain fees that were earned in 2025

and were paid in early 2026.

(2)The amounts in the stock award column represent the grant date fair value of equity grants of RSUs

received by non-employee directors serving on the Board on May 6, 2025, as computed in accordance with

stock-based compensation accounting rules (Financial Standards Accounting Board ASC Topic 718).

Assumptions used in the calculation of these amounts are included in the footnotes to our 2025

consolidated financial statements, which are included in our Annual Report on Form 10-K for the year

ended December 31, 2025 filed with the SEC. The non-employee directors then-serving on the Board

received an equity grant of RSUs on May 6, 2025. The equity grants vest on the earlier of the one-year

anniversary of the grant date or the completion of their final year of director service, subject to the director's

continuous service through the vesting date. Each of the listed directors held 729 shares of unvested RSUs

as of December 31, 2025.

(3)Amounts shown in the All Other Compensation column represent payments made by the Company (i)

through our Matching Gift Program and (ii) by matching Cboe Political Action Committee ("PAC")

contributions, both of which are available to non-employee directors, subject to program limits. The amounts

for Mr. Fong also include matching gifts with respect to 2024 that were paid out in 2025.

(4)The amount shown in the Fees Earned or Paid in Cash column for Mr. Farrow also includes the non-

executive Chairman cash retainer fee.

(5)The amount shown in the Fees Earned or Paid in Cash column also include cash fees of $20,000 for

Messrs. Farrow, Matturri, Palmore and Parisi for their roles in connection with the CEO search.

(6)Mr. Fitzpatrick and Ms. Froetscher each elected to defer 100% of their 2025 cash fees (excluding any fees

paid from service to a subsidiary board of directors or committee), and Messrs. Farrow and Parisi and

Mses. Goodman and Mao each elected to defer 100% of their 2025 equity grant.

(7)The amounts shown in the Fees Earned or Paid in Cash column also include committee meeting

attendance fees of $1,500 for Messrs. Farrow, Matturri, Palmore, and Parisi and Mses. Froetscher,

Goodman, and Mansfield for attending an Executive Committee meeting and $4,500 for Mr. Fong and Ms.

Mao, $3,000 for Mr. Fitzpatrick and Ms. Froetscher, and $1,500 for Ms. Mansfield for attending Risk

Committee meetings in excess of the baseline meeting number plus two.

---

| | |
|:---|:---|
| 28 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Deferred Compensation**

U.S. based non-employee directors may elect to defer receipt of all or a portion of his or her annual cash

retainer and any meeting fees pursuant to a valid deferral election under the Cboe Global Markets, Inc.

Deferred Compensation Plan (the "Cash Deferral Plan"). To the extent that any such cash payments are

deferred, they are credited to a notional account and will be invested in either a retirement target date fund or

other investment option selected by the director under the terms of the Cash Deferral Plan.

Non-employee directors may elect to defer all of their annual RSU grants into a stock account pursuant to a

valid deferral election under the Cboe Global Markets, Inc. Director Equity Deferral Plan (the "Equity Deferral

Plan"). Subject to and following satisfaction of the applicable vesting requirements, the plan credits notional

stock units for the RSU until distribution in the form of shares of common stock upon the distribution date.

Deferred RSUs will remain eligible for dividend equivalents, with U.S. based directors receiving dividend

equivalents on a current basis and non-U.S. based directors having their dividend equivalents deferred (but not

reinvested) until the underlying shares are distributed.

Neither plan permits matching contributions and deferred cash amounts are fully vested and deferred equity

grants are subject to applicable vesting requirements. In general, amounts deferred are paid to a non-employee

director dependent on the elections of the director, which could be: (i) the date elected by such director; (ii) the

director's separation from service; or (iii) the date a change of control (as defined in the Cash Deferral Plan and

the Equity Deferral Plan) occurs. In the event the director's death or qualifying disability, the elections of the

director are overridden. Amounts deferred under the Cash Deferral Plan are paid in cash in a single sum

payment or, at the director's election, in installments (other than on a change in control). Amounts deferred

under the Equity Deferral Plan are paid in shares of common stock in a single lump sum.

**Director Stock Ownership and Holding Guidelines**

The Compensation and Human Capital Committee has adopted stock ownership and holding guidelines, which

provide that each non-employee director should own stock equal to 5 times the cash annual retainer for

directors. For purposes of this ownership and holding requirement, (a) shares owned outright or in trust and (b)

vested, deferred RSUs, are included. In addition, each non-employee director is required to hold all shares

received from annual equity awards until the guidelines are met, except for sales of shares to pay taxes with

respect to the vesting or exercising of equity grants. Other than Mses. Mansfield and Mao who were first elected

to our Board in 2024, each of the non-employee incumbent directors as of December 31, 2025 has met the

ownership requirement as of December 31, 2025.

**Director Hedging and Pledging Policies**

Under our Insider Trading Policy, our directors are prohibited from entering into transactions involving options to

purchase or sell our common stock or other derivatives related to our common stock. Our Insider Trading Policy

also prohibits directors from entering into any pledges or margin loans on shares of our common stock. In 2025,

none of the directors had hedges, pledges, or margin loans on shares of our common stock. See also

"Corporate Governance—Insider Trading Policy".

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 29 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**<u>EXECUTIVE COMPENSATION</u>**

**PROPOSAL 2—ADVISORY VOTE TO APPROVE** 

**EXECUTIVE COMPENSATION**

In accordance with Section 14A of the Exchange Act, the Board is providing our stockholders with an advisory

vote to approve executive compensation. This advisory vote, commonly known as a "say-on-pay" vote, is a non-

binding vote to approve the compensation paid to our named executive officers as disclosed in this Proxy

Statement in accordance with SEC rules. The Board has adopted a policy of providing for annual "say-on-pay"

votes in accordance with the results of our last stockholder advisory vote.

As discussed in the "Compensation Discussion and Analysis" section, our executive compensation program is

designed to meet the following objectives:

Attract and retain talented and dedicated executives,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Motivate our executives to achieve corporate goals that create value for our stockholders, and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Align the compensation of our executive officers with stockholder returns.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

The Compensation and Human Capital Committee has implemented the following best practices applicable to

our executive officers to help achieve these objectives:

A high proportion of total compensation is in the form of performance-based compensation with limits on

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

all incentive award payouts,

Incentive awards are linked to the achievement of financial and relative stock price performance goals,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Stock ownership and holding guidelines,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Double trigger change in control provisions in equity awards and for severance benefits under an

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

employment agreement and the Executive Severance Plan,

Prohibition on hedging of Company stock,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Prohibition on pledging of Company stock,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

No tax gross-up payments in the event of a change in control, and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Mandatory and supplemental clawback policies applicable to cash incentives and equity awards.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

We believe that the compensation paid to the named executive officers is appropriate to align their interests with

those of our stockholders to generate stockholder returns. Accordingly, the Board recommends that our

stockholders vote in favor of the say-on-pay vote as set forth in the following non-binding resolution:

RESOLVED, that our stockholders approve, on an advisory basis, the compensation paid to our named

executive officers, as disclosed in this Proxy Statement, including under the heading "Compensation

Discussion and Analysis", the accompanying compensation tables and the corresponding narrative

discussion.

As this is an advisory vote, the outcome of the vote is not binding on us with respect to executive compensation

decisions, including those relating to our named executive officers. Our Compensation and Human Capital

Committee and Board value the opinions of our stockholders. The Compensation and Human Capital

Committee and Board will consider the results of the say-on-pay vote and evaluate whether any actions should

be taken in the future.

The Board recommends that the stockholders vote **FOR** approval, in a non-binding resolution, of the

compensation paid to our executive officers.

---

| | |
|:---|:---|
| 30 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**COMPENSATION DISCUSSION AND ANALYSIS**

This Compensation Discussion and Analysis section is intended to provide our stockholders with an

understanding of our compensation practices and philosophy, material elements of our executive compensation

program, and the decisions made in 2025 with respect to the total compensation awarded to, earned by, or paid

to each of the following 2025 "named executive officers" or "NEOs":

---

| | |
|:---|:---|
| **Name** | **Title\*** |
| Craig S. Donohue | Chief Executive Officer and President |
| Jill M. Griebenow  | Executive Vice President, Chief Financial Officer |
| Christopher A. Isaacson (1) | Executive Vice President, Chief Operating Officer |
| Patrick Sexton  | Executive Vice President, General Counsel and Corporate Secretary  |
| Timothy Lipscomb | Executive Vice President, Chief Technology Officer |
| Fredric J. Tomczyk (2) | Former Chief Executive Officer |
| David Howson (3) | Former Executive Vice President, Global President |
| Catherine R. Clay (4) | Former Executive Vice President, Head of Global Derivatives |

---

________________________________________________

\*Titles are as of December 31, 2025.

(1)Mr. Isaacson resigned as Executive Vice President, Chief Operating Officer at the end of March 6, 2026 and

his last day with the Company was March 6, 2026. He will provide the Company with consulting services

until December 31, 2026.

(2)Mr. Tomczyk resigned as Chief Executive Officer at the end of May 6, 2025 and remained an employee of

the Company serving in an advisory capacity until June 30, 2025.

(3)Mr. Howson resigned as Executive Vice President, Global President at the end of August 1, 2025 and his

last day with the Company was August 1, 2025.

(4)Ms. Clay resigned as Executive Vice President, Head of Global Derivatives at the end of September 30,

2025 and her last day with the Company was October 15, 2025.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 31 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

This Compensation Discussion and Analysis section is organized as follows:

---

| | |
|:---|:---|
| **[Executive Summary](#i6fe99c16e7ba4527ada2d89600dfba88_55)** | **[32](#i6fe99c16e7ba4527ada2d89600dfba88_55)** |
| [Principal Components of 2025 Executive Compensation](#i6fe99c16e7ba4527ada2d89600dfba88_58) | [32](#i6fe99c16e7ba4527ada2d89600dfba88_58) |
| [Performance Affecting Fiscal 2025 Annual Incentive Pay Outcomes](#i6fe99c16e7ba4527ada2d89600dfba88_61) | [33](#i6fe99c16e7ba4527ada2d89600dfba88_61) |
| [Performance Affecting 2023-2025 PSU Pay Outcomes](#i6fe99c16e7ba4527ada2d89600dfba88_64) | [33](#i6fe99c16e7ba4527ada2d89600dfba88_64) |
| [Compensation Governance Practices](#i6fe99c16e7ba4527ada2d89600dfba88_67) | [33](#i6fe99c16e7ba4527ada2d89600dfba88_67) |
| [2025 Business Highlights](#i6fe99c16e7ba4527ada2d89600dfba88_70) | [34](#i6fe99c16e7ba4527ada2d89600dfba88_70) |
| **[Executive Compensation Program Practices](#i6fe99c16e7ba4527ada2d89600dfba88_73)** | **[35](#i6fe99c16e7ba4527ada2d89600dfba88_73)** |
| [Compensation Philosophy and Summary](#i6fe99c16e7ba4527ada2d89600dfba88_76) | [35](#i6fe99c16e7ba4527ada2d89600dfba88_76) |
| [Company's Response to Stockholder Vote on Say-on-Pay](#i6fe99c16e7ba4527ada2d89600dfba88_79) | [36](#i6fe99c16e7ba4527ada2d89600dfba88_79) |
| [Compensation Refinements](#i6fe99c16e7ba4527ada2d89600dfba88_82) | [36](#i6fe99c16e7ba4527ada2d89600dfba88_82) |
| [Executive Compensation Program Governance Cycle](#i6fe99c16e7ba4527ada2d89600dfba88_85) | [37](#i6fe99c16e7ba4527ada2d89600dfba88_85) |
| [Independent Compensation Consultant](#i6fe99c16e7ba4527ada2d89600dfba88_88) | [37](#i6fe99c16e7ba4527ada2d89600dfba88_88) |
| [Peer Group and Comparative Data](#i6fe99c16e7ba4527ada2d89600dfba88_91) | [38](#i6fe99c16e7ba4527ada2d89600dfba88_91) |
| **[2025 Elements of Executive Compensation Program](#i6fe99c16e7ba4527ada2d89600dfba88_94)** | **[38](#i6fe99c16e7ba4527ada2d89600dfba88_94)** |
| [Base Salary](#i6fe99c16e7ba4527ada2d89600dfba88_97) | [38](#i6fe99c16e7ba4527ada2d89600dfba88_97) |
| [Annual Incentive](#i6fe99c16e7ba4527ada2d89600dfba88_100) | [39](#i6fe99c16e7ba4527ada2d89600dfba88_100) |
| [Overview](#i6fe99c16e7ba4527ada2d89600dfba88_103) | [39](#i6fe99c16e7ba4527ada2d89600dfba88_103) |
| [2025 Target Annual Incentive Opportunity](#i6fe99c16e7ba4527ada2d89600dfba88_106) | [40](#i6fe99c16e7ba4527ada2d89600dfba88_106) |
| [Annual Incentive Payout Formula and Opportunity](#i6fe99c16e7ba4527ada2d89600dfba88_109) | [41](#i6fe99c16e7ba4527ada2d89600dfba88_109) |
| [Corporate Financial Performance Measures, Goals, and Outcomes](#i6fe99c16e7ba4527ada2d89600dfba88_112) | [42](#i6fe99c16e7ba4527ada2d89600dfba88_112) |
| [Individual Performance](#i6fe99c16e7ba4527ada2d89600dfba88_115) | [43](#i6fe99c16e7ba4527ada2d89600dfba88_115) |
| [Actual Annual Incentive Payouts](#i6fe99c16e7ba4527ada2d89600dfba88_121) | [50](#i6fe99c16e7ba4527ada2d89600dfba88_121) |
| [Long-Term Incentive Plan](#i6fe99c16e7ba4527ada2d89600dfba88_124) | [51](#i6fe99c16e7ba4527ada2d89600dfba88_124) |
| [Overview](#i6fe99c16e7ba4527ada2d89600dfba88_127) | [51](#i6fe99c16e7ba4527ada2d89600dfba88_127) |
| [2025 Grants](#i6fe99c16e7ba4527ada2d89600dfba88_130) | [51](#i6fe99c16e7ba4527ada2d89600dfba88_130) |
| [2025 Promotion Grants](#i6fe99c16e7ba4527ada2d89600dfba88_133) | [53](#i6fe99c16e7ba4527ada2d89600dfba88_133) |
| [2025 One Time Grants](#i6fe99c16e7ba4527ada2d89600dfba88_780) | [54](#i6fe99c16e7ba4527ada2d89600dfba88_780) |
| [Mr. Tomczyk's 2025 Time-Based RSU Grant](#i6fe99c16e7ba4527ada2d89600dfba88_136) | [54](#i6fe99c16e7ba4527ada2d89600dfba88_136) |
| [Mr. Donohue's Sign-On Grant](#i6fe99c16e7ba4527ada2d89600dfba88_757) | [55](#i6fe99c16e7ba4527ada2d89600dfba88_757) |
| [2023 PSU Grants Vested](#i6fe99c16e7ba4527ada2d89600dfba88_139) | [55](#i6fe99c16e7ba4527ada2d89600dfba88_139) |
| **[Other Executive Compensation Program Considerations](#i6fe99c16e7ba4527ada2d89600dfba88_142)** | **[56](#i6fe99c16e7ba4527ada2d89600dfba88_142)** |
| [Stock Ownership and Holding Guidelines](#i6fe99c16e7ba4527ada2d89600dfba88_145) | [56](#i6fe99c16e7ba4527ada2d89600dfba88_145) |
| [Hedging Policy](#i6fe99c16e7ba4527ada2d89600dfba88_148) | [57](#i6fe99c16e7ba4527ada2d89600dfba88_148) |
| [Pledging Policy](#i6fe99c16e7ba4527ada2d89600dfba88_151) | [57](#i6fe99c16e7ba4527ada2d89600dfba88_151) |
| [Clawback Policies](#i6fe99c16e7ba4527ada2d89600dfba88_154) | [58](#i6fe99c16e7ba4527ada2d89600dfba88_154) |
| [Employee Benefit Plans, Severance, Change in Control, and Employment-Related](#i6fe99c16e7ba4527ada2d89600dfba88_157)<br>[Agreements](#i6fe99c16e7ba4527ada2d89600dfba88_157)<br>| [58](#i6fe99c16e7ba4527ada2d89600dfba88_157) |
| [Tax and Accounting Considerations](#i6fe99c16e7ba4527ada2d89600dfba88_160) | [59](#i6fe99c16e7ba4527ada2d89600dfba88_160) |

---

---

| | |
|:---|:---|
| 32 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Executive Summary**

***Principal Components of 2025 Executive Compensation***

---

| |
|:---|
| **Base Salary**  |
| Fixed level of cash compensation based on performance, ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>expertise, experience, and market value<br>|
| Target annual incentive is based on percentage of base salary![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| **Annual Incentive Bonus**  |
| Provides variable cash compensation payout opportunities if ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>pre-established EBITDA and net revenue corporate and <br>individual performance goals are met over a one-year <br>performance period<br>|
| Individual performance goals include corporate strategy goals ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>and individual goals tailored to the executive<br>|
| Payout range is 0% to 200% of executive's target bonus ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>opportunity<br>|
| **Long-Term Equity Awards—Restricted Stock Units** |
| Provides compensation in the form of Company shares if 3-![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>year graded service period is met<br>|
| Aligns interests of our executives with those of our ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>stockholders, encourages retention of executives, and <br>motivates executives to focus on our long-term growth and <br>increase stockholder value<br>|
| **Long-Term Equity Awards—Performance Stock Units** |
| Provides variable compensation in the form of Company ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>shares if pre-established relative total stockholder return <br>("TSR") and earnings per share ("EPS") goals are met over a <br>3-year period<br>|
| Aligns the interests of our executives with stockholders, ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>provides significant incentive for retention, and motivates our <br>executives to focus on our long-term growth and increase <br>stockholder value<br>|
| Payout range is 0% to 200% of executive's target number of ![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>PSUs<br>|

---

**CEO's Target Pay Mix\***

![1](cboe-20260401_g23.gif)

![13](cboe-20260401_g24.gif)

**at risk**

**Other NEOs' Target Pay Mix**

![51](cboe-20260401_g25.gif)

![63](cboe-20260401_g26.gif)

**at risk**

_____________________________________

\*The "CEO's Target Pay Mix" chart set forth above excludes the sign-on long-term equity award with a target

grant date value of $6,000,000 granted to Mr. Donohue in connection with his appointment as Chief

Executive Officer of the Company given the one-time nature of the award and that the award is not

representative of the Company's typical compensation practices.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 33 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***Performance Affecting Fiscal 2025 Annual Incentive Pay Outcomes***

---

| | |
|:---|:---|
| **2025 Net Revenues** | **2025 Adjusted EBITDA (1)** |
| **$2,429 Million** | **$1,655 Million** |
| ![cboe-20240516xdef14a_a220.jpg](cboe-20260401_g27.jpg) | ![cboe-20240516xdef14a_a220.jpg](cboe-20260401_g27.jpg) |
| **110.8% of Target Achieved** | **117.5% of Target Achieved** |

---

***Performance Affecting 2023-2025 PSU Pay Outcomes***

---

| | |
|:---|:---|
| **3-Year Relative TSR** | **3-Year Cumulative Adjusted** <br>**Diluted EPS (1)**<br>|
| **86th Percentile** | **$27.08** |
| ![cboe-20240516xdef14a_a220.jpg](cboe-20260401_g27.jpg) | ![cboe-20240516xdef14a_a220.jpg](cboe-20260401_g27.jpg) |
| **200% of Target PSUs Earned** | **200% of Target PSUs Earned** |

---

_________________________________________________

(1)Adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA"), excluding minority

investments, and 3-year cumulative adjusted diluted EPS are non-U.S. generally accepted accounting

principles ("GAAP") measures and reconciliations to GAAP measures are provided in Appendix A.

***Compensation Governance Practices***

---

| | |
|:---|:---|
| **What we do** | **What we don't do** |
| Mitigate compensation risk![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>Enforce robust mandatory stock ownership ![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>and holding guidelines<br>Utilize independent compensation consultant![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>Maintain a Compensation and Human ![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>Capital Committee that is composed solely of <br>independent directors<br>Active engagement with stockholders![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>Maintain double trigger change in control ![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>provisions in equity awards and for <br>severance benefits under an employment <br>agreement and the Executive Severance <br>Plan<br>Apply mandatory and supplemental ![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>clawback policies to cash incentive and <br>equity incentive awards for executives<br>Impose maximum caps and limits on short- ![cboe-20240516xdef14a_a225.jpg](cboe-20260401_g18.jpg)<br>and long-term incentive award payouts<br>| No hedging of Company stock by executives![xincircle.jpg](cboe-20260401_g28.jpg)<br>No pledging of Company stock by executives![xincircle.jpg](cboe-20260401_g28.jpg)<br>No payment of tax gross-ups upon a change ![xincircle.jpg](cboe-20260401_g28.jpg)<br>in control or otherwise<br>No excessive use of employment contracts![xincircle.jpg](cboe-20260401_g28.jpg)<br>No payouts for corporate performance below ![xincircle.jpg](cboe-20260401_g28.jpg)<br>threshold level<br>No excessive perquisites![xincircle.jpg](cboe-20260401_g28.jpg)<br>No guaranteed incentive payments![xincircle.jpg](cboe-20260401_g28.jpg)<br>|

---

---

| | |
|:---|:---|
| 34 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***2025 Business Highlights***

Cboe Global Markets and its Board are committed to a corporate mission and strategy designed to create long-

term stockholder value. Our strategic path forward includes:

1. Rationalizing our business portfolio to optimize our return on invested capital and potential growth

trajectory;

2. Optimizing our core businesses of Index Options, Multi-List Options, Futures, U.S. Equities, European

Equities, and Global FX, while expanding Data Vantage offerings that draw upon these businesses;

3. Capitalizing on emerging industry trends that align with our core strengths and potentially unlocking new

opportunities to create value for our clients; and

4. Maintaining a disciplined and financially rigorous approach to capital allocation.

The following is a brief summary of our 2025 business highlights as they relate to the ongoing commitment of

our team and the Board to this strategy and the key performance metrics used in our performance-based

compensation program.

Net revenues of $2,429 million for 2025, up 17% from $2,072 million for 2024.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Achieved record volumes in our options segment:

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

• total options average daily volume ("ADV") reached an all-time high of contracts traded per day -

the sixth consecutive record-breaking year; and

• set several ADV records for the year, including in multi-list options, S&P 500 Index (SPX) options,

SPX zero-days-to expiry (ODTE) options, Cboe Volatility Index (VIX®) options, and XSP (Mini-SPX)

options.

Expanded our derivatives product suite, including the launch of:

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

• cash-settled futures and options on a new index tracking 10 U.S.-listed large-cap stocks of

technology and growth-oriented companies (the "Cboe Magnificent 10 Index"), and

• continuous Bitcoin and Ether futures.

Conducted a comprehensive review of our global business operations, resulting in a strategic

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

realignment of our business portfolio and an enhanced focus on core strengths and emerging growth

opportunities.

Began enhancing our governance, risk, and compliance framework.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Enhanced existing collaborations with S&P Dow Jones Indices by launching options on the S&P 500

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Equal Weight Index and with FTSE Russell to offer Cboe FTSE Bitcoin Index Futures.

Expanded retail access with the launch of a Pan-European Best Bid and Offer trading solution.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Expanded dedicated cores technology offering internationally, enhancing order processing performance

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

and reliability for participants across our global markets.

Advanced cloud-based data access with launch of index datasets.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Completed key migrations, including the transition of Cboe Digital Exchange futures to CFE and the

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

migration of Cboe Canada's technology platform.

Successfully navigated key executive transitions.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

In U.S. equities, off-exchange, BIDS Trading reported a yearly ADV record.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Cboe Europe Equities achieved record average daily notional value ("ADNV") and market share.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Cboe FX achieved a record full year spot ADNV, eclipsing last year's record.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

We believe that the performance of the Company demonstrates that management is keenly focused on driving

the Company for sustainable long-term growth, while obtaining short-term results. Our business continued to

generate strong cash flows from operations and we were able to return $350 million to stockholders through

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 35 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

dividends and share repurchases while retaining the flexibility to pursue new growth opportunities. To that end,

in 2025:

In keeping with our goal of consistent and sustainable dividend growth, we increased our quarterly

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

dividend by 14% to $0.72 per share and paid cash dividends of $284 million; and

We repurchased 305,317 of our outstanding shares of common stock under a share repurchase

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

program for a total of $65 million.

As a result of our strong performance in 2025 and capital allocation decisions, as of December 31, 2025, we

achieved total stockholder returns and compound annual growth rates ("CAGR"), including reinvested

dividends, of approximately:

30% over the past year;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

108% over the past three years, a 28% CAGR;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

189% over the past five years, a 24% CAGR; and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

359% over the past ten years, a 15% CAGR.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

**Executive Compensation Program Practices**

***Compensation Philosophy and Summary***

Our executive compensation program is designed to attract and retain talented and dedicated executives who

are instrumental in our achievement of key strategic business objectives. To meet these objectives, the

Compensation and Human Capital Committee designed and implemented a program that links a substantial

portion of executive compensation to the achievement of pre-set corporate and individual performance goals.

The Compensation and Human Capital Committee believes that our executive compensation program plays a

vital role in contributing to the achievement of key strategic business objectives that ultimately drive long-term

business success. Accordingly, we designed our executive compensation program to focus our executives on

achieving critical corporate financial and strategic goals, while taking steps to position the business for

sustained growth in financial performance over time.

Our 2025 executive compensation program generally consisted of the following elements, in addition to

retirement, health, and welfare benefits:

Base Salary

Net Revenue

![](cboe-20260401_g29.gif)

![](cboe-20260401_g30.gif)

![](cboe-20260401_g31.gif)

![](cboe-20260401_g32.gif)

70%

Corporate

Performance

![](cboe-20260401_g33.gif)

![](cboe-20260401_g34.gif)

![](cboe-20260401_g35.gif)

![](cboe-20260401_g31.gif)

Adjusted EBITDA

![](cboe-20260401_g30.gif)

Annual Incentive

(Bonus)

**Total** 

**Pay**

![](cboe-20260401_g31.gif)

![](cboe-20260401_g36.gif)

![](cboe-20260401_g37.gif)

Individual Goals

30%

Individual

Performance

![](cboe-20260401_g38.gif)

![](cboe-20260401_g31.gif)

![](cboe-20260401_g33.gif)

50%

Restricted Stock

Units

Time-Based

Vesting

![](cboe-20260401_g33.gif)

![](cboe-20260401_g31.gif)

![](cboe-20260401_g39.gif)

![](cboe-20260401_g38.gif)

Long-Term Equity

Awards

25%

Total Stockholder

Return

![](cboe-20260401_g36.gif)

![](cboe-20260401_g31.gif)

Performance Stock

Units

![](cboe-20260401_g30.gif)

![](cboe-20260401_g40.gif)

![](cboe-20260401_g41.gif)

50%

![](cboe-20260401_g33.gif)

![](cboe-20260401_g31.gif)

![](cboe-20260401_g31.gif)

25%

Earnings Per Share

![](cboe-20260401_g30.gif)

![](cboe-20260401_g41.gif)

The following charts show the 2025 total target compensation mix for the CEO and the other NEOs as a group.

The majority of 2025 total target compensation is "at-risk" (i.e., linked to achievement of performance goals and/

or the value is tied to our common stock price) and, further, the majority of "at-risk" pay is in the form of equity

---

| | |
|:---|:---|
| 36 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

awards. Total target compensation is the sum of an executive officer's 2025 target annual pay opportunities for

their respective roles and does not include Messrs. Tomczyk's or Howson's 2025 compensation, Ms. Clay's

2025 compensation and special one-time long-term equity award, or Mr. Donohue's sign-on grant.

**CEO's Target Pay Mix**

**Other NEOs' Target Pay Mix**

![839](cboe-20260401_g42.gif)

![889](cboe-20260401_g43.gif)

![901](cboe-20260401_g44.gif)

![851](cboe-20260401_g45.gif)

**at risk**

**at risk**

***Company's Response to Stockholder Vote on Say-on-Pay***

At the 2025 Annual Meeting of Stockholders, our "say-on-pay" proposal received the support of approximately

93.5% of the votes cast for approval of our 2024 executive compensation program, as disclosed in our 2025

Proxy Statement, and every year since going public in 2010 we have received over 84.4% stockholder support

of our executive compensation programs.

The Compensation and Human Capital Committee has reviewed the results of the stockholder vote on our 2024

executive compensation program and considered such results supportive of our executive compensation

program and the Compensation and Human Capital Committee's measured approach to modifying our

compensation practices to enhance their alignment with stockholder interests. In addition, the Compensation

and Human Capital Committee has determined that the vote result and stockholder engagement did not warrant

any large-scale changes to our executive compensation program; however, as discussed below, the

Compensation and Human Capital Committee continues to take steps to help ensure our compensation

practices remain aligned with best practices and stockholder interests. See "Corporate Governance—

Stockholder Engagement" for more information about our stockholder outreach.

***Compensation Refinements***

The Board and the Compensation and Human Capital Committee approved the following two refinements to our

executive compensation program: (i) modified the weightings of the performance metrics of our annual incentive

plan and (ii) modified the payout scale by adding a net revenue threshold to, among other things, help ensure a

more balanced approach to achieving performance metrics.

More specifically, for 2025, with respect to the NEOs, the Compensation and Human Capital Committee

discontinued the use of the diversity, equity, and inclusion performance metric originally adopted in 2023 and

reallocated the 10% of the overall weight allocated to that metric to the individual performance metric of the

annual incentive program. This change was made to provide more flexibility in establishing applicable

performance metrics and evaluating the performances of the NEOs. However, the individual performance goals

for 2025 included, among others, goals related to enhancing the Company's culture and associate experience

and promoting an inclusive environment. Further, the Compensation and Human Capital Committee also added

a new rule to the annual incentive program to provide that in order for an NEO to achieve a payout of over

100% with respect to corporate-wide adjusted EBITDA, corporate-wide net revenue achievement must be at

least 97% of target. This change was made to better align the interests of our NEOs with our revenues,

business strategy, and investing in our business as well as our stockholders.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 37 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***Executive Compensation Program Governance Cycle***

Throughout the year, the Board and the Compensation and Human Capital Committee are heavily involved in

reviewing, monitoring, and approving, as applicable, the executive compensation program. The Compensation

and Human Capital Committee, composed of all independent directors, is responsible for reviewing the various

components of the total compensation program for all executive officers. The Compensation and Human Capital

Committee met 16 times in 2025.

The Compensation and Human Capital Committee either approves or makes recommendations to the Board

regarding compensation-related decisions. Ms. Griebenow and Messrs. Tomczyk and Donohue, along with the

EVP, Chief Human Resources Officer, generally attended portions of the 2025 meetings of the Compensation

and Human Capital Committee to provide information and assistance, other than when the Compensation and

Human Capital Committee discussed the respective executive's compensation.

While specific topics may vary from meeting to meeting and quarter to quarter, the following illustration

describes the general annual cycle of the Board's and Compensation and Human Capital Committee's activities.

![](cboe-20260401_g46.gif)

**Q1**

- For prior service year:

+ Review company and PSU performance

+ Evaluate individual performance

+ Determine incentive payment amounts

+ Approve CD&A and Compensation and Human Capital

Committee Report

- For current service year:

+ Finalize base salary and target annual incentive opportunity

+ Finalize amounts, structure, mix and equity performance goals

+ Finalize corporate strategic and individual goals

+ Approve non-employee director compensation

- Discuss investor outreach, including executive compensation

feedback

![](cboe-20260401_g47.gif)

![](cboe-20260401_g48.gif)

![](cboe-20260401_g49.gif)

**Q4**

- Review year-to-date company and PSU performance

- Discuss potential structure, mix and equity

performance goals

- Discuss potential corporate strategic and individual

goals

![](cboe-20260401_g50.gif)

**Q2**

- Determine peer group composition

- Review stock ownership and holding levels

- Review stockholder vote on "say-on-pay" proposal

- Approve non-employee director equity awards

![](cboe-20260401_g51.gif)

![](cboe-20260401_g52.gif)

![](cboe-20260401_g53.gif)

**Q3**

- Review proxy advisory firm feedback

- Evaluate independence of compensation consultant

- Assess any potential risks arising from compensation policies and

practices

- Executive succession planning

- Conduct Compensation and Human Capital Committee annual

self-assessment

***Independent Compensation Consultant***

For 2025, the Compensation and Human Capital Committee engaged Meridian as its independent

compensation consultant to provide the Compensation and Human Capital Committee with advice and

assistance related to the design of our executive compensation program.

Meridian reviews our executive compensation program and advises the Compensation and Human Capital

Committee on best practices and plan design to help improve the program's effectiveness and alignment with

market practices. In addition, Meridian provides advice to the Compensation and Human Capital Committee on

the Company's compensation peer group and on the competitive positioning of the various components of the

executive compensation program.

Meridian consultants regularly attend meetings of the Compensation and Human Capital Committee. Meridian

also meets with the Compensation and Human Capital Committee in executive session without management

present and may communicate directly, as needed, with members of the Compensation and Human Capital

Committee and the Board at large. Based on a review of its engagement of Meridian, and consideration of

---

| | |
|:---|:---|
| 38 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

factors set forth in SEC and BZX rules, the Compensation and Human Capital Committee determined that

Meridian's work did not raise any conflicts of interest and that Meridian is independent from management.

***Peer Group and Comparative Data***

For 2025 compensation decisions, the Compensation and Human Capital Committee considered competitive

market data derived from a 20-company custom peer group and an executive compensation survey published

by a third party that solely covered exchange holding companies, financial services firms, and technology-

focused companies of similar size to the Company.

The 20-company custom peer group was composed of exchange holding companies, financial services firms,

and technology-focused companies with corporate profiles similar to ours. The Company's annual revenue,

market capitalization, and EBITDA fell near the median of the peer group, and number of employees fell below

the median of the peer group.

The Compensation and Human Capital Committee used the market data derived from the peer group and the

executive compensation survey as points of reference, rather than as the sole determining factor in setting

compensation for our NEOs.

---

| | |
|:---|:---|
| **Peer Group** | **Peer Group** |
| Akamai Technologies, Inc. | London Stock Exchange Group plc |
| Broadridge Financial Solutions, Inc. | LPL Financial Holdings Inc. |
| CME Group Inc. | MarketAxess Holdings Inc. |
| Deutsche Borse AG | MSCI Inc. |
| Equifax Inc. | Nasdaq, Inc. |
| Euronet Worldwide, Inc. | SEI Investments Company |
| FactSet Research Systems Inc. | Stifel Financial Corp. |
| Fortinet, Inc. | TransUnion |
| Intercontinental Exchange, Inc. | Verisk Analytics, Inc. |
| Jack Henry & Associates, Inc. | Virtu Financial, Inc. |

---

Following the 2025 compensation decisions, the Compensation and Human Capital Committee reviewed the

peer group. The Committee reviewed the data provided by Meridian and compared our corporate performance

to our peer group in the areas of revenues, EBITDA, market capitalization, and number of employees. The

Committee also considered business descriptions, complexity of business, and other qualitative factors. The

Committee determined no changes were necessary to the peer group in 2025.

**2025 Elements of Executive Compensation Program**

***Base Salary***

The base salary for our NEOs is designed to be part of a competitive total compensation package when

compared to our peer group and market survey data. Base salary provides our NEOs with a measure of

certainty within their total compensation package and provides a baseline for their target payout opportunity

under the annual incentive plan. In setting base salary, in addition to considering market benchmark data

derived from our peer group and an executive compensation survey, the Compensation and Human Capital

Committee also considered for each NEO the following factors:

---

| | |
|:---|:---|
| Position,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| Individual performance,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| Experience,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| Potential to influence our future success, and![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| Industry specific knowledge,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| Total compensation.![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| Level of responsibility,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|  |

---

For 2025, the Compensation and Human Capital Committee approved or made recommendations to the Board

regarding the base salaries for each of the NEOs, with input in part from Messrs. Donohue or Tomczyk

regarding the individual performances of Messrs. Isaacson, Sexton, Lipscomb, and Howson and Mses.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 39 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

Griebenow and Clay. The table below shows each NEO's annualized base salary at December 31, 2025 and

2024, respectively, and the year over year percentage change in base salary.

---

| | | | |
|:---|:---|:---|:---|
| **Named Executive Officer** | **2024 Base**<br>**Salary (1)**<br>| **2025 Base**<br>**Salary (1)**<br>| **Percent**<br>**Change**<br>|
| Craig S. Donohue (2) | $— | $1300 | —% |
| Jill M. Griebenow | $500 | $500 | —% |
| Christopher A. Isaacson | $650 | $650 | —% |
| Patrick Sexton | $450 | $450 | —% |
| Timothy Lipscomb (2)(3)  | $— | $465 | —% |
| Fredric J. Tomczyk (4) | $1000 | $1000 | —% |
| David Howson | $625 | $625 | —% |
| Catherine R. Clay | $500 | $500 | —% |

---

____________________________________

(1)In thousands.

(2)Mr. Donohue and Mr. Lipscomb became NEOs for the first time in 2025, and thus no amounts are shown in

the table for 2024.

(3)Mr. Lipscomb's 2025 base salary from January 1, 2025 through February 28, 2025 was $437,000, from

March 1, 2025 through May 31, 2025 was $450,000, and from June 1, 2025 through December 31, 2025

was $465,000. The base salary for Mr. Lipscomb increased due to his assumption of additional

responsibilities and to align his compensation more closely with comparative market data.

(4)Mr. Tomczyk's employment with the Company ended on June 30, 2025. Starting on July 1, 2025, Mr.

Tomczyk participated in the Company's 2025 director compensation program for non-employee directors on

a pro rata basis for 2025 based on his service as a non-employee director.

***Annual Incentive***

***Overview.*** The annual incentive, or bonus, component of the total compensation package paid to our NEOs is

designed to reward the achievement of key corporate and individual performance goals that drive our annual

operating and financial results.

The Compensation and Human Capital Committee established a target annual incentive opportunity for each of

the NEOs by considering market benchmark data derived from our peer group and an executive compensation

survey, and separately by considering the following factors:

---

| | |
|:---|:---|
| Position,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| Individual performance,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| Experience,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| Potential to influence our future success, and![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| Industry specific knowledge,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>| Total compensation.![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|
| Level of responsibility,![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)<br>|  |

---

---

| | |
|:---|:---|
| 40 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***2025 Target Annual Incentive Opportunity.*** The table below shows each NEO's 2024 and 2025 target annual

incentive opportunity, shown as a percentage of salary, and the year over year percentage point change in

target annual incentive opportunity.

---

| | | | |
|:---|:---|:---|:---|
| **Named Executive Officer** | **2024 Target** <br>**Annual**<br>**Incentive**<br>**Opportunity as**<br>**Percentage of**<br>**Base Salary**<br>| **2025 Target** <br>**Annual**<br>**Incentive**<br>**Opportunity as**<br>**Percentage of**<br>**Base Salary**<br>| **Change in** <br>**Percentage**<br>**Points**<br>|
| Craig S. Donohue (1) | —% | 150% | — pts |
| Jill M. Griebenow (2) | 130% | 130% | — pts |
| Christopher A. Isaacson | 150% | 150% | — pts |
| Patrick Sexton | 120% | 120% | — pts |
| Timothy Lipscomb (1)(3) | —% | 110% | — pts |
| Fredric J. Tomczyk  | 165% | 165% | — pts |
| David Howson (4) | 150% | 150% | —pts |
| Catherine R. Clay (5) | 100% | 130% | 30pts |

---

____________________________________

(1)Mr. Donohue and Mr. Lipscomb became NEOs for the first time in 2025, and thus no amounts are shown in

the table for 2024.

(2)Ms. Griebenow's 2024 target annual incentive opportunity from January 1, 2024 through February 29, 2024

was 120% of her base salary and then from March 1, 2024 through December 31, 2024 was 130% of her

base salary.

(3)Mr. Lipscomb's 2025 target annual incentive opportunity from January 1, 2025 through May 31, 2025 was

90% of his base salary and then from June 1, 2025 through December 31, 2025 was 110% of his base

salary.

(4)Mr. Howson's 2024 target annual incentive opportunity from January 1, 2024 through February 29, 2024

was 135% of his base salary and then from March 1, 2024 through December 31, 2024 was 150% of his

base salary.

(5)Ms. Clay's 2025 target annual incentive opportunity from January 1, 2025 through February 28, 2025 was

100% of her base salary, from March 1, 2025 through May 31, 2025 was 110% of her base salary, and from

June 1, 2025 through her last day with the Company was 130% of her base salary.

The target annual incentive opportunity for Mr. Lipscomb and Ms. Clay increased due to their assumption of

additional responsibilities and to align their compensation more closely with comparative market data.

The Compensation and Human Capital Committee determines actual annual incentive bonus payouts based on

achieved results measured against pre-established performance goals. The use of pre-established performance

metrics and related goals creates an annual incentive plan that rewards our executive officers for strong

performance, reduces payouts when performance does not meet target and eliminates payouts if performance

does not meet threshold. In addition, the performance metrics and related goals create a structured, formulaic

annual incentive plan—the executive officers know throughout the year what needs to be accomplished and

what specific bonus dollar amounts can be earned at different performance levels.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 41 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***Annual Incentive Payout Formula and Opportunity.*** The following is a graphical depiction showing the

formula used for determining annual incentive bonus payouts.

Base Salary

Target

Incentive

Percentage

Opportunity

Percentage

of Target

Incentive

Earned

Annual

Incentive

Payout

![Equals.jpg](cboe-20260401_g54.jpg)

![Multiply.jpg](cboe-20260401_g55.jpg)

![Multiply.jpg](cboe-20260401_g55.jpg)

![](cboe-20260401_g56.gif)

Weighted Sum of Percentage

Payouts of Target for Corporate

and Individual Metrics

![](cboe-20260401_g57.gif)

![](cboe-20260401_g58.gif)

![](cboe-20260401_g58.gif)

![](cboe-20260401_g59.gif)

Percentage

Payout of

Target for

each Metric

Metric

Weighting

![Multiply.jpg](cboe-20260401_g55.jpg)

For the 2025 annual incentive plan the Compensation and Human Capital Committee approved two types of

performance metrics: (i) corporate financial performance metrics (weighted 70%) and (ii) individual performance

metrics (weighted 30%). The Compensation and Human Capital Committee established goals at threshold,

target, and maximum performance levels with respect to the corporate financial performance metrics. However,

given the nature of the individual performance metrics, the Committee did not set a range of individual

performance levels. Rather, the Committee determined each NEO's payout based on the assessment of the

executive officer's actual performance measured against pre-established individual performance goals, which

are set forth in further detail below. In general, changes to base salary and target annual incentive opportunity

are effective March 1, 2025.

The Company will pay no annual incentive bonus to an NEO with respect to a corporate financial metric if the

actual performance for such corporate financial metric is below threshold. The following chart shows the annual

incentive payout opportunity for each NEO at specified performance levels.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Base**<br>**Salary (1)** | **Target Annual**<br>**Incentive**<br>**Opportunity as**<br>**Percentage of**<br>**Base Salary** | **Annual Incentive Payout**<br>**Opportunity (1)** | **Annual Incentive Payout**<br>**Opportunity (1)** | **Annual Incentive Payout**<br>**Opportunity (1)** |
| **Named Executive Officer** | **Base**<br>**Salary (1)** | **Target Annual**<br>**Incentive**<br>**Opportunity as**<br>**Percentage of**<br>**Base Salary** | **Threshold** | **Target** | **Maximum** |
| Craig S. Donohue (2) | $851 | 150% | $223 | $1277 | $2554 |
| Jill M. Griebenow | $500 | 130% | $114 | $650 | $1300 |
| Christopher A. Isaacson | $650 | 150% | $171 | $975 | $1950 |
| Patrick Sexton | $450 | 120% | $95 | $540 | $1080 |
| Timothy Lipscomb (3) | $457 | See note 3 | $81 | $466 | $931 |
| Fredric J. Tomczyk (4) | $496 | 165% | $143 | $818 | $1636 |
| David Howson (5) | $625 | 150% | $164 | $938 | $1875 |
| Catherine R. Clay (5)(6) | $500 | See note 6 | $105 | $601 | $1201 |

---

_____________________________________

(1)In thousands.

(2)Mr. Donohue's annual incentive payout opportunity is based on his base salary, which started on May 7,

2025 at a rate of $1,300,000 on an annualized basis in connection with his appointment to CEO.

(3)Mr. Lipscomb's 2025 base salary from January 1, 2025 through February 28, 2025 was $437,000, from

March 1, 2025 through May 31, 2025 was $450,000, and from June 1, 2025 through December 31, 2025

was $465,000. Mr. Lipscomb's 2025 target annual incentive opportunity from January 1, 2025 through May

---

| | |
|:---|:---|
| 42 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

31, 2025 was 90% of his base salary and then from June 1, 2025 through December 31, 2025 was 110% of

his base salary.

(4)Mr. Tomczyk's employment with the Company ended on June 30, 2025. Mr. Tomczyk received a prorated

portion of his 2025 annual incentive bonus based on his employment through June 30, 2025 and payable

based on actual performance and at the same time as paid to other executives of the Company. Mr.

Tomczyk's base salary was paid at a rate of $1,000,000 on an annualized basis. Mr. Tomczyk did not

receive any severance or additional payments upon the termination of his employment with the Company.

(5)Mr. Howson and Ms. Clay were ineligible for an annual bonus for fiscal year 2025 due to their resignations

in 2025.

(6)Ms. Clay's 2025 target annual incentive opportunity from January 1, 2025 through February 28, 2025 was

100% of her base salary, from March 1, 2025 through May 31, 2025 was 110% of her base salary, and from

June 1, 2025 through her last day with the Company was 130% of her base salary.

***Corporate Financial Performance Measures, Goals, and Outcomes*.** For the 2025 annual incentive plan, the

Compensation and Human Capital Committee approved the following corporate financial performance metrics

for Messrs. Donohue, Isaacson, Sexton, Lipscomb, Tomczyk, and Howson and Mses. Griebenow and Clay (as

of June 1, 2025): (i) corporate-wide net revenue (weighted 30%) and (ii) corporate-wide adjusted EBITDA

(weighted 40%). These performance metrics, in the aggregate, are weighted 70% of each NEO's target annual

incentive opportunity.

For the portion of the year prior to June 1, the Compensation and Human Capital Committee approved the

following corporate performance metrics for Ms. Clay: (i) corporate-wide net revenue (weighted 15%), (ii)

corporate-wide adjusted EBITDA (weighted 15%), (iii) business unit revenue (weighted 20% in the aggregate of

the applicable business units), and (iv) business unit EBITDA or adjusted EBITDA (weighted 20% in the

aggregate of the applicable business units).

The Compensation and Human Capital Committee approved the corporate financial performance metrics for the

NEOs for the following reasons:

To align the interests of our executives with stockholders,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

To focus our executives on long-term growth by continuing to increase our revenue and earnings by

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

increasing volumes in our products, and

To allocate a larger weighting to adjusted EBITDA growth rather than to revenue growth because

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

executives are able to influence adjusted EBITDA growth to a greater degree than revenue growth.

The Committee also established goals at threshold, target, and maximum performance levels and payouts with

respect to the corporate performance metrics. The Committee used straight-line interpolation to determine

payouts for performance results in between the threshold and target performance levels and in between the

target and maximum performance levels. The percentage payout of target incentive opportunity for each of the

metrics is 25% for threshold, 100% for target, and 200% for maximum.

For each NEO, the table below shows the corporate performance metric threshold, target, and maximum goals,

actual performances and percentage payouts of target for 2025. The table below also shows each officer's 2025

Percentage Payout of Target based on achieved performance.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Performance Metrics** | **Weighting** | **Threshold\*** | **Target\*** | **Maximum\*** | **Actual\*** | **Percentage**<br>**Payout of**<br>**Target**<br>|
| Net Revenue (1) | 30% | $1973 | $2192 | $2411 | $2429 | 200% |
| Adjusted EBITDA (2) | 40% | $1197 | $1409 | $1620 | $1655 | 200% |

---

____________________________________

\*In millions.

(1)In order for an NEO to receive a payout of above target with respect to adjusted EBITDA, actual net

revenue achievement must be at least 97% of target net revenue. For 2025, actual net revenue

achievement was 110.8% of target.

(2)Adjusted EBITDA, excluding minority investments, for the Company is a non-GAAP measure used by the

Company and a reconciliation of actual performance to a GAAP measure is provided in Appendix A.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 43 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

The achievement of net revenue and adjusted EBITDA are measured as of December 31, 2025. The target

2025 net revenue and adjusted EBITDA goals were presented to and reviewed by the Board as part of the

Company's annual budgeting process in February 2025. The adjusted EBITDA goal for the Company excludes

the performance of our minority investments, such as 7Ridge Fund (which owns Trading Technologies and from

which we exited our investment in the fourth quarter of 2025), since earnings related to these investments do

not reflect actual corporate performance. In February 2026, the Board approved the actual performances of the

corporate-wide net revenue and corporate-wide adjusted EBITDA.

***Individual Performance.*** For the 2025 annual incentive plan, individual performance goals comprised 30% of

each NEO's target annual incentive opportunity. Based upon the level of achievement for the individual

performance goals, the Compensation and Human Capital Committee determined the payout percentage of

target annual incentive award opportunity for individual performance for each NEO.

In 2025, with respect to each NEO, the Compensation and Human Capital Committee set the following

corporate strategic goals and considered, among other items, the following achieved performance in 2025:

---

| | |
|:---|:---|
| **Goal** | **Performance** |
| **Empower Our People with a World** <br>**Class Associate Experience**<br>Key focus areas include cultivating <br>careers, growing the next generation, <br>and building for the future<br>| •Held succession planning meetings to determine appropriate <br>talent pipeline and extended succession planning deeper into <br>the organization<br>•Communicated with employees on a regular basis, including <br>through town hall meetings and periodic letters<br>•Completed and analyzed the employee engagement survey <br>and implemented targeted action plans to enhance the <br>employee experience<br>•Named best place to work by third parties<br>|
| **Accelerate Core Business Expansion** <br>**in Global Derivatives**<br>Key focus areas include driving market <br>innovation, expanding international <br>footprint and global ecosystem, and <br>unlocking access<br>| •Launched new products and indices such as cash-settled <br>futures and options on a new index tracking the Cboe <br>Magnificent 10 Index and continuous Bitcoin and Ether <br>futures<br>•Enhanced existing collaborations with S&P Dow Jones <br>Indices with launching options on the S&P 500 Equal Weight <br>Index and with FTSE Russell to offer Cboe FTSE Bitcoin <br>Index futures <br>•Made wide range of functionality, market structure, and <br>technology improvements across options and futures<br>|
| **Maximize Recurring Revenue through** <br>**Data Vantage Growth**<br>Key focus areas include innovative data <br>solutions, global sales and distribution, <br>and venue excellence<br>| •Advanced cloud-based data access with launch of index <br>datasets <br>•Reduced costs associated with Risk and Market Analytics <br>businesses<br>|

---

---

| | |
|:---|:---|
| 44 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **Leverage Global Network to Deliver** <br>**Client-Driven Solutions Across** <br>**Business Lines**<br>Key focus areas include cross selling <br>opportunities, client-centric innovation, <br>and extract network value<br>| •Expanded dedicated cores technology offering internationally, <br>enhancing order processing performance and reliability for <br>participants across our global markets while increasing <br>recurring revenue <br>|
| **Drive Innovation with Our Trusted** <br>**Leading-Edge Technology**<br>Key focus areas include trusted <br>platforms, technology leadership and <br>innovation, and technology and data <br>maximization<br>| •Unveiled a new brand for our exchange technology platform, <br>Cboe Titanium® <br>•100% uptime across 26 of our 27 markets in 2025 and <br>greater than 99.9% uptime across our markets globally, while <br>significantly reducing latencies<br>•Transitioned Cboe Digital Exchange futures to CFE <br>•Completed Cboe Canada migration<br>•Continued to expand utilization and adoption of AI and <br>matured an AI Center of Excellence<br>•Supported the listing of new options classes, new products, <br>new order types, and market enhancements<br>•Significant performance improvements were seamlessly <br>implemented in our largest markets (options) and products <br>(SPX, VIX)<br>|

---

The Committee received input from Mr. Donohue regarding the individual performances and recommendations

regarding incentive compensation of the executive officers (other than himself and Mr. Tomczyk), including

Messrs. Isaacson, Sexton, and Lipscomb and Ms. Griebenow (and, in the case of Mr. Lipscomb, with input from

Mr. Isaacson provided to Mr. Donohue). The Committee, with input from the Board, also evaluated the individual

performances of Mr. Donohue and Mr. Tomczyk. More specifically, with respect to Messrs. Donohue, Isaacson,

and Tomczyk and Ms. Griebenow, the Committee set the following individual goals and considered, among

other items, the following achieved performance in 2025.

The table below shows Mr. Donohue's individual goals and achieved performance highlights in 2025.

---

| | |
|:---|:---|
| **Goal** | **Performance** |
| Manage the Company and its affiliates to <br>achieve the corporate strategic goals <br>listed above<br>| •As discussed above and in "2025 Business Highlights", <br>overall, achieved the targeted 2025 strategic goals<br>|
| Manage communications with the <br>investment community, rating agencies, <br>the government, regulators, and<br>the public to promote confidence in the <br>Company and in the integrity of its <br>markets<br>| •Engaged with customers and stockholders at investor and <br>industry conferences, and by participating in informational <br>fireside chats and hosting meetings<br>•Regulatory engagement helped advocate for the Company's <br>interests and led to positive changes, such as streamlined <br>oversight of BIDS Trading<br>•Met with global government officials, lawmakers, and <br>regulators<br>•Continued to communicate sharpened strategic focus with <br>stockholders and employees<br>|

---

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 45 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| Enhance the Company's growth strategy <br>by increasing the focus on optimizing our <br>core businesses, completing<br>business reviews and delivering <br>recommendations, and furthering the <br>development of new growth<br>opportunities outside our core<br>| •Achieved record financial results in 2025 <br>•Executed on a strategic realignment <br>•Completed a comprehensive strategic review of global <br>business operations, resulting in several meaningful <br>decisions <br>•Continued and expanded our relationships with key strategic <br>index providers <br>•Increased focus on our core businesses of derivatives, Data <br>Vantage, equities, and FX <br>•Continued to explore potential new growth opportunities <br>outside of our core businesses, such as event prediction <br>markets <br>|
| Further developing and recruiting <br>executive talent by creating an <br>environment that develops and<br>empowers a cohesive leadership team<br>| •Transformed the executive leadership team culture by <br>making it more cohesive, adding more rigor, and expanding <br>and empowering the executive team<br>•Oversaw the hiring of new executives and the creating and <br>filling of new roles to better align ourselves with secular <br>trends<br>|
| Enhance key corporate processes | •Initiated several initiatives to help mature foundational <br>corporate processes <br>•Developed a framework outlining strategic and financial <br>criteria used to evaluate our businesses and initiatives<br>•Began enhancing our governance, risk, and compliance <br>framework<br>|
| Begin to create a more robust succession <br>planning process for a broad group of <br>leaders<br>| •Held succession planning meetings with the Compensation <br>and Human Capital Committee and the Board<br>•Held succession planning meetings to determine appropriate <br>processes, talent pipeline and retention risk<br>•Refined and developed a successor talent bench across <br>critical positions and extended succession planning deeper <br>into the organization<br>•Adeptly handled significant executive management turnover, <br>such as the roles of President, Global Head of Derivatives, <br>and Global Head of Data Vantage<br>|
| Enhance the Company's culture and <br>associate experience, including by <br>supporting communities where we<br>operate and promoting an inclusive <br>environment that supports innovation and <br>growth<br>| •Continued to support employee resource groups<br>•Encouraged employees to support a culture of inclusion <br>•Initiated small group discussions among senior leaders<br>•Evaluated employee engagement scores and strove to <br>address several key areas<br>•Enhanced leadership development training and opportunities<br>•Continued charitable donation match benefit<br>|

---

---

| | |
|:---|:---|
| 46 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

The table below shows Mr. Tomczyk's individual goals and achieved performance highlights in 2025.

---

| | |
|:---|:---|
| **Goal** | **Performance** |
| Manage the Company and its affiliates to <br>achieve the corporate strategic goals <br>listed above<br>| •As discussed above and in "2025 Business Highlights", <br>overall, achieved the targeted 2025 strategic goals<br>|
| Manage global internal and external <br>communications with the investment <br>community, the government, regulators <br>and the public to promote integrity of the <br>markets and confidence in our innovation <br>superiority and products<br>| •Managed and stabilized employee and senior management <br>team retentions and transitions<br>•Engaged with customers and stockholders at investor and <br>industry conferences, and by participating in informational <br>fireside chats and hosting meetings<br>•Met with global government officials, lawmakers, and <br>regulators<br>•Refocused investor relations messaging on the long term<br>|
| Manage business continuity with <br>scalable, efficient growth across global <br>footprint<br>| •Achieved record financial results in 2025<br>•Continued and expanded our relationships with key strategic <br>index providers<br>•Continued exploration of emerging technologies, such as AI <br>and event prediction markets<br>|
| Execute on our sharpened strategy with a <br>greater focus on organic growth <br>leveraging our global securities exchange <br>platform<br>Outline the role of inorganic investments <br>in the execution of our overall strategy <br>| •Continued to communicate sharpened strategic focus with <br>stockholders and employees <br>•Developed and implemented a more robust and disciplined <br>approach to capital allocation<br>•Refocused the role of inorganic investments <br>|
| Advance the Company's culture and <br>talent<br>| •Continued to support employee resource groups<br>•Encouraged employees to support a culture of inclusion <br>•Sustained a high level of employee inclusivity engagement <br>score<br>•Continued charitable donation match benefit <br>|
| Implement succession plan for both an <br>unexpected and an orderly succession<br>| •Held succession planning meetings with the Compensation <br>and Human Capital Committee and the Board <br>•Along with the Compensation and Human Capital Committee <br>and Board, identified and hired a new CEO <br>•Successfully transitioned the CEO role to Mr. Donohue<br>•Held succession planning meetings to determine appropriate <br>talent pipeline and retention risk<br>•Refined and developed a successor talent bench across <br>critical positions and extended succession planning deeper <br>into the organization<br>|

---

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 47 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

The table below shows Ms. Griebenow's individual goals and achieved performance highlights in 2025.

---

| | |
|:---|:---|
| **Goal** | **Performance** |
| Manage the Company and its affiliates to <br>achieve the corporate strategic goals <br>listed above<br>| •As discussed above and in "2025 Business Highlights", <br>overall, achieved the targeted 2025 strategic goals<br>|
| Manage the financial and administrative <br>functions of the Company and its affiliates<br>| •Continued timely and accurate financial reporting<br>•Continued to strengthen and enhance internal controls <br>•Developed a framework outlining strategic and financial <br>criteria used to evaluate our businesses and initiatives <br>•Completed the build out of new office space in Overland <br>Park, Kansas and began trading floor enhancements<br>|
| Effective communication with investment <br>(equity and credit) community, and the <br>public to articulate investment thesis, <br>strategic priorities, capital allocation <br>approach and key performance metrics<br>| •Engaged with stockholders at investor and industry <br>conferences, and by participating in informational fireside <br>chats and hosting meetings<br>•Continued open dialogue with customers and investors<br>•Maintained strong relationships with banking syndicate group <br>and rating agencies<br>•Continued to communicate growth story to investors<br>|
| Execute our sharpened strategy with a <br>greater focus on organic growth <br>leveraging our global securities platform<br>Outline the role of inorganic investments <br>in the execution of our overall strategy <br>| •Completed a comprehensive strategic review of global <br>business operations<br>•Helped to drive meaningful change in the budgeting process <br>and overall expense discipline<br>•Maintained financial rigor to help position for potential future <br>inorganic investments<br>|
| Ensure recruitment, retention and <br>rewarding of diverse, top performing <br>talent and institutional knowledge by <br>driving overall engagement and <br>innovation<br>| •Continued to maintain high employee retention and <br>engagement, despite competitive job market and leadership <br>transitions<br>•Held routine succession planning meetings to determine <br>appropriate talent pipeline, including focus on leadership <br>development, recruitment, extending succession planning <br>deeper into the organization, and retaining key talent <br>throughout 2025<br>|
| Advance the Company's culture and <br>talent<br>| •Helped promote integrity, inclusivity and ethical conduct<br>•Participated in employee resource groups, mentorship <br>programs, the Company's Charity Board, and Cboe <br>Empowers <br>•Executive sponsor of the Company's Women's Initiative and <br>the Company-wide senior director/director group<br>|

---

The table below shows Mr. Isaacson's individual goals and achieved performance highlights in 2025.

---

| | |
|:---|:---|
| **Goal** | **Performance** |
| Manage the Company and its affiliates to <br>achieve the corporate strategic goals <br>listed above<br>| •As discussed above and in "2025 Business Highlights", <br>overall, achieved the targeted 2025 strategic goals<br>|

---

---

| | |
|:---|:---|
| 48 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| Manage global internal and external <br>communications with the investment <br>community, the government, regulators <br>and the public to promote integrity of the <br>markets and confidence in our innovation <br>superiority and products<br>| •Engaged with stockholders at investor and industry <br>conferences, and by participating in informational fireside <br>chats and hosting meetings<br>•Regulatory engagement helped advocate for the Company's <br>interests and led to positive changes, such as streamlined <br>oversight of BIDS Trading and the SEC Rule 611 roundtable<br>•Continued open dialogue with customers, investors, and <br>regulators<br>•Hosted a Company technology summit incorporating <br>customer, vendor, and Board perspectives<br>•Continued board leadership and governance at Cboe Global <br>Markets and its subsidiaries (Cboe Clear U.S. and Cboe <br>Digital)<br>•Met with global government officials, lawmakers, and <br>regulators<br>|
| Manage the operation of the Company <br>and its affiliates to ensure resilient, <br>efficient, and innovative service at a <br>competitive cost<br>Maintain best in class platforms with a <br>high level of performance, availability, <br>and resilience while driving innovation, <br>organic initiatives, and merger and <br>acquisition integrations<br>| •Achieved record financial results in 2025 <br>•Completed dedicated cores roll out globally <br>•Continued weekly software releases across our platforms, <br>executing against strategic technology roadmap <br>•100% uptime across 26 of our 27 markets in 2025 and <br>greater than 99.9% uptime across all our markets globally, <br>while significantly reducing latencies <br>•Completed Cboe Canada and Cboe Digital Exchange <br>migrations <br>•Supported global business lines' introductions of a wide <br>range of differentiated new features, offerings, and market <br>structure changes in a globally consistent, locally optimized <br>manner <br>•Managed prudent expense growth and monitoring to help <br>fuel revenue growth<br>|
| Execute on our sharpened strategy with a <br>greater focus on organic growth <br>leveraging our strengths and global <br>exchange platform.<br>Outline the role of inorganic investments <br>in the execution of our overall strategy <br>| •Continued to communicate internally technology strategy and <br>key principles<br>•Improved resource tracking and allocation<br>•Continued to drive technology innovation <br>•Reviewed data center strategy and capacity planning for <br>long-term growth, and executed multiple data center <br>migrations<br>•Coached business leaders on compelling organic growth <br>opportunities<br>|

---

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 49 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| Assess risks to the Company and ensure <br>they are monitored and minimized<br>| •Reviewed and analyzed enterprise risk management <br>program and key risk indicators on a periodic basis with key <br>Company leaders and the Risk Committee<br>•Managed key risks within risk tolerance<br>•Progressed on cyber security preparedness and resilience, <br>including holding cyber security tabletop exercises <br>•Continued to strengthen and enhance internal controls and <br>began enhancing our governance, risk, and compliance <br>framework<br>•Monitored and improved global technology and operations <br>capacity and performance to handle the most volatile market <br>times <br>|
| Ensure recruitment, retention and <br>rewarding of diverse, top performing <br>talent and institutional knowledge by <br>driving overall engagement and <br>innovation, including during integration of <br>any mergers and acquisitions<br>| •Assumed leadership of Global Cash Equities, FX, Clearing <br>and BIDS business lines in May 2025<br>•Continued to maintain high employee retention and <br>engagement, despite competitive job market, leadership <br>transitions, and strategic realignment decisions<br>•Continued to lead leadership development program<br>•Held routine succession planning meetings to determine <br>appropriate talent pipeline, including focus on recruitment, <br>extending succession planning deeper into the organization, <br>and retaining key talent throughout 2025<br>•Implemented multiple leadership transitions <br>•Conducted extensive coaching of and engagement with team <br>members to help with development and retention<br>|
| Advance the Company's culture and <br>talent<br>| •Helped promote integrity, inclusivity and ethical conduct<br>•Participated in employee resource groups, mentorship <br>program, and women in technology and operations groups <br>•Promoted greater financial rigor<br>•Office and culture leader for the Overland Park, Kansas <br>office, including through new office space opening <br>•Sustained a high level of employee engagement scores<br>|
| Provide leadership and oversight of <br>global cash equities, clearing, FX, and <br>BIDS business lines<br>| •Led business leaders through comprehensive strategic <br>review of global business operations, resulting in several <br>meaningful decisions<br>•Enhanced financial rigor through leadership and strategic <br>review of businesses under oversight<br>•Multiple businesses under oversight exceeded budgeted <br>expectations and worked to improve the sole outlier<br>•Continued and improved collaboration across business lines <br>and functions<br>|

---

The Compensation and Human Capital Committee did not evaluate Mr. Howson's or Ms. Clay's performances

as they each forfeited their respective bonus as a result of their resignations.

In addition to contributions to corporate performance, in determining the achievement of NEOs' 2025

performance, the Compensation and Human Capital Committee considered the following individual

contributions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Sexton: As discussed above and in "2025 Business Highlights", overall, achieved the targeted 2025

![cboe-20240516xdef14a_a004 (1).jpg](cboe-20260401_g9.jpg)

strategic goals; supported business organic growth initiatives by navigating global regulatory

frameworks to assist the Company in offering new products and features; maintained and improved

---

| | |
|:---|:---|
| 50 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

existing regulatory relationships; regulatory engagement helped advocate for the Company's interests

and led to positive changes, such as streamlined oversight of BIDS Trading; supported control

functions; supported cyber security preparedness; expanded role in May 2025 with oversight of the

Public Policy and Government Affairs and Internal Audit functions; developed succession plans and

cross training; globalized the legal function; oversaw successful leadership transitions; defended the

Company's positions; and actively participated in employee resource groups and community programs.

Mr. Lipscomb: As discussed above and in "2025 Business Highlights", overall, achieved the targeted

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

2025 strategic goals; advanced the Company's culture and talent aspirations and enhanced the

employee experience; delivered best-in-class trading technology and superior service; provided stable

and resilient markets through all types of market conditions; further expanded access to our products,

data and services for customers globally; effectively completed Cboe Canada migration and re-

platforming and Cboe Digital migration to CFE; prepared for multiple leadership transitions; guided our

technology team through major milestones; utilized technology, such as AI, to enhance productivity,

competitiveness, and customer quality.

Based on, among other items, the above performances, the performance of each NEO and the business unit(s)

or function(s) under his or her leadership, input from Mr. Donohue regarding performances (other than himself

and Mr. Tomczyk), and its deliberations, the Compensation and Human Capital Committee and the Board of

Directors, as applicable, determined the payout percentage for individual performance of each NEO's target

annual incentive award opportunity. Such individual performance payouts ranged from 125% to 200% of target.

***Actual Annual Incentive Payouts.*** For 2025, the following table shows the combined payout percentage for

corporate and individual performance of each NEO's target annual incentive award opportunity. The "Non-

Equity Incentive Plan Compensation" column of the Summary Compensation Table ("SCT") below reflects

amounts paid under the annual incentive plan.

---

| | | |
|:---|:---|:---|
| **Named Executive Officer** | **2025 Target Annual**<br>**Incentive**<br>**Opportunity as**<br>**Percentage of**<br>**Base Salary**<br>| **2025 Percentage**<br>**Payout of**<br>**Target Incentive**<br>**Opportunity**<br>|
| Craig S. Donohue (1) | 150% | 200% |
| Jill M. Griebenow | 130% | 185% |
| Christopher A. Isaacson | 150% | 185% |
| Patrick Sexton | 120% | 185% |
| Timothy Lipscomb (2) | See note 2 | 177% |
| Fredric J. Tomczyk (3) | 165% | 185% |
| David Howson (4) | 150% | n/a |
| Catherine R. Clay (4)(5) | See note 5 | n/a |

---

____________________________________

(1)Mr. Donohue was appointed as Chief Executive Officer effective May 7, 2025. Mr. Donohue received a

prorated portion of his 2025 annual incentive bonus based on his employment from May 7, 2025 through

December 31, 2025.

(2)Mr. Lipscomb's 2025 target annual incentive opportunity from January 1, 2025 through May 31, 2025 was

90% of his base salary and then from June 1, 2025 through December 31, 2025 was 110% of his base

salary.

(3)Mr. Tomczyk's employment with the Company ended on June 30, 2025. Mr. Tomczyk received a prorated

portion of his 2025 annual incentive bonus based on his employment through June 30, 2025 and payable

based on actual performance and at the same time as paid to other executives of the Company. Mr.

Tomczyk did not receive any severance or additional payments upon the termination of his employment with

the Company.

(4)Mr. Howson and Ms. Clay each forfeited their 2025 annual incentive opportunity in connection with their

respective resignations.

(5)Ms. Clay's 2025 target annual incentive opportunity from January 1, 2025 through February 28, 2025 was

100% of her base salary, from March 1, 2025 through May 31, 2025 was 110% of her base salary, and from

June 1, 2025 through her last day with the Company was 130% of her base salary.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 51 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***Long-Term Incentive Plan***

***Overview.*** The Compensation and Human Capital Committee strongly believes that a stock ownership culture

enhances our long-term success. We have adopted the Third Amended and Restated Cboe Global Markets,

Inc. Long-Term Incentive Plan, which was approved by stockholders at the 2025 Annual Meeting of

Stockholders. Under the plan, the Compensation and Human Capital Committee may grant equity or cash

awards, including restricted stock, RSUs, and options. Stock options were not featured in our long-term

incentive program in 2025.

The Compensation and Human Capital Committee believes that equity awards assist us in meeting the

following goals:

Aligning the financial interests of our executive officers with the interests of our stockholders;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Aligning our executive compensation with that of our peers in terms of components and value;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Providing competitive compensation to assist in retaining highly skilled and qualified executives; and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Providing strong retentive value and linking the ultimate value of the award to our future stock price.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

***2025 Grants.*** The Compensation and Human Capital Committee set each NEO's 2025 target long-term

incentive value following a review of comparative peer group and executive compensation survey market data

and individual performance. Once the Compensation and Human Capital Committee set the target long-term

incentive value for each NEO, one-half of the target value was granted in the form of time-based RSUs and

one-half of the target value was granted in the form of PSUs, except that in the case of Mr. Tomczyk all of the

target value was granted in the form of time-based RSUs. Mr. Donohue's target value was set in connection

with his appointment as Chief Executive Officer on May 7, 2025. One-half of the target value of Mr. Donohue's

award was granted in the form of time-based RSUs and one-half of the target value was granted in the form of

PSUs. These grants were prorated and vest on the same schedule as 2025 grants for other NEOs.

Described below are the equity awards granted to each NEO in 2025, other than Mr. Tomczyk.

***Time-Based Restricted Stock Units.*** Time-based RSUs comprise 50% of each NEO's 2025 total

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

target long-term incentive award value. These RSUs are subject to a 3 year vesting period, with one-

third of the RSUs vesting on each of the first, second, and third anniversaries of the grant date. The

vesting of these awards is not subject to performance conditions. The Compensation and Human

Capital Committee granted time-based RSUs to align the interests of management with those of our

stockholders and to provide a retention incentive.

***Performance-Based Restricted Stock Units.*** PSUs comprise the remaining 50% of each NEO's 2025

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

total target long-term incentive award value. As described below, one-half of PSU grants are subject to

the achievement of Company TSR measured against pre-determined relative performance goals and

one-half of PSU grants are subject to the achievement of EPS measured against pre-determined

performance goals, both over a 3 year performance period. The PSU grants cliff-vest following the

completion of the 3 year performance period, to the extent performance goals are achieved.

◦ ***Performance-Based Restricted Stock Units subject to Relative Total Stockholder Return***

***("PSUs-TSR").*** 25% of the 2025 total target long-term incentive award value is subject to the

achievement of Company TSR measured against pre-determined relative performance goals over a

3 year performance period. The number of PSUs-TSR that will vest at the end of the 3 year

performance period will vary from 0% to 200% of the target number of PSUs-TSR granted to each

NEO, based on our TSR relative to the TSR for the S&P 500 Index during the 3 year performance

period. We calculate TSR as the increase in our stock price over the performance period plus

reinvested dividends, divided by the stock price at the beginning of the performance period.

The Compensation and Human Capital Committee selected the relative TSR performance metric to

incent management to increase TSR for the benefit of stockholders, and believes that tying a

portion of each executive's compensation to TSR compared to a broad index encourages

management to generate superior returns.

◦ ***Performance-Based Restricted Stock Units subject to Earnings Per Share ("PSUs-EPS").*** 

25% of the 2025 total target long-term incentive award value is subject to the achievement of

cumulative adjusted diluted EPS measured against pre-determined performance goals over a 3

year performance period. The number of PSUs-EPS that will vest at the end of the 3 year

performance period will vary from 0% to 200% of the target number of PSUs-EPS granted to each

---

| | |
|:---|:---|
| 52 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

NEO, based on our cumulative adjusted diluted EPS during the 3 year performance period, as

adjusted for certain extraordinary, unusual or non-recurring items.

The Compensation and Human Capital Committee selected the cumulative adjusted diluted EPS

performance metric to encourage management to continue growing the business and increasing

trading and listings on our exchanges. Because of the operating leverage inherent in our business,

the Compensation and Human Capital Committee believes that EPS growth over the next 3 years

is an appropriate performance measure for these awards.

PSUs-TSR and PSUs-EPS are equally weighted to encourage management to maintain an equal focus on

enhancing Company TSR and profitably growing the Company.

For each vested RSU or PSU, the NEO will receive one share of our common stock. To receive shares earned

under RSUs and PSUs, an NEO generally must be continuously employed during the applicable service period

or performance period. Vesting of RSUs and PSUs will be accelerated in the event of a change in control

followed by a qualified termination or in the event of a participant's earlier death or disability. Upon a qualified

retirement, all unvested outstanding RSUs will continue to vest and be settled in the normal course, and a pro-

rata portion of unvested outstanding PSUs will vest based on achieved performance over the applicable

performance period and be settled in the normal course, except that, with respect to Mr. Donohue, unvested

outstanding PSUs will not be pro-rated. For qualified retirement vesting, the equity grants starting in 2024 are

subject to a 6 or 12-month advance notice requirement, as applicable.

***2025 Time-Based RSU Grants.*** The following table shows the target equity award value and number of

time-based RSUs that were granted to each NEO on February 19, 2025, except for Mr. Donohue, who received

his grant on May 7, 2025. The target equity award value and the closing share price on February 19, 2025 were

used to calculate the number of RSUs that were granted on February 19, 2025 and the target equity award

value and the closing share price on May 7, 2025 were used to calculate the number of RSUs that were granted

to Mr. Donohue on May 7, 2025. Mr. Tomczyk's time-based RSU grant is discussed separately below.

---

| | | |
|:---|:---|:---|
| **Named Executive Officer** | **# of RSUs** | **Target Value**<br> **of RSUs**<br>|
| Craig S. Donohue | 14048 | $3290343 |
| Jill M. Griebenow | 5589 | $1175000 |
| Christopher A. Isaacson | 4459 | $937500 |
| Patrick Sexton | 2640 | $555000 |
| Timothy Lipscomb | 1249 | $262500 |
| David Howson | 8175 | $1718750 |
| Catherine R. Clay | 3568 | $750000 |

---

***2025 Performance-Based RSU Grants.*** The following table shows the target equity award value and

number of PSUs (tied to TSR and EPS performance) that were granted to each NEO on February 19, 2025,

except for Mr. Donohue, who received his grant on May 7, 2025, and the number of PSUs that would be paid at

achievement of threshold, target, and maximum performance goals. The target equity award value and the

closing share price on February 19, 2025 were used to calculate the number of PSUs that were granted on

February 19, 2025 and the target equity award value and the closing share price on May 7, 2025 were used to

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 53 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

calculate the number of PSUs that were granted to Mr. Donohue on May 7, 2025. Mr. Tomczyk did not receive

any PSU awards in 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **# of PSUs** | **# of PSUs** | **# of PSUs** | **Target Value of** <br>**PSUs** |
| **Named Executive Officer** | **Performance Metric** | **Threshold**<br>**(50% Payout)**<br>| **Target**<br>**(100% Payout)**<br>| **Maximum**<br>**(200% Payout)**<br>| **Target Value of** <br>**PSUs** |
| Craig S. Donohue | 2025-2027 TSR | 3512 | 7024 | 14048 | $1645171 |
|  | 2025-2027 EPS | 3512 | 7024 | 14048 | $1645171 |
| Jill M. Griebenow | 2025-2027 TSR | 1398 | 2795 | 5590 | $587500 |
|  | 2025-2027 EPS | 1398 | 2795 | 5590 | $587500 |
| Christopher A. Isaacson | 2025-2027 TSR | 1115 | 2230 | 4460 | $468750 |
|  | 2025-2027 EPS | 1115 | 2230 | 4460 | $468750 |
| Patrick Sexton | 2025-2027 TSR | 660 | 1320 | 2640 | $277500 |
|  | 2025-2027 EPS | 660 | 1320 | 2640 | $277500 |
| Timothy Lipscomb | 2025-2027 TSR | 313 | 625 | 1250 | $131250 |
|  | 2025-2027 EPS | 313 | 625 | 1250 | $131250 |
| David Howson | 2025-2027 TSR | 2044 | 4088 | 8176 | $859375 |
|  | 2025-2027 EPS | 2044 | 4088 | 8176 | $859375 |
| Catherine R. Clay | 2025-2027 TSR | 892 | 1784 | 3568 | $375000 |
|  | 2025-2027 EPS | 892 | 1784 | 3568 | $375000 |

---

The following table displays the threshold, target, and maximum performance goals for the PSU awards granted

in 2025, measured over the performance period beginning on January 1, 2025 and ending on December 31,

2027. ---

| | | | |
|:---|:---|:---|:---|
|  | **Threshold**<br>**(50% Payout)**<br>| **Target**<br>**(100% Payout)**<br>| **Maximum**<br>**(200% Payout)**<br>|
| Relative TSR Compared to S&P 500 | 25th Percentile | 50th Percentile | 75th Percentile |
| Cumulative Adjusted Diluted EPS | $27.90 | $30.69 | $33.66 |

---

For performance levels that fall between the goals shown above, the percentage of PSUs that vest will be

determined by straight line interpolation, provided that no PSUs will vest if the performance does not equal or

exceed the threshold amount.

***2025 Promotion Grants.*** During July 2025, the Compensation and Human Capital Committee and the Board,

as applicable, granted equity awards ("Promotion Grants") to Ms. Clay and Messrs. Isaacson, Sexton, and

Lipscomb to reflect their increased responsibilities following the reorganization of the Chief Executive Officer's

direct reports and the leadership of our global businesses that occurred following our recent Chief Executive

Officer transition. The Compensation and Human Capital Committee reviewed market benchmark data derived

from our peer group and executive compensation survey source to determine the value of the Promotion

Grants.

The Promotion Grants were granted on July 15, 2025 and were equally split between (i) time-based RSUs that

will vest in three equal annual installments on February 19, 2026, February 19, 2027, and February 19, 2028,

subject to continuous employment with the Company through such vesting dates and (ii) PSUs subject to the

achievement of the same performance goals as our other 2025 PSUs granted relating to (A) cumulative

adjusted diluted EPS and (B) relative TSR (each 25% of the total Promotion Grants) that will vest at the

conclusion of the performance period, each subject to continuous employment with the Company through such

dates.

The following table shows the target equity award value for the RSU portion of the Promotion Grants and the

number of time-based RSUs. The target equity award value and the closing share price on July 15, 2025 were

used to calculate the number of RSUs that were granted on July 15, 2025.

---

| | |
|:---|:---|
| 54 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | | |
|:---|:---|:---|
| **Named Executive Officer** | **# of RSUs** | **Target Value**<br> **of RSUs**<br>|
| Christopher A. Isaacson | 940 | $219863 |
| Patrick Sexton | 251 | $58630 |
| Timothy Lipscomb | 376 | $87945 |
| Catherine R. Clay | 627 | $146576 |

---

The following table shows the target equity award value for the PSU portion of the Promotion Grants and the

number of PSUs (tied to TSR and EPS performance) that were granted on July 15, 2025. The target equity

award value and the closing share price on July 15, 2025 were used to calculate the number of PSUs that were

granted on July 15, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **# of PSUs** | **# of PSUs** | **# of PSUs** | **Target Value of** <br>**PSUs** |
| **Named Executive Officer** | **Performance Metric** | **Threshold**<br>**(50% Payout)**<br>| **Target**<br>**(100% Payout)**<br>| **Maximum**<br>**(200% Payout)**<br>| **Target Value of** <br>**PSUs** |
| Christopher A. Isaacson | 2025-2027 TSR | 235 | 470 | 940 | $109932 |
|  | 2025-2027 EPS | 235 | 470 | 940 | $109932 |
| Patrick Sexton | 2025-2027 TSR | 63 | 126 | 252 | $29315 |
|  | 2025-2027 EPS | 63 | 126 | 252 | $29315 |
| Timothy Lipscomb | 2025-2027 TSR | 94 | 188 | 376 | $43973 |
|  | 2025-2027 EPS | 94 | 188 | 376 | $43973 |
| Catherine R. Clay | 2025-2027 TSR | 157 | 314 | 628 | $73288 |
|  | 2025-2027 EPS | 157 | 314 | 628 | $73288 |

---

Please see the above 2025 PSU Performance Goals Table which displays the threshold, target, and maximum

performance goals for the PSU awards granted in 2025, measured over the performance period beginning on

January 1, 2025 and ending on December 31, 2027.

For performance levels that fall between the goals shown above, the percentage of PSUs that vest will be

determined by straight line interpolation, provided that no PSUs will vest if the performance does not equal or

exceed the threshold amount.

***2025 One Time Grants.*** Based on a review of Ms. Clay's compensation, the Compensation and Human Capital

Committee determined that Ms. Clay's then outstanding equity awards did not adequately reflect the value of

her role in the Company. Therefore, on February 19, 2025, the Committee granted Ms. Clay an additional equity

award of time-based RSUs (the "One Time Grant") with a grant date target value of $500,000 and that cliff vest

in full on February 19, 2028, subject to her continuous employment with the Company through such vesting

date.

The Compensation and Human Capital Committee established the target value of the One Time Grant by

considering market benchmark data derived from our peer group and executive compensation survey source.

The following table shows the target equity award value and the number of time-based RSUs. The target equity

award value and the closing share price on February 19, 2025 were used to calculate the number of RSUs that

were granted on February 19, 2025 pursuant to the One Time Grant. Ms. Clay forfeited the One Time Grant

upon her resignation in 2025.

---

| | | |
|:---|:---|:---|
| **Named Executive Officer** | **# of RSUs** | **Target Value**<br> **of RSUs**<br>|
| Catherine R. Clay | 2379 | $500000 |

---

***Mr. Tomczyk's 2025 Time-Based RSU Grant.*** In February 2025, the Compensation and Human Capital

Committee determined to grant Mr. Tomczyk time-based RSUs in lieu of the time-based RSUs and PSUs

granted to other NEOs, consistent with the structure of his initial equity grant in 2023. These RSUs will vest in

three equal annual installments, with the first installment having vested on February 19, 2026 and the remaining

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 55 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

installments vesting on February 19, 2027 and February 19, 2028, respectively, subject to Mr. Tomczyk's

continued service as either Chief Executive Officer or as a director through each such vesting date.

The RSUs provide that if Mr. Tomczyk ceases to serve as Chief Executive Officer, but remains as a director, the

number of shares awarded will be multiplied by a fraction, the numerator of which is the number of days served

as Chief Executive Officer plus 90 (not to exceed 365) and the denominator of which is 365.

In connection with Mr. Tomczyk's resignation as Chief Executive Officer, this provision was revised to provide

that Mr. Tomczyk will receive vesting credit through his termination of employment on June 30, 2025 plus 90

days.

The target value of the grant was determined following a review of comparative peer group and executive

compensation survey market data and individual performance. The following table shows the initial target value

and number of time-based RSUs that were granted to Mr. Tomczyk on February 19, 2026, as well as the target

value and number of time-based RSUs as adjusted pursuant to the pro rata provision. The target value and the

closing share price on February 19, 2025 were used to calculate the number of RSUs that were granted on

February 19, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Named Executive Officer** | **Initial # of** <br>**RSUs**<br>| **Initial Target** <br>**Value**<br> **of RSUs**<br>| **# of RSUs as** <br>**adjusted**<br>| **Target Value**<br> **of RSUs as** <br>**adjusted**<br>|
| Fredric J. Tomczyk | 44471 | $9350000 | 32896 | $6916384 |

---

***Mr. Donohue's Sign-On Grant.*** On May 7, 2025, Mr. Donohue received a sign-on long-term equity award with

a grant date target value of $6,000,000 (equally split between time-based RSUs and PSUs) (the "Sign-On

Grant") in connection with his appointment as Chief Executive Officer.

The time-based RSUs cliff-vest in full on May 7, 2028. The PSUs are subject to the achievement of the same

performance goals as our other 2025 PSUs relating to (A) cumulative adjusted diluted EPS and (B) relative TSR

(each 25% of the total Sign-On Grant) that will vest at the conclusion of the performance period. Both awards

are subject to Mr. Donohue's continuous employment with the Company through such date.

If Mr. Donohue is terminated "without cause" or resigns from the Company for "good reason," he will fully vest in

the Sign-On Grant, subject to actual performance at the end of the performance period with respect to the PSU

portion of the Sign-On Grant, subject to Mr. Donohue's execution and non-revocation of a waiver and release of

claims in favor of the Company.

The following table shows the target equity award value for the RSU portion of the Sign-On Grant and number

of time-based RSUs. The target equity award value and the closing share price on May 7, 2025 were used to

calculate the number of RSUs that were granted on May 7, 2025.

---

| | | |
|:---|:---|:---|
| **Named Executive Officer** | **# of RSUs** | **Target Value**<br> **of RSUs**<br>|
| Craig S. Donohue | 12808 | $3000000 |

---

The following table shows the target equity award value for the PSU portion of the Sign-On Grant and number

of PSUs (tied to TSR and EPS performance). The target equity award value and the closing share price on May

7, 2025 were used to calculate the number of PSUs that were granted on May 7, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **# of PSUs** | **# of PSUs** | **# of PSUs** | **Target Value of** <br>**PSUs** |
| **Named Executive Officer** | **Performance Metric** | **Threshold**<br>**(50% Payout)**<br>| **Target**<br>**(100% Payout)**<br>| **Maximum**<br>**(200% Payout)**<br>| **Target Value of** <br>**PSUs** |
| Craig S. Donohue | 2025-2027 TSR | 3202 | 6404 | 12808 | $1500000 |
|  | 2025-2027 EPS | 3202 | 6404 | 12808 | $1500000 |

---

Please see the above 2025 PSU Performance Goals Table which displays the threshold, target, and maximum

performance goals for the PSU awards granted in 2025, measured over the performance period beginning on

January 1, 2025 and ending on December 31, 2027.

For performance levels that fall between the goals shown above, the percentage of PSUs that vest will be

determined by straight line interpolation, provided that no PSUs will vest if the performance does not equal or

exceed the threshold amount.

***2023 PSU Grants Vested.*** The Compensation and Human Capital Committee and the Board, as applicable,

approved grants on February 19, 2023 of PSUs (the "Regular 2023 PSUs") to our NEOs, except for Messrs.

Donohue, Tomczyk, and Lipscomb, who did not receive grants of 2023 PSUs. Additionally, the Compensation

---

| | |
|:---|:---|
| 56 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

and Human Capital Committee and the Board approved promotion related grants of PSUs to Mses. Griebenow

and Clay on August 19, 2023 and November 19, 2023, respectively (together with the Regular 2023 PSUs, the

"2023 PSUs"). The 2023 PSUs were subject to the achievement of TSR and EPS measured against the pre-

determined performance goals, both over a 3 year performance period beginning on January 1, 2023 and

ending on December 31, 2025. In early 2026, the Compensation and Human Capital Committee determined

that the following performance was achieved resulting in the indicated payout:

The TSR percentile attained was the 86th percentile, which resulted in the vesting of 200% of the target

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

number of PSUs-TSR granted to each applicable NEO.

The 3-year cumulative adjusted diluted EPS attained was $27.08<sup>(1)</sup>, which resulted in the vesting of

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

200% of the target number of PSUs-EPS granted to each applicable NEO.

____________________________________

(1)The 3 year adjusted EPS is a non-GAAP measure used by the Company and a reconciliation to a GAAP

measure is provided in Appendix A.

The specific performance goals for the PSUs-TSR and PSUs-EPS for the 2023-2025 performance period were

previously disclosed in our proxy statement covering 2023 compensation.

The table below shows the number of 2023 PSUs that vested at the conclusion of the applicable performance

period for each applicable NEO and does not include dividend equivalent payments. With respect to Mr.

Howson, he was allowed to retain a pro rata portion of the outstanding 2023 PSUs that would have vested in

February 2026 based on the number of days worked through his transition date, and which were paid out based

on target performance through the end of the applicable performance period for each award, and he forfeited

the remainder of such awards and all other outstanding 2023 PSUs. Ms. Clay's 2023 PSUs vested in

connection with her separation from service, which qualified as a retirement under the terms of the underlying

awards, subject to the determination of achievement of the underlying awards.

---

| | | | |
|:---|:---|:---|:---|
| **Named Executive Officer** | **Performance Metric** | **# of PSUs**<br>**at Target**<br>**(100% Payout)**<br>| **# of PSUs**<br>**Vested**<br>|
| Jill M. Griebenow | 2023-2025 TSR | 1627 | 3254 |
|  | 2023-2025 EPS | 1627 | 3254 |
| Christopher A. Isaacson | 2023-2025 TSR | 3731 | 7462 |
|  | 2023-2025 EPS | 3731 | 7462 |
| Patrick Sexton  | 2023-2025 TSR | 2339 | 4678 |
|  | 2023-2025 EPS | 2339 | 4678 |
| Catherine R. Clay (1) | 2023-2025 TSR | 1418 | 2640 |
|  | 2023-2025 EPS | 1418 | 2640 |

---

____________________________________

(1)Ms. Clay received pro rata vesting of her 2023 PSU awards, subject to the determination of achievement of

the underlying awards, in connection with her resignation, as she was retirement eligible at the time of her

separation from service. The prorated vesting shown above in the # of PSUs Vested column reflects Ms.

Clay's continuous service for a portion of the performance period.

**Other Executive Compensation Program Considerations**

***Stock Ownership and Holding Guidelines***

Our stock ownership and holding guidelines specify the levels of stock ownership that each NEO must maintain

while employed by us. Shares owned outright or in trust count toward the stock ownership guidelines. Shares of

restricted stock or stock units, including PSUs, that are unvested do not count towards the stock ownership

guidelines.

Each NEO is required to hold all shares until the guidelines are met, except for sales of shares to pay taxes with

respect to the vesting or exercising of equity grants. As of December 31, 2025, each of our NEOs then subject

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 57 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

to the guidelines, other than Messrs. Donohue and Lipscomb, has met the applicable holding requirement

based on his or her position with us.

---

| | |
|:---|:---|
| **Named Executive Officer** | **Holding Requirement** |
| Craig S. Donohue | Six times base salary  |
| Jill M. Griebenow | Four times base salary  |
| Christopher A. Isaacson | Four times base salary |
| Patrick Sexton | Three times base salary |
| Timothy Lipscomb | Three times base salary |

---

***Hedging Policy***

Our Insider Trading Policy prohibits our executive officers and all employees, except as set forth below, from

entering into transactions involving options to purchase or sell our common stock or other derivatives related to

our common stock.

In 2025, none of our executive officers had hedges on shares of our common stock.

Employees, other than our executive officers, may enter into the following types of security transactions on our

common stock through the purchase or sale of exchange-traded options, provided that they otherwise comply

with the remainder of our Insider Trading Policy:

Covered calls (i.e., the writing of exchange-traded call options covering a number of shares less than or

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

equal to the total number of unrestricted shares and vested shares owned by the call writer); and

Collars for hedging purposes (i.e., the sale of exchange-traded call options and the purchase of an

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

equivalent number of put options, in each case, covering a number of shares less than or equal to the

total number of unrestricted shares and vested shares owned by the holder).

As one of the world's largest exchange holding companies, offering cutting-edge trading and investment

solutions to investors around the world and owning the largest options exchange, we believe options are first

and foremost incredibly useful and powerful risk mitigation tools that can help protect an investor's financial

portfolio. From buying puts to hedge the downside risk of owning a stock to writing covered calls to collect

income, listed options strategies are protective tools employed by institutions, pension funds, and individual

investors. As such, we believe that it is appropriate for our employees, other than our executive officers, to

engage in the above mentioned selected hedging transactions, because:

These strategies help empower our employees to preserve their investment capital and protect their

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

financial future, while continuing to own our common stock and be invested in their workplace;

Employees are required to comply with our Insider Trading Policy and other policies, which may include

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

trade monitoring, receiving certain pre-approvals, and observing blackout periods when purchasing or

selling options;

Employees must wait generally 1 year until a portion of their equity grants vest before they are able to

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

purchase or sell options on the related vested common stock;

The interests of our employees continue to be aligned with our stockholders through their continued

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

ownership of our common stock and ability to retain their rights to voting and dividends as our

stockholders;

Employees are able to collect income on their common stock from the sale of options without having to

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

sell our stock; and

Due to their continued ownership of our common stock, employees continue to be discouraged from

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

excessive risk-taking that could negatively impact our business and stock price over time.

See also "Corporate Governance—Insider Trading Policy" for more information.

***Pledging Policy***

Our Insider Trading Policy prohibits our executive officers and all employees from entering into any pledges or

margin loans on shares of our common stock. In 2025, none of our executive officers had pledges or margin

loans on shares of our common stock. See also "Corporate Governance—Insider Trading Policy" for more

information.

---

| | |
|:---|:---|
| 58 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***Clawback Policies***

***Mandatory Clawback Policy.*** Effective October 11, 2023, we adopted a mandatory clawback policy with

respect to incentive compensation received by executive officers on or after October 2, 2023. The policy

provides that following an accounting restatement, the Compensation and Human Capital Committee must

assess whether any incentive amounts paid to current and former executive officers were in excess of what

should have been paid based on the revised financial statements, and thus should be subject to mandatory

recovery (subject to certain limited regulatory exceptions). The policy has a 3 year look-back and applies to both

current and former executives, regardless of such executive's fault, misconduct or involvement in causing the

restatement. The equity award agreements contain provisions applying the clawback policy to equity grants.

The clawback policy is intended to meet the requirements of Section 954 of the Dodd-Frank Act, the final rules

issued by the SEC on October 26, 2022, and BZX listing requirements.

Additionally, the Company's prior clawback policy will continue to cover compensation received prior to October

2, 2023. The prior clawback policy provides that we will attempt to recover incentive amounts paid to executive

officers in the event of a restatement of our financial statements due to any material noncompliance with any

financial reporting requirement. The prior policy has a 3 year look-back and applies to both current and former

executives, regardless of such executive's fault, misconduct or involvement in causing the restatement.

***Supplemental Discretionary Clawback Policy.*** Effective December 18, 2024, we adopted a supplemental

discretionary clawback policy covering any cash and equity compensation, such as annual incentives, time-

based RSUs, performance-based PSUs, severance and termination related benefits, but excluding base salary,

commissions, and other qualified retirement benefits (collectively, "Covered Compensation"), received by

current and former executive officers and other executive vice presidents who are not already executive officers

("Covered Persons"). The policy provides that following a covered event, the Compensation and Human Capital

Committee may, in its sole discretion, recover up to 100% of the Covered Compensation paid to applicable

Covered Persons.

Covered events include engaging, after the effective date, in any breach of any restrictive covenants owed to

the Company and in any conduct that is or could be grounds for termination for cause, which includes, among

other items, (a) willful failure to perform material duties owed to the Company, (b) fraud, breach of fiduciary duty,

dishonesty, misappropriation or any other action causing damage to the Company, (c) admission or conviction

of any felony that adversely affects the Company, and (d) any act or omission in violation of the Company's

policies, including the Company's harassment and discrimination policies and the Code of Business Conduct

and Ethics, that causes damage to the Company.

Additionally, if a Covered Person is not covered by the mandatory clawback policy, the supplemental

discretionary clawback policy provides that following an accounting restatement, the Compensation and Human

Capital Committee may recover any incentive amounts paid to a Covered Person that was in excess of what

should have been paid based on the revised financials, regardless of such executive's fault, misconduct or

involvement in causing the restatement.

The policy has a 3 year look-back. The equity award agreements contain provisions applying the supplemental

discretionary clawback policy to equity grants. This policy applies to compensation received on or after

December 18, 2024.

***Employee Benefit Plans, Severance, Change in Control, and Employment-Related Agreements***

We provide medical, life, and disability insurance coverage to all of our employees, including our NEOs. In

addition, for NEOs and certain other employees, we provide participation in the Supplemental Executive

Retirement Plan ("SERP") and the Cash Deferral Plan, which are described more fully below under "Summary

Compensation—Non-Qualified Deferred Compensation Plans". We offer this coverage to provide a competitive

benefits program, a level of protection for catastrophic events, and income during retirement. The SERP and the

Cash Deferral Plan are defined contribution plans. We do not provide any defined benefit retirement plans to our

executive officers or employees.

In May 2018, the Company's stockholders approved an Employee Stock Purchase Plan ("ESPP") under which

a total of 750,000 shares of the Company's common stock are made available for purchase to employees and,

starting in September 15, 2022, to our executive officers. The ESPP is a broad-based plan that permits

employees to contribute up to 10% of wages and base salary to purchase shares of the Company's common

stock at a discount, subject to applicable annual Internal Revenue Service limitations. Under the ESPP, a

participant may not purchase more than a maximum of 312 shares of the Company's common stock during any

single offering period. No participant may accrue options to purchase shares of the Company's common stock

at a rate that exceeds $25,000 in fair market value of the Company's common stock (determined at the time

such options are granted) for each calendar year in which such rights are outstanding at any time. The exercise

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 59 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

price per share of common stock shall be 85% of the lesser of the fair market value of the stock on the first day

of the applicable offering period or the applicable exercise date.

Other than Mr. Donohue, our executive officers are covered under the Executive Severance Plan to encourage

retention, maintain a consistent management team to effectively run our operations, assist with separation

proceedings, and allow executives to focus on our strategic business priorities. The Executive Severance Plan

contains severance and change in control provisions and is described more fully below under "Severance,

Change in Control, and Employment-Related Agreements". Any payments under the Executive Severance Plan

upon a change in control will only occur if an NEO's employment is terminated without cause or he or she

resigns for good reason during a set period following the change in control, known as a double trigger provision.

Mr. Donohue's employment agreement contains severance provisions and is described more fully below under

"Severance, Change in Control, and Employment-Related Agreements".

***Tax and Accounting Considerations***

The Compensation and Human Capital Committee considers the tax and accounting implications of

compensation to us and the tax implications to our NEOs. However, changes in tax laws or their interpretation

and other outside factors may affect the deductibility of certain compensation payments. The Compensation and

Human Capital Committee reserves the right to pay compensation that is not deductible for tax purposes when,

in its judgment, such compensation is appropriate.

**COMPENSATION AND HUMAN CAPITAL COMMITTEE REPORT**

The Compensation and Human Capital Committee consists of Ms. Froetscher (Chair), Mr. Farrow, Ms.

Mansfield, Mr. Matturri, and Mr. Parisi, each of whom the Board has determined is independent under BZX

listing rules and our Corporate Governance Guidelines. The Compensation and Human Capital Committee has

duties and powers as described in its written charter adopted by the Board. A copy of the charter can be found

on our Investor Relations page at http://ir.Cboe.com.

The Compensation and Human Capital Committee has reviewed and discussed with management the

disclosures contained in the foregoing section entitled "Compensation Discussion and Analysis". Based on this

review and discussion, the Compensation and Human Capital Committee recommended to the Board that the

section entitled "Compensation Discussion and Analysis" be included in this Proxy Statement for the Annual

Meeting.

**Compensation and Human Capital Committee**

Janet P. Froetscher (Chair)

William M. Farrow, III

Erin A. Mansfield

Alexander J. Matturri, Jr.

James E. Parisi

**RISK ASSESSMENT**

We believe that any potential risks arising from our employee compensation policies and practices are not likely

to have a material adverse effect on us. With assistance from Meridian, the Compensation and Human Capital

Committee reviewed and discussed a risk assessment of our compensation policies and practices for all

employees for 2025, including non-executive officers, in its oversight capacity.

The Compensation and Human Capital Committee and management considered a number of factors, including

the following factors, when reviewing potential risk from our employee compensation policies and practices:

Our compensation program is designed to provide a mix of both fixed and variable incentive

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

compensation.

The variable ("at-risk") portions of compensation are designed to reward both annual and long-term

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

performance. We believe that this design mitigates any incentive for short-term risk-taking that could be

detrimental to the Company's long-term best interests.

Our senior executives are subject to stock ownership and holding guidelines, which we believe provide

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

incentives for our executives to consider the long-term interests of the Company and our stockholders

and discourage excessive risk-taking that could negatively impact our stock price over time.

---

| | |
|:---|:---|
| 60 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

We include clawback provisions in our executives' cash incentive and equity incentive awards as a

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

mechanism to recover compensation.

We utilize an independent compensation consultant to provide the Compensation and Human Capital

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Committee with advice on best practices and the risks associated with various compensation policies.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 61 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**SUMMARY COMPENSATION**

**2025 Summary Compensation Table** 

The table below sets forth, for the years indicated below, the compensation earned by our NEOs.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name and Principal Position** | **Year** | **Salary** | **Bonus (1)** | **Stock**<br>**Awards (2)**<br>| **Non-Equity**<br>**Incentive Plan**<br>**Compensation (3)**<br>| **All Other**<br>**Compensation (4)**<br>| **Total** |
| Craig S. Donohue (5) | 2025 | $846970 |  | $14742574 | $2553699 | $203795 | $18347037 |
| Chief Executive Officer and |  |  |  |  |  |  |  |
| President |  |  |  |  |  |  |  |
| Jill M. Griebenow | 2025 | $500000 |  | $2645952 | $1202500 | $116782 | $4465234 |
| Executive Vice President, | 2024 | $500000 |  | $2343978 | $800650 | $77673 | $3722301 |
| Chief Financial Officer | 2023 | $430522 | $150000 | $1039970 | $454911 | $78503 | $2153906 |
| Christopher A. Isaacson | 2025 | $650000 |  | $2661147 | $1803750 | $170100 | $5284997 |
| Executive Vice President,  | 2024 | $650000 |  | $2695626 | $1209000 | $158735 | $4713361 |
| Chief Operating Officer | 2023 | $650000 |  | $2091848 | $1130688 | $201720 | $4074256 |
| Patrick Sexton | 2025 | $450000 |  | $1398747 | $999000 | $82922 | $2930669 |
| Executive Vice President,  | 2024 | $446667 |  | $1422809 | $662041 | $62455 | $2593972 |
| General Counsel and Corporate <br>Secretary<br>| 2023 | $427500 |  | $1085605 | $595942 | $66256 | $2175303 |
| Timothy Lipscomb (5) | 2025 | $456583 |  | $794326 | $823967 | $95314 | $2170190 |
| Executive Vice President, |  |  |  |  |  |  |  |
| Chief Technology Officer |  |  |  |  |  |  |  |
| Fredric J. Tomczyk | 2025 | $500000 |  | $9350028 | $1513705 | $302451 | $11666184 |
| Former Chief Executive Officer | 2024 | $1000000 |  | $— | $2087250 | $238169 | $3325419 |
|  | 2023 | $287500 |  | $7150104 | $584990 | $343916 | $8366510 |
| David Howson | 2025 | $366951 |  | $5499750 | $— | $155842 | $6022543 |
| Former Executive Vice President, | 2024 | $625000 |  | $4427097 | $1132684 | $321888 | $6506669 |
| Global President | 2023 | $625000 |  | $3058526 | $978480 | $294250 | $4956256 |
| Catherine R. Clay | 2025 | $395833 |  | $2537683 | $— | $106872 | $3040388 |
| Former Executive Vice President, | 2024 | $500000 |  | $1116479 | $623450 | $94713 | $2334642 |
| Head of Global Derivatives | 2023 | $483333 |  | $1324372 | $513873 | $89681 | $2411259 |

---

_____________________________________

(1)The amount reported in this column for Ms. Griebenow for 2023 represents a one-time retention bonus of

$150,000.

(2)The amounts in the stock award column for 2025 include the grant date aggregate fair value of the awards

of RSUs and PSUs granted in 2025, as computed in accordance with stock-based compensation

accounting rules (Financial Standards Accounting Board ASC Topic 718) and do not represent realized or

realizable compensation. Actual value ultimately received by executives may differ materially based on

stock price performance and achievement of performance conditions. The award date value of PSUs is

based upon the probable outcome of the performance conditions and is consistent with the estimate of

aggregate compensation cost to be recognized over the service period determined as of the grant date,

excluding the effect of estimated forfeitures. For purposes of the SCT, we have assumed that the probable

outcome of the PSUs-EPS performance conditions would result in the awards vesting at approximately

target and the best estimate available for the aggregate compensation cost to be recognized over the

service period as of the grant date would reflect the value of each PSU-EPS at the Company's stock price

on the grant date and each PSU-TSR computed in accordance with the Monte Carlo valuation model. There

can be no assurance that these values will ever be realized. Assumptions used in the calculation of these

amounts are included in the footnotes to our 2025 consolidated financial statements, which are included in

our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC. The grant date

fair value of the PSUs awarded to each NEO, assuming the highest level of performance conditions will be

achieved, is $12,580,962 for Mr. Donohue, $2,350,595 for Ms. Griebenow, $2,315,256 for Mr. Isaacson,

$1,228,031 for Mr. Sexton, $701,555 for Mr. Lipscomb, $3,438,008 for Mr. Howson and $1,794,185 for Ms.

Clay. With respect to Mr. Donohue, the amount in the stock award column for 2025 also includes the one-

time sign-on long-term equity awards granted to Mr. Donohue in connection with his appointment as Chief

Executive Officer of the Company. See "Compensation Discussion and Analysis—2025 Elements of

---

| | |
|:---|:---|
| 62 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

Executive Compensation Program—Long-Term Incentive Plan—Mr. Donohue's Sign-On Grant" above for

additional information about the one-time sign-on long-term equity awards. With respect to Mr. Howson, the

amount in the stock award column for 2025 also includes $1,584,469, the incremental fair value as of the

modification date associated with Mr. Howson being allowed to retain a pro rata portion of his outstanding

time-based RSUs that would vest in February 2026 and outstanding PSUs that would vest in February

2026, in each case based on the number of days worked through Mr. Howson's transition date in

connection with Mr. Howson's resignation. See "Severance, Change in Control, and Employment Related

Agreements—Mr. Howson's Separation Letter Agreement" for additional information.

(3)The amounts shown reflect awards to the NEOs under our annual incentive plan. Annual incentive

payments for services performed in 2023, 2024, and 2025 by NEOs were paid in early 2024, 2025, and

2026, respectively. See "Compensation Discussion and Analysis—2025 Elements of Executive

Compensation Program—Annual Incentive" above for additional information about the Company's annual

incentive program.

(4)The amounts shown represent benefits that were, from time to time, made available to our executives,

including retirement plan contributions. For more information on the amounts shown in this column for 2025,

please see the following "2025 All Other Compensation Detail Table".

(5)Mr. Donohue and Mr. Lipscomb each became an NEO for the first time in 2025, and thus no amounts are

shown in the table for 2023 or 2024.

**2025 All Other Compensation Detail Table**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name** | **Qualified Defined**<br>**Contributions (1)**<br>| **Non-Qualified Defined**<br>**Contributions (2)**<br>| **Insurance (3)** | **Matching Gift**<br>**Program (4)**<br>| **Other (5)** |
| Craig S. Donohue (6) | $28000 | $39758 | $1848 | $10000 | $124189 |
| Jill M. Griebenow  | $28000 | $76052 | $630 | $11350 | $750 |
| Christopher A. Isaacson | $28000 | $120720 | $630 | $20000 | $750 |
| Patrick Sexton | $28000 | $31500 | $2772 | $20000 | $650 |
| Timothy Lipscomb (6)  | $28000 | $45910 | $966 | $16300 | $4138 |
| Fredric J. Tomczyk (7)(8) | $— | $— | $2534 | $— | $299917 |
| David Howson (9) | $28000 | $91969 | $394 | $4000 | $31479 |
| Catherine R. Clay (10) | $28000 | $48967 | $1430 | $— | $28476 |

---

_____________________________________

(1)The amounts shown are matching contributions to our qualified 401(k) plan, the Cboe Global Markets

SMART Plan, on behalf of each of the officers listed. In 2025 and early 2026 with respect to 2025, we

matched 200% of employee contributions up to 4% of the employee's compensation, subject to statutory

limitations.

(2)The amounts shown are our contributions to the SERP, a non-qualified defined contribution plan, on behalf

of each NEO. We matched 200% of such employee's contributions up to 4% of the employee's

compensation, subject to statutory limitations. The SERP is described more fully below under "Non-

Qualified Defined Contribution Plans".

(3)Represents the amount attributable to taxable life insurance in excess of $50,000.

(4)Amounts represent payments made by the Company (i) through our Matching Gift Program and (ii) by

matching PAC contributions, both of which are available to all eligible full-time employees, subject to

program limits. The amounts for Ms. Griebenow and Messrs. Isaacson and Howson also include matching

gifts with respect to 2024 that were paid out in 2025.

(5)The amounts shown in the "Other" column include airline club membership of $350 for Mr. Tomczyk, $650

for Messrs. Sexton and Howson, and $750 for Mr. Isaacson and Ms. Griebenow. Certain NEOs are also

provided with elevated or preferential status or access to club facilities with travel partners based on the

Company's procurement business relationship, with no incremental cost incurred by the Company.

(6)In connection with Mr. Lipscomb's appointment to Executive Vice President, Chief Technology Officer, he

received a payout of all accrued, unpaid paid time-off of $4,138, which is included in the "Other" column for

Mr. Lipscomb.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 63 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

(7)The amounts shown in the "Other" column for Messrs. Donohue and Tomczyk include the reimbursement of

$55,000 and $50,518, respectively, representing relocation assistance benefits and housing allowance and

$42,997 and $40,179, respectively, representing a tax gross-up on such benefits, related to their relocation

to the Company's headquarters in Chicago, Illinois at the Company's request in connection with their roles

as CEO. The relocation assistance benefits and housing allowance include, among others, housing and

services for tax liability assistance. The amounts shown in the "Other" column for Messrs. Donohue and

Tomczyk also include $18,518 and $8,853, respectively, for car service benefits and $7,674 and $7,041,

respectively, representing a tax gross-up on such benefits.

(8)Following Mr. Tomczyk's resignation as an employee, he continued to serve as a non-employee director on

the Board. The amount shown in the "Other" column for Mr. Tomczyk includes the following compensation

paid in connection with his partial-year service as a non-employee director of the Board: $48,440 in director

fees paid in cash and $144,536 representing the grant date fair value of an equity grant of RSUs received

by Mr. Tomczyk for his service as a non-employee director of the Board, as computed in accordance with

stock-based compensation accounting rules (Financial Standards Accounting Board ASC Topic 718).

Assumptions used in the calculation of this amount are included in the footnotes to our 2025 consolidated

financial statements, which are included in our Annual Report on Form 10-K for the year ended December

31, 2025 filed with the SEC. The equity grant vests on the earlier of the one-year anniversary of the grant

date or the completion of Mr. Tomczyk's final year of director service, subject to his continuous service

through the vesting date. Mr. Tomczyk's cash compensation as a non-employee director was established in

U.S. dollars and then paid in Canadian dollars. The amounts shown are in U.S. dollars.

(9)The amount shown in the "Other" column for Mr. Howson includes $17,172 for services for tax liability

assistance and $13,657 representing a tax gross-up on such tax liability assistance.

(10)In connection with Ms. Clay's separation, she received a payout of all accrued, unpaid paid time-off of

$28,476, which is included in the "Other" column for Ms. Clay.

**2025 Grants of Plan-Based Awards Table**

The 2025 grants of plan-based awards are as follows and are explained in more detail below:

---

| | |
|:---|:---|
| 64 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Grant**<br>**Date** | **Approval**<br>**Date** | **Estimated Future Payouts**<br>**Under Non-Equity Incentive**<br>**Plan Awards** | **Estimated Future Payouts**<br>**Under Non-Equity Incentive**<br>**Plan Awards** | **Estimated Future Payouts**<br>**Under Non-Equity Incentive**<br>**Plan Awards** | **Estimated Future Payouts**<br>**Under Equity Incentive**<br>**Plan Awards** | **Estimated Future Payouts**<br>**Under Equity Incentive**<br>**Plan Awards** | **Estimated Future Payouts**<br>**Under Equity Incentive**<br>**Plan Awards** | **All Other**<br>**Stock**<br>**Awards:**<br>**Number**<br>**of** <br>**Shares**<br>**of Stock**<br>**or Units** | **Grant Date**<br>**Fair Value of**<br>**Stock and**<br>**Option**<br>**Awards** |
|  | **Grant**<br>**Date** | **Approval**<br>**Date** | **Threshold** | **Target** | **Maximum** | **Threshold** | **Target** | **Maximum** | **All Other**<br>**Stock**<br>**Awards:**<br>**Number**<br>**of** <br>**Shares**<br>**of Stock**<br>**or Units** | **Grant Date**<br>**Fair Value of**<br>**Stock and**<br>**Option**<br>**Awards** |
| **Name** | **(1)** | **(1)** | **($)\*** | **($)\*** | **($)\*** | **(#)** | **(#)** | **(#)** | **(#)** | **($) (2)** |
| Craig S. Donohue | n/a | 5/1/2025 | $223 | $1277 | $2554 |  |  |  |  | $— |
|  | 5/7/2025 | 5/1/2025 |  |  |  | 3512 | 7024 | 14048 |  | $1721077 |
|  | 5/7/2025 | 5/1/2025 |  |  |  | 3512 | 7024 | 14048 |  | $2700096 |
|  | 5/7/2025 | 5/1/2025 |  |  |  | 3202 | 6404 | 12808 |  | $1569159 |
|  | 5/7/2025 | 5/1/2025 |  |  |  | 3202 | 6404 | 12808 |  | $2461762 |
|  | 5/7/2025 | 5/1/2025 |  |  |  |  |  |  | 14048 | $3290463 |
|  | 5/7/2025 | 5/1/2025 |  |  |  |  |  |  | 12808 | $3000018 |
| Jill M. Griebenow  | n/a | 2/10/2025 | $114 | $650 | $1300 |  |  |  |  | $— |
|  | 2/19/2025 | 2/10/2025 |  |  |  | 1398 | 2795 | 5590 |  | $633427 |
|  | 2/19/2025 | 2/10/2025 |  |  |  | 1398 | 2795 | 5590 |  | $837438 |
|  | 2/19/2025 | 2/10/2025 |  |  |  |  |  |  | 5589 | $1175087 |
| Christopher A. Isaacson | n/a | 2/11/2025 | $171 | $975 | $1950 |  |  |  |  | $— |
|  | 2/19/2025 | 2/11/2025 |  |  |  | 1115 | 2230 | 4460 |  | $505381 |
|  | 2/19/2025 | 2/11/2025 |  |  |  | 1115 | 2230 | 4460 |  | $668153 |
|  | 7/15/2025 | 7/14/2025 |  |  |  | 235 | 470 | 940 |  | $113816 |
|  | 7/15/2025 | 7/14/2025 |  |  |  | 235 | 470 | 940 |  | $173317 |
|  | 2/19/2025 | 2/11/2025 |  |  |  |  |  |  | 4459 | $937505 |
|  | 7/15/2025 | 7/14/2025 |  |  |  |  |  |  | 940 | $219913 |
| Patrick Sexton  | n/a | 2/10/2025 | $95 | $540 | $1080 |  |  |  |  | $— |
|  | 2/19/2025 | 2/10/2025 |  |  |  | 660 | 1320 | 2640 |  | $299150 |
|  | 2/19/2025 | 2/10/2025 |  |  |  | 660 | 1320 | 2640 |  | $395498 |
|  | 7/15/2025 | 7/14/2025 |  |  |  | 63 | 126 | 252 |  | $30512 |
|  | 7/15/2025 | 7/14/2025 |  |  |  | 63 | 126 | 252 |  | $46464 |
|  | 2/19/2025 | 2/10/2025 |  |  |  |  |  |  | 2640 | $555060 |
|  | 7/15/2025 | 7/14/2025 |  |  |  |  |  |  | 251 | $58721 |
| Timothy Lipscomb | n/a | 7/14/2025 | $81 | $466 | $931 |  |  |  |  | $— |
|  | 2/19/2025 | 2/10/2025 |  |  |  | 313 | 625 | 1250 |  | $141643 |
|  | 2/19/2025 | 2/10/2025 |  |  |  | 313 | 625 | 1250 |  | $187263 |
|  | 7/15/2025 | 7/14/2025 |  |  |  | 94 | 188 | 376 |  | $45526 |
|  | 7/15/2025 | 7/14/2025 |  |  |  | 94 | 188 | 376 |  | $69327 |
|  | 2/19/2025 | 2/10/2025 |  |  |  |  |  |  | 1249 | $262602 |
|  | 7/15/2025 | 7/14/2025 |  |  |  |  |  |  | 376 | $87965 |
| Fredric J. Tomczyk  | n/a | 2/11/2025 | $143 | $818 | $1636 |  |  |  |  | $— |
|  | 2/19/2025 | 2/11/2025 |  |  |  |  |  |  | 44471 | $9350028 |
| David Howson | n/a | 2/11/2025 | $164 | $938 | $1875 |  |  |  |  | $— |
|  | 2/19/2025 | 2/11/2025 |  |  |  | 2044 | 4088 | 8176 |  | $926457 |
|  | 2/19/2025 | 2/11/2025 |  |  |  | 2044 | 4088 | 8176 |  | $1224847 |
|  | 2/19/2025 | 2/11/2025 |  |  |  |  |  |  | 8175 | $1718794 |
|  | 5/27/2025 | 5/27/2025 |  |  |  | 2367 | 4734 | 9468 |  | $1094785 |
|  | 5/27/2025 | 5/27/2025 |  |  |  | 2367 | 4734 | 9468 |  | $1094785 |
|  | 5/27/2025 | 5/27/2025 |  |  |  |  |  |  | 1647 | $380885 |
|  | 5/27/2025 | 5/27/2025 |  |  |  |  |  |  | 1379 | $318908 |
|  | 5/27/2025 | 5/27/2025 |  |  |  |  |  |  | 1217 | $281443 |
| Catherine R. Clay | n/a | 7/14/2025 | $105 | $601 | $1201 |  |  |  |  | $— |
|  | 2/19/2025 | 2/10/2025 |  |  |  | 892 | 1784 | 3568 |  | $404305 |
|  | 2/19/2025 | 2/10/2025 |  |  |  | 892 | 1784 | 3568 |  | $534522 |
|  | 7/15/2025 | 7/14/2025 |  |  |  | 157 | 314 | 628 |  | $76039 |
|  | 7/15/2025 | 7/14/2025 |  |  |  | 157 | 314 | 628 |  | $115791 |
|  | 2/19/2025 | 2/10/2025 |  |  |  |  |  |  | 3568 | $750172 |
|  | 2/19/2025 | 2/10/2025 |  |  |  |  |  |  | 2379 | $500185 |
|  | 7/15/2025 | 7/14/2025 |  |  |  |  |  |  | 627 | $146687 |

---

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 65 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

____________________________________

\*In thousands.

(1)For Messrs. Donohue, Isaacson, Tomczyk, and Howson, the date reported in the "Approval Date" column is

the date the Board of Directors ratified the grants previously approved by the Compensation and Human

Capital Committee. For all other NEOs, the date is the date of Compensation and Human Capital

Committee approval. The grant date is the date the equity award was actually granted and effective.

(2)Represents the grant date aggregate fair value of the awards of RSUs and PSUs that were granted in 2025,

as computed in accordance with stock-based compensation accounting rules (Financial Standards

Accounting Board ASC Topic 718). The award date value of PSUs is based upon the probable outcome of

the performance conditions and is consistent with the estimate of aggregate compensation cost to be

recognized over the service period determined as of the grant date, excluding the effect of estimated

forfeitures. For purposes of the Grants of Plan-Based Awards, we have assumed that the probable outcome

of the PSUs-EPS performance conditions would result in the awards vesting at approximately target and the

best estimate available for the aggregate compensation cost to be recognized over the service period as of

the grant date would reflect the value of each PSU-EPS at the Company's stock price on the grant date and

each PSU-TSR computed in accordance with the Monte Carlo valuation model. There can be no assurance

that these values will ever be realized. Assumptions used in the calculation of these amounts are included

in the footnotes to our 2025 consolidated financial statements, which are included in our Annual Report on

Form 10-K for the year ended December 31, 2025 filed with the SEC.

***Non-Equity Incentives***

A summary of the Company's annual incentive program is set forth above under the heading, "Compensation

Discussion and Analysis—2025 Elements of Executive Compensation Program—Annual Incentive".

***Equity Incentives***

All of the equity incentive awards were granted pursuant to the Third Amended and Restated Cboe Global

Markets, Inc. Long-Term Incentive Plan and were made in the form of RSUs, half of which are subject to

performance conditions and also known as PSUs. Except as noted in the table below, the RSU awards that are

not subject to performance conditions have a 3 year vesting schedule under which one-third of the shares

granted will vest each year on the anniversary of the grant date. Dividend equivalent payments are made on

these RSUs and PSUs.

Half of the PSUs, or 25% of the total RSUs, have a performance condition under which the number of units that

will ultimately be awarded will vary from 0% to 200% of the original grant, based on our total stockholder return

(calculated as the increase in our stock price over the performance period plus reinvested dividends, divided by

the stock price at the beginning of the performance period) relative to the total stockholder returns for the S&P

500 Index during the performance period. The remaining half of the PSUs, or 25% of the total RSUs, have a

performance condition under which the number of units that will ultimately be awarded will vary from 0% to

200% of the original grant, based on our cumulative earnings per share during the performance period.

Dividend equivalent payments on these PSUs accrue and are paid out in shares upon vesting. The PSUs cliff-

vest following the completion of the 3 year performance period and are issued following the determination of the

achievement of the performance conditions.

For all of the awards, vesting will accelerate upon death, disability, or the occurrence of a qualified termination

following a change in control. If Mr. Donohue is terminated "without cause" or resigns from the Company for

"good reason," Mr. Donohue will fully vest in his Sign-On Grant, subject to attainment of the applicable

performance goals through the full performance period for the PSU portion of the Sign-On Grant, subject to Mr.

Donohue's execution and non-revocation of a waiver and release of claims in favor of the Company.

The award agreements provide that in the event of a participant's qualified retirement, all unvested outstanding

RSUs and a pro-rata portion of unvested outstanding PSUs, based on the number of days in employment

during the performance period, will remain outstanding and be distributed in accordance with the award's

original vesting and settlement schedule, subject to attainment of the applicable performance goals through the

full performance period, and not engaging in any activity that constitutes cause, even after the applicable

retirement date. Retirement eligibility generally requires, in addition to attaining 55 years of age and 10 years of

continuous service, submission of 6 months of advance written notice of a retirement and submission, approval,

and satisfactory completion of a transition plan. With respect to Mr. Donohue, retirement eligibility requires

attaining 55 years of age and 5 years of continuous service, together with submission of 1 year of advanced

written notice of retirement. Mr. Donohue's awards do not provide for proration of any shares issuable upon

settlement of PSUs based on the number of days in employment during the performance period following his

retirement.

---

| | |
|:---|:---|
| 66 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

Unless retirement eligible, unvested portions of the RSUs and PSUs will be forfeited if the executive officer

terminates employment with us prior to the applicable vesting date.

The RSUs and PSUs are subject to non-compete, non-solicitation, and confidentiality covenants. See

"Severance, Change in Control, and Employment-Related Agreements" for more information.

**2025 Outstanding Equity Awards at Fiscal Year-End Table** 

The following table sets forth outstanding equity awards held by each NEO at December 31, 2025 based on the

market value of our common stock on December 31, 2025 (the last trading day of the year).

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Stock Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** |
| **Name** | **Number of Shares or**<br>**Units of Stock That**<br>**Have Not Vested (#)** | **Number of Shares or**<br>**Units of Stock That**<br>**Have Not Vested (#)** | **Market Value of Shares**<br>**or Units of Stock**<br>**That Have Not Vested** <br>| **Equity Incentive Plan** <br>**Awards:**<br>**Number of Unearned**<br>**Shares, Units or Other**<br> **Rights That Have**<br>**Not Yet Vested (#)** | **Equity Incentive Plan** <br>**Awards:**<br>**Number of Unearned**<br>**Shares, Units or Other**<br> **Rights That Have**<br>**Not Yet Vested (#)** | **Equity Incentive Plan** <br>**Awards:** <br>**Market or Payout Value**<br>**of Unearned Shares, Units**<br>**or Other Rights That** <br>**Have Not Yet Vested** <br>|
| Craig S. Donohue | 14048 | (1) | $3526048 |  |  |  |
|  | 12808 | (2) | $3214808 |  |  |  |
|  |  |  |  | 14048 | (3) | $3526048 |
|  |  |  |  | 14048 | (4) | $3526048 |
|  |  |  |  | 12808 | (3) | $3214808 |
|  |  |  |  | 12808 | (4) | $3214808 |
| Jill M. Griebenow | 432 | (5) | $108432 |  |  |  |
|  | 653 | (6) | $163903 |  |  |  |
|  | 3304 | (7) | $829304 |  |  |  |
|  | 670 | (8) | $168170 |  |  |  |
|  | 5589 | (9) | $1402839 |  |  |  |
|  | 1345 | (10) | $337595 |  |  |  |
|  | 1345 | (11) | $337595 |  |  |  |
|  | 2022 | (12) | $507522 |  |  |  |
|  | 2022 | (13) | $507522 |  |  |  |
|  |  |  |  | 4956 | (14) | $1243956 |
|  |  |  |  | 4956 | (15) | $1243956 |
|  |  |  |  | 670 | (16) | $168170 |
|  |  |  |  | 670 | (17) | $168170 |
|  |  |  |  | 5590 | (18) | $1403090 |
|  |  |  |  | 5590 | (19) | $1403090 |
| Christopher A. Isaacson  | 2488 | (5) | $624488 |  |  |  |
|  | 3348 | (7) | $840348 |  |  |  |
|  | 1340 | (8) | $336340 |  |  |  |
|  | 4459 | (9) | $1119209 |  |  |  |
|  | 940 | (20) | $235940 |  |  |  |
|  | 7756 | (10) | $1946756 |  |  |  |
|  | 7756 | (11) | $1946756 |  |  |  |
|  |  |  |  | 5022 | (14) | $1260522 |
|  |  |  |  | 5022 | (15) | $1260522 |
|  |  |  |  | 1340 | (16) | $336340 |
|  |  |  |  | 1340 | (17) | $336340 |
|  |  |  |  | 4460 | (18) | $1119460 |
|  |  |  |  | 4460 | (19) | $1119460 |
|  |  |  |  | 940 | (21) | $235940 |
|  |  |  |  | 940 | (22) | $235940 |
| Patrick Sexton | 976 | (5) | $244976 |  |  |  |
|  | 1804 | (7) | $452804 |  |  |  |
|  | 670 | (8) | $168170 |  |  |  |
|  | 2640 | (9) | $662640 |  |  |  |
|  | 251 | (20) | $63001 |  |  |  |
|  | 1821 | (23) | $457071 |  |  |  |
|  | 1821 | (24) | $457071 |  |  |  |

---

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 67 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | 3042 | (10) | $763542 |  |  |  |
|  | 3042 | (11) | $763542 |  |  |  |
|  |  |  |  | 2706 | (14) | $679206 |
|  |  |  |  | 2706 | (15) | $679206 |
|  |  |  |  | 670 | (16) | $168170 |
|  |  |  |  | 670 | (17) | $168170 |
|  |  |  |  | 2640 | (18) | $662640 |
|  |  |  |  | 2640 | (19) | $662640 |
|  |  |  |  | 252 | (21) | $63252 |
|  |  |  |  | 252 | (22) | $63252 |
| Timothy Lipscomb | 796 | (5) | $199796 |  |  |  |
|  | 1090 | (7) | $273590 |  |  |  |
|  | 1249 | (9) | $313499 |  |  |  |
|  | 376 | (20) | $94376 |  |  |  |
|  |  |  |  | 1250 | (18) | $313750 |
|  |  |  |  | 1250 | (19) | $313750 |
|  |  |  |  | 376 | (21) | $94376 |
|  |  |  |  | 376 | (22) | $94376 |
| Fredric J. Tomczyk | 14818 | (25) | $3719318 |  |  |  |
|  | 32896 | (9) | $8256896 |  |  |  |
| Catherine R. Clay (26) | 2503 | (10) | $628253 |  |  |  |
|  | 2503 | (11) | $628253 |  |  |  |
|  | 239 | (27) | $59989 |  |  |  |
|  | 239 | (28) | $59989 |  |  |  |
|  | 863 | (29) | $216613 |  |  |  |
|  | 83 | (30) | $20833 |  |  |  |

---

_____________________________________

(1)Grant of RSUs not subject to performance conditions on May 7, 2025. These RSUs vested one-third on

February 19, 2026 and will vest one-third on each of February 19, 2027 and February 19, 2028.

(2)Grant of RSUs not subject to performance conditions on May 7, 2025. The award cliff-vests in full on May 7,

2028. (3)Grant of PSUs on May 7, 2025 subject to a performance condition of total stockholder return relative to the

S&P 500 Index for the period from January 1, 2025 through December 31, 2027. Under Item 402 of

Regulation S-K, these awards are shown at the maximum performance amount. These PSUs will be settled

in shares on or about February 19, 2028 upon determination of the achievement of the performance

conditions.

(4)Grant of PSUs on May 7, 2025 subject to an earnings per share performance condition for the period from

January 1, 2025 through December 31, 2027. Under Item 402 of Regulation S-K, these awards are shown

at the maximum performance amount. These PSUs will be settled in shares on or about February 19, 2028

upon determination of the achievement of the performance conditions.

(5)Grant of RSUs not subject to performance conditions on February 19, 2023. This portion of the RSUs

vested on February 19, 2026.

(6)Grant of RSUs not subject to performance conditions on August 19, 2023. These RSUs vested on February

19, 2026.

(7)Grant of RSUs not subject to performance conditions on February 19, 2024. These RSUs vested one-half

on February 19, 2026 and will vest one-half on February 19, 2027.

(8)Grant of RSUs not subject to performance conditions on February 19, 2024. The award cliff-vests in full on

February 19, 2027. These RSUs do not provide for qualified retirement eligibility.

(9)Grant of RSUs not subject to performance conditions on February 19, 2025. These RSUs vested one-third

on February 19, 2026 and will vest one-third on each of February 19, 2027 and February 19, 2028.

(10)Grant of PSUs on February 19, 2023 subject to a performance condition of total stockholder return relative

to the S&P 500 Index for the period from January 1, 2023 through December 31, 2025. These awards are

shown at the actual performance amount and include dividend equivalent payments. These PSUs were

---

| | |
|:---|:---|
| 68 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

settled in shares on February 12, 2026 upon determination of the achievement of the performance

conditions. See "Compensation Discussion and Analysis—2025 Elements of Executive Compensation

Program—Long-Term Incentive Plan—2023 PSU Grants Vested" for more details.

(11)Grant of PSUs on February 19, 2023 subject to an earnings per share performance condition for the period

from January 1, 2023 through December 31, 2025. These awards are shown at the actual performance

amount and include dividend equivalent payments. These PSUs were settled in shares on February 12,

2026 upon determination of the achievement of the performance conditions. See "Compensation

Discussion and Analysis—2025 Elements of Executive Compensation Program—Long-Term Incentive Plan

—2023 PSU Grants Vested" for more details.

(12)Grant of PSUs on August 19, 2023 subject to a performance condition of total stockholder return relative to

the S&P 500 Index for the period from January 1, 2023 through December 31, 2025. These awards are

shown at the actual performance amount and include dividend equivalent payments. These PSUs were

settled in shares on February 12, 2026 upon determination of the achievement of the performance

conditions. See "Compensation Discussion and Analysis—2025 Elements of Executive Compensation

Program—Long-Term Incentive Plan—2023 PSU Grants Vested" for more details.

(13)Grant of PSUs on August 19, 2023 subject to an earnings per share performance condition for the period

from January 1, 2023 through December 31, 2025. These awards are shown at the actual performance

amount and include dividend equivalent payments. These PSUs were settled in shares on February 12,

2026 upon determination of the achievement of the performance conditions. See "Compensation

Discussion and Analysis—2025 Elements of Executive Compensation Program—Long-Term Incentive Plan

—2023 PSU Grants Vested" for more details.

(14)Grant of PSUs on February 19, 2024 subject to a performance condition of total stockholder return relative

to the S&P 500 Index for the period from January 1, 2024 through December 31, 2026. Under Item 402 of

Regulation S-K, these awards are shown at the maximum performance amount. These PSUs will be settled

in shares on or about February 19, 2027 upon determination of the achievement of the performance

conditions.

(15)Grant of PSUs on February 19, 2024 subject to an earnings per share performance condition for the period

from January 1, 2024 through December 31, 2026. Under Item 402 of Regulation S-K, these awards are

shown at the maximum performance amount. These PSUs will be settled in shares on or about February

19, 2027 upon determination of the achievement of the performance conditions.

(16)Grant of PSUs on February 19, 2024 subject to a performance condition of total stockholder return relative

to the S&P 500 Index for the period from January 1, 2024 through December 31, 2026. Under Item 402 of

Regulation S-K, these awards are shown at the maximum performance amount. These PSUs will be settled

in shares on or about February 19, 2027 upon determination of the achievement of the performance

conditions. These PSUs do not provide for qualified retirement eligibility.

(17)Grant of PSUs on February 19, 2024 subject to an earnings per share performance condition for the period

from January 1, 2024 through December 31, 2026. Under Item 402 of Regulation S-K, these awards are

shown at the maximum performance amount. These PSUs will be settled in shares on or about February

19, 2027 upon determination of the achievement of the performance conditions. These PSUs do not provide

for qualified retirement eligibility.

(18)Grant of PSUs on February 19, 2025 subject to a performance condition of total stockholder return relative

to the S&P 500 Index for the period from January 1, 2025 through December 31, 2027. Under Item 402 of

Regulation S-K, these awards are shown at the maximum performance amount. These PSUs will be settled

in shares on or about February 19, 2028 upon determination of the achievement of the performance

conditions.

(19)Grant of PSUs on February 19, 2025 subject to an earnings per share performance condition for the period

from January 1, 2025 through December 31, 2027. Under Item 402 of Regulation S-K, these awards are

shown at the maximum performance amount. These PSUs will be settled in shares on or about February

19, 2028 upon determination of the achievement of the performance conditions.

(20)Grant of RSUs not subject to performance conditions on July 15, 2025. These RSUs vested one-third on

February 19, 2026 and will vest one-third on each of February 19, 2027 and February 19, 2028.

(21)Grant of PSUs on July 15, 2025 subject to a performance condition of total stockholder return relative to the

S&P 500 Index for the period from January 1, 2025 through December 31, 2027. Under Item 402 of

Regulation S-K, these awards are shown at the maximum performance amount. These PSUs will be settled

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 69 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

in shares on or about February 19, 2028 upon determination of the achievement of the performance

conditions.

(22)Grant of PSUs on July 15, 2025 subject to an earnings per share performance condition for the period from

January 1, 2025 through December 31, 2027. Under Item 402 of Regulation S-K, these awards are shown

at the maximum performance amount. These PSUs will be settled in shares on or about February 19, 2028

upon determination of the achievement of the performance conditions.

(23)Grant of PSUs on February 19, 2023 subject to a performance condition of total stockholder return relative

to the S&P 500 Index for the period from January 1, 2023 through December 31, 2025. Under Item 402 of

Regulation S-K, these awards are shown at the actual performance amount and include dividend equivalent

payments. These PSUs were settled in shares on February 12, 2026 upon determination of the

achievement of the performance conditions. See "Compensation Discussion and Analysis—2025 Elements

of Executive Compensation Program—Long-Term Incentive Plan—2023 PSU Grants Vested" for more

details. These PSUs do not provide for qualified retirement eligibility.

(24)Grant of PSUs on February 19, 2023 subject to an earnings per share performance condition for the period

from January 1, 2023 through December 31, 2025. Under Item 402 of Regulation S-K, these awards are

shown at the actual performance amount. These PSUs were settled in shares on February 12, 2026 upon

determination of the achievement of the performance conditions and include dividend equivalent payments.

See "Compensation Discussion and Analysis—2025 Elements of Executive Compensation Program—Long-

Term Incentive Plan—2023 PSU Grants Vested" for more details. These PSUs do not provide for qualified

retirement eligibility.

(25)Grant of RSUs not subject to performance conditions on October 12, 2023. These RSUs will vest on

October 12, 2026. Vesting will accelerate in full on Mr. Tomczyk's service as a member of the Board

terminating due to a failure to be renominated or re-elected to the Board for any reason other than cause or

a voluntary resignation, in each case provided that this event occurs before the award has otherwise

forfeited. If Mr. Tomczyk remains in continuous service as a director, (i) his award will vest in full upon a

change in control if he is still a director as of such date, and (ii) he will be eligible for partial, prorated vesting

based on his service between October 12, 2024 and his separation date if he voluntarily resigns from the

Board and there is no basis by which his service could have been terminated for cause.

(26)See "Severance, Change in Control and Employment-Related Agreements—Ms. Clay's Equity Award

Acceleration" for a description of the vesting treatment of Ms. Clay's awards in connection with her

resignation.

(27)Grant of PSUs on November 19, 2023 subject to a performance condition of total stockholder return relative

to the S&P 500 Index for the period from January 1, 2023 through December 31, 2025. These awards are

shown at the actual performance amount and include dividend equivalent payments. These PSUs were

settled in shares on February 12, 2026 upon determination of the achievement of the performance

conditions. See "Compensation Discussion and Analysis—2025 Elements of Executive Compensation

Program—Long-Term Incentive Plan—2023 PSU Grants Vested" for more details.

(28)Grant of PSUs on November 19, 2023 subject to an earnings per share performance condition for the

period from January 1, 2023 through December 31, 2025. These awards are shown at the actual

performance amount and include dividend equivalent payments. These PSUs were settled in shares on

February 12, 2026 upon determination of the achievement of the performance conditions. See

"Compensation Discussion and Analysis—2025 Elements of Executive Compensation Program—Long-

Term Incentive Plan—2023 PSU Grants Vested" for more details.

(29)Grant of RSUs not subject to performance conditions on February 19, 2023 that vested in connection with

Ms. Clay's resignation, which qualified as a retirement under the terms of the underlying awards. The

shares of common stock underlying the RSUs that vested in connection with her resignation will be

delivered to her, as applicable, following a 6-month delay contemplated by the distribution timing rules

under Section 409A of the Internal Revenue Code.

(30)Grant of RSUs not subject to performance conditions on November 19, 2023 that vested in connection with

Ms. Clay's resignation, which qualified as a retirement under the terms of the underlying awards. The

shares of common stock underlying the RSUs that vested in connection with her resignation will be

delivered to her, as applicable, following a 6-month delay contemplated by the distribution timing rules

under Section 409A of the Internal Revenue Code.

---

| | |
|:---|:---|
| 70 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**2025 Stock Vested Table**

The following table sets forth the equity awards that vested during 2025.

---

| | | |
|:---|:---|:---|
|  | **Stock Awards** | **Stock Awards** |
| **Name** | **Number of Shares**<br>**Acquired on Vesting (#) (1)**<br>| **Value Realized on**<br>**Vesting (2)**<br>|
| Craig S. Donohue |  | $— |
| Jill M. Griebenow  | 3561 | $748700 |
| Christopher A. Isaacson  | 25265 | $5301964 |
| Patrick Sexton  | 8623 | $1809889 |
| Timothy Lipscomb | 2990 | $646744 |
| Fredric J. Tomczyk | 14817 | $3625868 |
| David Howson (3) | 44156 | $9799636 |
| Catherine R. Clay (4) | 6886 | $1445464 |

---

_____________________________________

(1)Number of shares acquired on vesting represent RSUs and PSUs that were vested in 2025, and do not

include any of the 2023 PSU awards, as the underlying shares were not issued until the settlement date of

February 12, 2026.

(2)Amounts are calculated by multiplying the number of shares underlying RSUs or PSUs by our closing stock

price on the date of vesting or issuance, or if the stock market was closed on such date, by our closing

stock price on the next preceding day on which the stock market was open.

(3)A portion of the awards reflected in the "Stock Awards" column represent Mr. Howson's RSUs and PSUs

that vested in connection with his resignation, including dividend equivalent payments made on the PSUs.

(4)A portion of the awards reflected in the "Stock Awards" column represent an additional 945 RSUs issued

prior to 2024 that vested in connection with Ms. Clay's resignation, which qualified as a retirement under the

terms of the underlying awards. The shares of common stock underlying the RSUs that vested in

connection with her resignation will be delivered to her, as applicable, following a 6-month delay

contemplated by the distribution timing rules under Section 409A of the Internal Revenue Code.

**2025 Non-Qualified Deferred Compensation Table** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Name (1)** |  | **Executive**<br>**Contributions**<br>**in Last**<br>**FY (2)**<br>| **Registrant**<br>**Contributions**<br>**in Last**<br>**FY (3)**<br>| **Aggregate**<br>**Earnings**<br>**in Last**<br>**FY (4)**<br>| **Aggregate**<br>**Withdrawals/**<br>**Distributions**<br>| **Aggregate**<br>**Balance at**<br>**Last FYE**<br>|
| Craig S. Donohue | SERP | $19879 | $39758 | $1184 | $— | $60815 |
| Jill M. Griebenow  | SERP | $38026 | $76052 | $88194 | $— | $538533 |
| Christopher A. Isaacson | SERP | $754500 | $120720 | $800650 | $— | $9265038 |
| Patrick Sexton | SERP | $39375 | $31500 | $221957 | $— | $1590021 |
| Timothy Lipscomb | SERP | $22955 | $45910 | $40908 | $— | $283464 |
| David Howson | SERP | $45985 | $91969 | $30343 | $— | $481651 |
| Catherine R. Clay | SERP | $48542 | $48967 | $37926 | $— | $641734 |

---

_____________________________________

(1)Executive and registrant contributions include contributions during 2025. Mr. Tomczyk did not make any

contributions. Numbers may not foot due to rounding.

(2)The amount of executive contributions made by each NEO and reported in this column is included in each

NEO's compensation reported in the SCT under the column labeled "Salary".

(3)The amount of registrant contributions reported in this column for each NEO is also included in his or her

compensation reported in the SCT under the column labeled "All Other Compensation".

(4)Earnings are based upon the investment fund selected by the NEO for each plan.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 71 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Non-Qualified Defined Contribution Plans**

We do not have a defined benefit retirement plan. We currently have two non-qualified defined contribution

plans in which the NEOs may, as applicable, participate: the Supplemental Executive Retirement Plan and the

Cash Deferral Plan. The investment options are aligned as closely as possible with those offered under the

qualified plan. If a fund available in the qualified plan is not available for the nonqualified plans, a comparable

fund that most closely matches the qualified plan fund is selected.

The SERP is designed for employees whose level of compensation exceeds the IRS defined annual

compensation limit ($350,000 for 2025). Under the SERP, we match deferral contributions made by the

employee under the SERP with respect to eligible compensation in excess of the IRS compensation limit. These

contributions mirror those under the 401(k) plan. In 2025, we matched employee contributions up to 4% of the

employee's compensation, subject to statutory limitations. We matched 200% of such contributions. Mr.

Tomczyk did not participate in the SERP in 2025.

All of our contributions to the SERP vest 20% for each year of continuous service, identical to the qualified plan.

All of our participating NEOs, except for Mr. Donohue, are fully vested in the SERP.

The Cash Deferral Plan is designed for employees whose level of compensation exceeds the IRS defined

annual compensation limit ($350,000 for 2025) and non-employee directors. Under the Cash Deferral Plan, we

do not match deferral contributions made by the employee and non-employee directors under the Cash Deferral

Plan. There are no vesting requirements under the Cash Deferral Plan.

**SEVERANCE, CHANGE IN CONTROL, AND EMPLOYMENT-**

**RELATED AGREEMENTS**

As of December 31, 2025, we had an employment agreement with Mr. Donohue and the other NEOs (other

than Messrs. Tomczyk and Howson and Ms. Clay) were covered by the Executive Severance Plan. In addition,

we entered into a letter agreement with Mr. Howson in connection with his separation. The material terms of the

agreements and the plan are discussed below. Mr. Tomczyk did not receive any severance or additional

payments upon the termination of his employment with the Company.

**Mr. Donohue's Employment Agreement**

Under the Employment Agreement, dated as of May 1, 2025 (the "Employment Agreement"), Mr. Donohue

serves as our CEO and as a member of the Board, if elected.

Under the terms of the Employment Agreement, Mr. Donohue will (i) receive an annual base salary of at least

$1,300,000, (ii) be eligible to receive an annual bonus with a target value of not less than one hundred fifty

percent (150%) of base salary, and (iii) subject to Compensation and Human Capital Committee approval and

Board ratification, be eligible for annual equity incentive awards, in amounts and subject to such terms as

determined by the Committee in its sole discretion; provided that the target grant date fair value of the annual

equity incentive awards granted to Mr. Donohue will not be less than $10,050,000. The vesting terms relating to

the annual equity incentive awards granted to Mr. Donohue, including the terms that apply in connection with a

change in control, will be no less favorable than those that apply to other senior executives of the Company. In

addition, Mr. Donohue received a one-time Sign-On Grant in 2025 with a grant date fair value of $6,000,000. Mr.

Donohue is entitled to participate in all of our employee benefit and fringe benefit plans that are generally

available to similarly situated members of senior management and is eligible to receive a monthly stipend of

$10,000 for housing until he purchases a home in the Chicago metropolitan area and the cost of car service.

Pursuant to the Employment Agreement, Mr. Donohue agreed to certain non-compete and non-solicit provisions

during the employment term and for two years thereafter, as well as indefinite confidentiality obligations.

Under the Employment Agreement, upon a termination of employment by the Company without cause or by Mr.

Donohue for good reason as defined in the Employment Agreement, Mr. Donohue will be entitled to receive the

following benefits (collectively, the "Benefits"): (i) accrued but unpaid base salary through the date of

termination; (ii) any unpaid bonus with respect to a prior fiscal year; (iii) an amount equal to Mr. Donohue's

housing stipend (and associated gross-up) for the remainder of his then current lease, not to exceed 12 months;

(iv) a pro-rated bonus equal to the bonus that Mr. Donohue would have received for the calendar year in which

termination occurs, based on target performance, pro-rated for the portion of the calendar year worked; (v) a

lump sum cash severance payment in an amount equal to the sum of (A) 2 times the annual base salary in

effect on the date of termination and (B) 2 times the target bonus for the year of termination; and (vi) a lump

sum cash payment in an amount equal to 24 months of premiums under the Consolidated Omnibus Budget

Reconciliation Act of 1985, as amended ("COBRA") (sufficient to cover full family health care). Additionally, with

respect to the Sign-On Grant, (i) the RSUs subject to time-based vesting criteria shall immediately become fully

---

| | |
|:---|:---|
| 72 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

vested as of the date of termination and (ii) the PSUs shall remain outstanding as if Mr. Donohue had remained

continuously employed through the performance period and shall fully vest upon the expiration of such

performance period, subject to and contingent upon achievement of the applicable performance goals.

The Employment Agreement provides that, notwithstanding anything to the contrary in the Third Amended and

Restated Cboe Global Markets, Inc. Long-Term Incentive Plan, the terms and conditions of all equity incentive

awards granted to Mr. Donohue will provide for: (i) retirement-vesting eligibility on 5 years of continuous service;

provided, however, that Mr. Donohue must provide no less than 1 year's advance notice to the Board of his

intent to retire to be eligible for retirement vesting of equity incentive awards; and (ii) no proration of any shares

issuable upon settlement of PSUs following Mr. Donohue's retirement based on the length of his tenure during

the relevant performance periods applicable to such PSUs.

If Mr. Donohue's employment is terminated due to death or disability, Mr. Donohue (or his estate, as applicable)

will be entitled to receive (i) accrued but unpaid base salary through the date of termination; (ii) any unpaid

bonus with respect to a prior fiscal year; and (iii) a pro-rated bonus equal to the bonus that Mr. Donohue would

have received for the calendar year in which termination occurs, based on target performance, pro-rated for the

portion of the calendar year worked.

The Employment Agreement does not provide for any enhanced benefits in connection with a termination of

employment following a change in control.

**Executive Severance Plan**

Except as disclosed herein, the other NEOs do not have employment agreements; however, the Compensation

and Human Capital Committee believes it is appropriate to provide an Executive Severance Plan to encourage

retention, maintain a consistent management team to effectively run our operations, and allow executives to

focus on our strategic business priorities. The CEO of the Company determines from time to time the executive

vice president ("EVP") and senior vice president ("SVP") participants in the plan. As of December 31, 2025, the

plan participants covered Ms. Griebenow and Messrs. Isaacson, Sexton, and Lipscomb, and other officers. Mr.

Tomczyk did not receive any severance benefits under the Executive Severance Plan in connection with the

termination of his employment as Chief Executive Officer with the Company.

Under the plan, a participant who experiences an involuntary termination (as defined in the plan, which includes

termination by us without cause and by the executive for good reason) is entitled to receive the following

severance benefits:

The participant's accrued salary, unpaid expenses, accrued and unpaid vacation days through the date

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

of termination, and any unpaid bonus earned in any year prior to the year in which the participant's

employment terminates;

An amount equal to a prorated bonus for the year of employment termination, based on target

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

performance for such year;

A severance payment in an amount equal to the sum of the participant's base salary and target annual

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

bonus; and

COBRA premiums for 18 months for EVP participants in the plan and 12 months for SVP and all other

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

participants (other than EVPs) in the plan.

Under the terms of the plan, if the participant's employment is terminated either by us for cause, or by the

participant other than for good reason (each as defined in the plan), we will pay the participant any unpaid

bonus and accrued benefits.

If the participant is terminated in connection with a change in control, which includes a termination without

cause or a resignation for good reason that occurs within a period beginning 6 months before a change in

control and ending 2 years after, such participant will receive the following severance benefits:

The participant's accrued salary, unpaid expenses, accrued and unpaid vacation days through the date

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

of termination, and any unpaid bonus earned in any year prior to the year in which the participant's

employment terminates;

An amount equal to a prorated bonus for the year of employment termination, based on target

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

performance for such year;

A severance payment in an amount equal to two times, with respect to EVP participants in the plan and,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

one and a half times, with respect to SVP and all other participants (other than EVPs) in the plan, the

sum of the participant's base salary and target annual bonus; and

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 73 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

COBRA premiums for 24 months for EVP participants in the plan and 18 months for SVP and all other

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

participants (other than EVPs) in the plan.

The plan also provides that we will require any successor to expressly assume and agree to maintain the plan.

**Mr. Howson's Separation Letter Agreement**

In connection with Mr. Howson's resignation, the Company and Mr. Howson entered into a Letter Agreement

dated May 27, 2025 (the "Letter Agreement"). Pursuant to the Letter Agreement, Mr. Howson was entitled to (i)

his current base salary and benefits through August 1, 2025, the transition date through which Mr. Howson

remained with the Company, (ii) retain a pro rata portion of certain of his outstanding time-based RSUs that

would vest in February 2026 based on the number of days worked through the transition date and forfeit the

remainder and other outstanding time-based RSUs, and (iii) retain a pro rata portion of the outstanding PSUs

that would vest in February 2026 based on the number of days worked through the transition date, and which

were paid out based on target performance through the end of the applicable performance period for each

award, and forfeit the remainder and other outstanding PSUs. Mr. Howson executed a customary release

agreement and a customary restrictive covenant agreement in connection with his separation. The dollar value

of Mr. Howson's incentive equity that vested pursuant to the Letter Agreement was $3,475,750, using the fair

market value of the Company's common stock as of the vesting date.

**Ms. Clay's Equity Award Acceleration**

Prior to her resignation, Ms. Clay was covered by the Executive Severance Plan. In connection with her

resignation effective October 15, 2025, Ms. Clay was only eligible for accrued, unpaid benefits under the plan.

Ms. Clay was entitled to acceleration of vesting in full of certain RSU awards and pro-rata vesting of certain

PSU awards, as applicable, because she had satisfied, as of her separation date, the retirement requirements

of 55 years of age and 10 years of service under the terms of the underlying award agreements. Ms. Clay

forfeited the remainder and other outstanding PSUs made in 2024 and 2025. As of December 31, 2025, the

dollar value of Ms. Clay's accelerated incentive equity was $1,613,930, using the fair market value of the

Company's common stock as of the last business day of the fiscal year.

**Severance Payments**

The following table shows the potential additional payment to each NEO serving on December 31, 2025, upon

the termination of the executive's employment by us without cause or by the executive for good reason

(including following a change in control), upon the executive's death or disability, qualified retirement (if eligible),

and by the executive without good reason, including pursuant to the Employment Agreement and the Executive

Severance Plan, each as discussed above.

---

| | |
|:---|:---|
| 74 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

The amounts shown assume that the termination or event occurred on December 31, 2025. Numbers may not

foot due to rounding.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Name** |  | **Salary** | **Cash**<br>**Incentive (6)**<br>| **Unvested Equity** <br>**Awards (7)**<br>| **Other (8)** | **Total** |
| Craig S. Donohue | (1) | $2600000 | $5176849 | $9644424 | $132992 | $17554265 |
|  | (2) | $2600000 | $5176849 | $20222568 | $132992 | $28132409 |
|  | (3) | $— | $1276849 | $13481812 | $— | $14758661 |
|  | (4) | $— | $— | $— | $— | $— |
|  | (5) | $— | $— | $— | $— | $— |
| Jill M. Griebenow | (1) | $500000 | $1300000 | $1690234 | $31162 | $3521396 |
|  | (2) | $1000000 | $1950000 | $9993314 | $41550 | $12984864 |
|  | (3) | $— | $— | $7178098 | $— | $7178098 |
|  | (4) | $— | $— | $— | $— | $— |
|  | (5) | $— | $— | $1690234 | $— | $1690234 |
| Christopher A. Isaacson | (1) | $650000 | $1950000 | $3893512 | $50197 | $6543709 |
|  | (2) | $1300000 | $2925000 | $12954361 | $66930 | $17246291 |
|  | (3) | $— | $— | $10002099 | $— | $10002099 |
|  | (4) | $— | $— | $— | $— | $— |
|  | (5) | $— | $— | $3893512 | $— | $3893512 |
| Patrick Sexton (9) | (1) | $450000 | $1080000 | $2441226 | $54130 | $4025356 |
|  | (2) | $900000 | $1620000 | $7179353 | $72173 | $9771526 |
|  | (3) | $— | $— | $5606085 | $— | $5606085 |
|  | (4) | $— | $— | $5252857 | $— | $5252857 |
|  | (5) | $— | $— | $2441226 | $— | $2441226 |
| Timothy Lipscomb | (1) | $465000 | $977050 | $— | $53724 | $1495774 |
|  | (2) | $930000 | $1488550 | $1697513 | $71633 | $4187696 |
|  | (3) | $— | $— | $1289387 | $— | $1289387 |
|  | (4) | $— | $— | $— | $— | $— |
|  | (5) | $— | $— | $— | $— | $— |

---

_____________________________________

(1)Represents amounts to be paid in connection with a termination of the executive's employment by us

without cause or by the executive for good reason.

(2)Represents amounts to be paid in connection with a termination of the executive's employment by us

without cause or by the executive for good reason following a change in control.

(3)Represents amounts to be paid in connection with death or disability.

(4)Represents amounts to be paid in connection with a qualified retirement. As of December 31, 2025, Messrs.

Isaacson and Lipscomb and Ms. Griebenow have not satisfied the retirement requirements of 55 years of

age and 10 years of service and Mr. Donohue has not satisfied the retirement requirement of 55 years of

age and 5 years of service.

(5)Represents amounts to be paid in connection with a termination of the executive's employment by the

executive without good reason.

(6)The amounts shown represent, in the aggregate, any unpaid bonus earned in any year prior to the year in

which the executive's employment terminates, a prorated target bonus amount, and a bonus payment in an

amount equal to one or two times target bonus, as applicable.

(7)Amounts for Messrs. Isaacson, Sexton, and Lipscomb and Ms. Griebenow assume satisfaction of the

performance period for the 2023 PSU awards as of December 31, 2025, which were certified and issued

subsequent to the end of 2025. The amounts shown are based on the market value of our common stock

on December 31, 2025. The amounts that include 2023 PSU awards are shown at actual performance

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 75 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

amount and include dividend equivalent payments. The amounts that include 2024 and 2025 PSU awards

are shown at the maximum performance amounts, except that, in the event of death or disability, amounts

are shown at the target performance amounts. Amounts for Mr. Donohue include vesting of the Sign-On

Grant, subject to actual performance at the end of the performance period for the PSU portion of the Sign-

On Grant.

(8)Amounts for Messrs. Isaacson, Sexton, and Lipscomb and Ms. Griebenow represent estimated COBRA

costs of 18 months of coverage or 24 months, in the case of a change in control. Amounts for Mr. Donohue

represent the estimated lump sum amount of (i) Mr. Donohue's housing stipend (and associated gross-up)

for the remainder of Mr. Donohue's then current lease, not to exceed 12 months and (ii) the equivalent of 24

months of premiums under COBRA. All of the participating NEOs, except for Mr. Donohue, are fully vested

in our qualified and non-qualified defined contribution plans, so there is no acceleration of vesting on these

events. As of December 31, 2025, Mr. Donohue has not vested in any matching or employer contributions

under our qualified and non-qualified defined contribution plans.

(9)If a retirement-eligible executive terminates for any reason, other than death or disability or a termination of

the executive's employment by us without cause or by the executive for good reason following a change in

control, the executive is assumed to have taken a retirement for purposes of equity awards issued prior to

2024. Amounts for Mr. Sexton in rows 1, 4, and 5 include acceleration of vesting of certain equity awards

issued prior to 2024, including pro-rata vesting of PSU awards, as applicable, because he has satisfied, as

of December 31, 2025, the retirement requirements of 55 years of age and 10 years of service. With

respect to awards issued starting in 2024, retirement eligibility requires, in addition to attaining 55 years of

age and 10 years of continuous service, submission of 6 months of advance written notice of a retirement

and submission, approval, and satisfactory completion of a transition plan. Amounts for Mr. Sexton in row 4

include all unvested outstanding RSUs and a pro-rata portion of unvested outstanding PSUs issued starting

in 2024, which, in the event of a qualified retirement, will remain outstanding and be distributed in

accordance with the award's original vesting and settlement schedule, even after the applicable retirement

date.

**PAY RATIO** 

As required by SEC rules, we are providing the following information about the relationship of the median of the

annual total compensation of our employees (other than Mr. Donohue, our CEO) and the annual total

compensation of Mr. Donohue. The pay ratio included in this information is a reasonable estimate calculated in

a manner consistent with Item 402(u) of Regulation S-K.

For 2025, the median of the annual total compensation of all employees of the Company (other than Mr.

Donohue) was $197,994 and the annual total compensation of Mr. Donohue was $20,160,177. Based on this

information, the ratio of the annual total compensation of Mr. Donohue, our CEO, to the median of the annual

total compensation of all employees (excluding Mr. Donohue) was 102:1.

*Median Employee*

We identified the median employee by reviewing the annual total compensation of all full-time, part-time, and

temporary employees employed by us on December 31, 2025 as reflected in our payroll records. Annual total

compensation included salary, commissions, bonus, value of equity grants, and value of benefits received. In

making this determination, we used our employee population size of 1,600 employees as of December 31,

2025, which excluded, under the non-U.S. de minimis exception to the pay ratio rule, all of our employees in the

Philippines (28), Japan (17), Hong Kong (8), and Singapore (8), out of a total of 1,661 employees, or 3.7%. After

identifying the median employee, we calculated annual total compensation for such employee using the same

methodology we use for calculating total compensation for each of our NEOs as set forth in the SCT above.

*CEO*

Mr. Donohue began serving as our CEO effective May 7, 2025. As permitted by Instruction 10 to Item 402(u) of

Regulation S-K, for pay ratio purposes, Mr. Donohue's compensation was annualized to represent his

compensation as if he were CEO for the entire 2025 fiscal year. The calculation included the amounts reported

in the SCT above for fiscal year 2025, except that (i) the salary was adjusted to assume Mr. Donohue received

his year-end base salary rate for the entire fiscal year, (ii) the non-equity incentive plan compensation was

adjusted to assume that Mr. Donohue received his year-end annual incentive plan award for the entire fiscal

year, and (iii) the car service element of "All Other Compensation" was adjusted to assume he was CEO for the

entire fiscal year. Consequently, the annual total compensation reported for CEO pay ratio purposes does not

reflect the "Total" column of our SCT above, nor does it reflect amounts actually paid to our CEO for fiscal year

---

| | |
|:---|:---|
| 76 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

2025. Instead, the annual total compensation reported for the CEO above reflects the pay ratio disclosure

requirements for a year in which a CEO transition occurs.

**PAY VERSUS PERFORMANCE**

As required by SEC rules, the following information provides a summary of the relationship between

compensation actually paid (determined in accordance with SEC rules) to our principal executive officer ("PEO")

and average compensation actually paid to our non-PEO NEOs (the "Other NEOs") and certain financial

performance of the Company, as required by SEC rules. This information is a reasonable estimate calculated in

a manner consistent with such SEC rules and there can be no assurances that some of the amounts reported

will ever be realized. For information concerning the Company's variable pay-for-performance philosophy and

how the Company aligns executive compensation with the Company's performance, refer to "Executive

Compensation—Compensation Discussion and Analysis".

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **Value Of Initial Fixed** <br>**$100**<br>**Investment Based On:** | **Value Of Initial Fixed** <br>**$100**<br>**Investment Based On:** |  |  |
| **Year** | **Summary**<br>**Compensation**<br>**Table Total**<br>**For PEO**<br>**(Donohue) (1)**<br>| **Compensation**<br>**Actually**<br>**Paid To PEO**<br>**(Donohue) (2)**<br>| **Summary**<br>**Compensation**<br>**Table Total**<br>**For PEO**<br>**(Tomczyk) (1)**<br>| **Compensation**<br>**Actually**<br>**Paid To PEO**<br>**(Tomczyk) (2)**<br>| **Summary**<br>**Compensation**<br>**Table Total**<br>**For PEO**<br>**(Tilly) (1)**<br>| **Compensation**<br>**Actually**<br>**Paid To PEO**<br>**(Tilly) (2)**<br>| **Average**<br>**Summary**<br>**Compensation**<br>**Table Total For**<br>**Other NEOs**<br>**(3)**<br>| **Average**<br>**Compensation**<br>**Actually**<br>**Paid To Other** <br>**NEOs (4)**<br>| **Total**<br>**Shareholder**<br>**Return (5)**<br>| **Peer**<br>**Group**<br>**Total**<br>**Shareholder**<br>**Return (6)**<br>| **Net** <br>**Income**<br>**(7)**<br>**(in** <br>**millions)**<br>| **Adjusted**<br>**EBITDA** <br>**(8)**<br>**(in** <br>**millions)**<br>|
| 2025 | $18347037 | $22673566 | $11666184 | $12303611 | $— | $— | $3985670 | $3909530 | $289.12 | $175.55 | $1095 | $1646 |
| 2024 | $— | $— | $3325419 | $4350104 | $— | $— | $4384076 | $5374354 | $222.49 | $149.67 | $761 | $1352 |
| 2023 | $— | $— | $8366510 | $9420432 | $9403311 | $6889839 | $3255931 | $5156162 | $200.90 | $125.49 | $758 | $1245 |
| 2022 | $— | $— | $— | $— | $11915247 | $14520578 | $4096611 | $4865964 | $139.15 | $102.26 | $234 | $1136 |
| 2021 | $— | $— | $— | $— | $10646558 | $16085506 | $3188615 | $4608036 | $142.23 | $129.80 | $527 | $987 |

---

_____________________________________

(1)The dollar amounts reported in this column are the amounts of total compensation reported for Messrs.

Donohue, Tomczyk, or Tilly in connection with their service as PEO of the Company during each

corresponding year, as applicable, in the "Total" column of the SCT. Refer to "Executive Compensation—

Summary Compensation—Summary Compensation Table".

(2)The dollar amounts reported in this column represent the amount of "compensation actually paid" to

Messrs. Donohue, Tomczyk, or Tilly, respectively, for the years during which they served as PEO. In

accordance with SEC rules, the following adjustments were made to Mr. Donohue's and Mr. Tomczyk's total

compensation as reported in the 2025 SCT to determine each of their 2025 compensation actually paid.

---

| | |
|:---|:---|
| **Craig S. Donohue** |  |
| **Amount Deducted or Added (1)** | **2025** |
| Subtract stock and option awards reported in SCT | $-14742574 |
| Add fair value of stock and option awards granted in covered fiscal years, valued at year-end, that are <br>outstanding and unvested as of the end of the covered fiscal years<br>| $19013511 |
| Add/Subtract stock and option awards granted in prior fiscal years that were unvested at the end of covered <br>fiscal years, the change in fair value from the end of prior fiscal years to end of covered fiscal years<br>| $— |
| Add stock and option awards that were granted and vested in the same year, the fair value as of the vesting date | $— |
| Add/Subtract stock and option awards granted in prior fiscal years that vested during covered fiscal years, the <br>changes in fair value from the end of prior covered fiscal years to vesting dates<br>| $— |
| Add dividends paid on unvested shares/units and stock options in the covered fiscal year | $55592 |

---

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 77 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **Fredric J. Tomczyk** |  |
| **Amount Deducted or Added (1)** | **2025** |
| Subtract stock and option awards reported in SCT | $-9350028 |
| Add fair value of stock and option awards granted in covered fiscal years, valued at year-end, that are <br>outstanding and unvested as of the end of the covered fiscal years<br>| $8256896 |
| Add/Subtract stock and option awards granted in prior fiscal years that were unvested at the end of covered <br>fiscal years, the change in fair value from the end of prior fiscal years to end of covered fiscal years<br>| $823881 |
| Add stock and option awards that were granted and vested in the same year, the fair value as of the vesting date | $— |
| Add/Subtract stock and option awards granted in prior fiscal years that vested during covered fiscal years, the <br>changes in fair value from the end of prior covered fiscal years to vesting dates<br>| $730626 |
| Add dividends paid on unvested shares/units and stock options in the covered fiscal year | $176052 |

---

____________________________________

(1)The assumptions used to calculate the values for each RSU award included in the calculation of

"compensation actually paid" did not differ materially from those used to calculate the grant date fair

value for such awards.

(3)The dollar amounts reported in this column represent the average of the amounts reported for the

Company's Other NEOs as a group in the "Total" column of the SCT in each applicable year. The Other

NEOs in each applicable year are as follows: (i) for 2025, Messrs. Isaacson, Sexton, Lipscomb, and

Howson and Mses. Griebenow and Clay; (ii) for 2024, Messrs. Howson, Isaacson, and Sexton and Ms.

Griebenow; (iii) for 2023, Messrs. Schell, Howson, and Isaacson, Mses. Griebenow and Clay; (iv) for 2022,

Messrs. Schell, Howson, Isaacson, and Sexton; and (v) for 2021, Messrs. Schell, Howson, Isaacson, and

Sexton.

(4)The dollar amounts reported in this column represent the average amount of "compensation actually paid"

to the Other NEOs as a group. In accordance with SEC rules, the following adjustments were made to

average total compensation for the Other NEOs as a group for 2025 to determine the compensation

actually paid. Numbers may not foot due to rounding.

---

| | |
|:---|:---|
| **Average Amount Deducted or Added (1)** | **2025** |
| Subtract average stock and option awards reported in SCT | $-2589601 |
| Add average fair value of stock and option awards granted in covered fiscal years, valued at year-end, that are <br>outstanding and unvested as of the end of the covered fiscal years<br>| $1829725 |
| Add/Subtract average stock and option awards granted in prior fiscal years that were unvested at the end of <br>covered fiscal years, the change in fair value from the end of prior fiscal years to end of covered fiscal years<br>| $1352441 |
| Add average for stock and option awards that were granted and vested in the same year, the fair value as of the <br>vesting date (2)<br>| $135206 |
| Add/Subtract average stock and option awards granted in prior fiscal years that vested during covered fiscal <br>years, the changes in fair value from the end of prior covered fiscal years to vesting dates<br>| $126532 |
| For awards granted in prior fiscal years that were forfeited during covered fiscal years, subtract the fair value of <br>forfeited awards determined at end of prior fiscal years<br>| $-953176 |
| Add average dividends paid on unvested shares/units and stock options in the covered fiscal year | $22733 |

---

____________________________________

(1)The assumptions used to calculate the values for each RSU and PSU award included in the calculation

of "compensation actually paid" did not differ materially from those used to calculate the grant date fair

value for such awards. For each PSU-TSR, we used a Monte Carlo model and made appropriate

adjustments to the grant date assumptions to reflect changes in the stock price volatility, actual relative

TSR and stock price performance, and risk-free interest rates as of the relevant measurement date. For

each PSU-EPS, we based the valuation on the probable outcome of earnings per share during the

awards' performance periods as of the last day of the fiscal year.

(2)The dollar amounts reported in this row include dividend equivalent units awarded from the

reinvestment of dividend equivalents on PSUs. The dividend equivalent units are subject to the same

terms regarding vesting, forfeiture, and distribution as the applicable PSUs.

(5)The cumulative TSR amounts reported in this column are calculated by dividing the sum of the cumulative

amount of dividends for the measurement period, assuming dividend reinvestment, and the difference

---

| | |
|:---|:---|
| 78 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

between the Company's share price at the end and the beginning of the measurement period by the

Company's share price at the beginning of the measurement period (here, December 31, 2020).

(6)The cumulative peer group TSR amounts reported in this column represent the weighted peer group TSR,

weighted according to the respective companies' stock market capitalization at the beginning of each period

for which a return is indicated. The peer group used for this purpose is the customized peer group included

in our Annual Report on Form 10-K that includes CME Group Inc., Intercontinental Exchange Inc., and

Nasdaq, Inc.

(7)The dollar amounts reported in this column represent the amount of net income reflected in the Company's

audited financial statements for the applicable year.

(8)The dollar amounts reported in this column represent adjusted EBITDA, which is a non-GAAP measure

used by the Company and reconciliations to GAAP measures are provided in Appendix A. While the

Company uses numerous financial and nonfinancial performance measures for the purpose of evaluating

performance for the Company's compensation programs, the Company has determined that adjusted

EBITDA is the financial performance measure that, in the Company's reasonable assessment, represents

the most important performance measure (that is not otherwise required to be disclosed in the table) used

by the Company to link compensation actually paid to the Company's NEOs, for the most recently

completed fiscal year, to company performance.

**Financial Performance Measures**

As described in greater detail in "Executive Compensation—Compensation Discussion and Analysis", the

Company's executive compensation program reflects a variable pay-for performance philosophy. The most

important financial performance measures used by the Company, listed in alphabetical order, to link

compensation actually paid to the Company's NEOs, for the most recently completed fiscal year, to the

Company's performance were as follows:

---

| |
|:---|
| **Financial Performance Measures** |
| Adjusted EBITDA |
| Net Revenue |
| 3-Year Cumulative Adjusted Diluted EPS |
| 3-Year Relative TSR Compared to S&P 500 |

---

**Analysis of the Information Presented in the Pay versus Performance Table**

As described in more detail in "Executive Compensation—Compensation Discussion and Analysis", the

Company's executive compensation program reflects a variable pay-for-performance philosophy. Approximately

18% of the total target compensation mix for the NEOs consists of amounts determined under the Company's

short-term annual incentive compensation program and approximately 68% of the total target compensation mix

for the NEOs is long-term incentive compensation generally composed of equity awards, including RSUs and/or

PSUs. Mr. Donohue's compensation paid for 2025 includes his Sign-On Grant. Mr. Tomczyk's compensation

paid for 2024 does not include any equity grants, as his CEO appointment grant in 2023 was meant to cover

equity grants for the 2023 and 2024 fiscal years.

While the Company utilizes several performance measures to align executive compensation with Company

performance, all of those Company measures are not presented in the Pay versus Performance table.

Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not

specifically align the Company's performance measures with compensation that is actually paid for a particular

year.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 79 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Description of Relationship between Compensation Actually Paid to our NEOs and Each Financial** 

**Metric Presented in the Pay versus Performance Table**

***Compensation Actually Paid and Cumulative TSR***

As demonstrated by the following graph, the amount of compensation actually paid to Messrs. Donohue,

Tomczyk, and Tilly and the average amount of compensation actually paid to the Company's Other NEOs as a

group is generally aligned with the Company's cumulative TSR over the period presented in the table.

![7678](cboe-20260401_g60.gif)

***Compensation Actually Paid and Net Income***

As demonstrated by the following table, the amount of compensation actually paid to Messrs. Donohue,

Tomczyk, and Tilly and the average amount of compensation actually paid to the Company's Other NEOs as a

group is generally aligned with the Company's net income over the period presented in the table.

![8015](cboe-20260401_g61.gif)

---

| | |
|:---|:---|
| 80 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***Compensation Actually Paid and Adjusted EBITDA***

As demonstrated by the following graph, the amount of compensation actually paid to Messrs. Donohue,

Tomczyk, and Tilly and the average amount of compensation actually paid to the Company's Other NEOs as a

group is generally aligned with the Company's adjusted EBITDA over the period presented in the table.

![8362](cboe-20260401_g62.gif)

***Cumulative TSR of the Company and Cumulative TSR of the Peer Group***

As demonstrated by the following graph, the Company's cumulative TSR over the period presented in the table

was 189%, while the cumulative TSR of the peer group presented for this purpose was 76% over the period

presented in the table. The Company's cumulative TSR generally matched the performance of the peer group in

2021, outperformed the peer group in 2022, outperformed the peer group in 2023, generally matched the

performance of the peer group in 2024, and outperformed the peer group in 2025. For more information

regarding the Company's performance and the companies that the Compensation and Human Capital

Committee considers when determining compensation, refer to "Executive Compensation—Compensation

Discussion and Analysis".

![9155](cboe-20260401_g63.gif)

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 81 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**POLICIES AND PRACTICES RELATED TO THE GRANT OF** 

**CERTAIN EQUITY AWARDS CLOSE IN TIME TO THE RELEASE** 

**OF MATERIAL NONPUBLIC INFORMATION**

Under the Third Amended and Restated Cboe Global Markets, Inc. Long-Term Incentive Plan, the Company

may grant equity or cash awards, including restricted stock, RSUs, and stock options. Stock options were not

featured in our long-term incentive program in 2025. However, the Company has a policy that stock option

grants may not be made during a "blackout period", as defined in the Insider Trading Policy, unless the

Compensation and Human Capital Committee determines that special circumstances warrant an equity grant

during the blackout period. Blackout periods generally occur when there is a presumption of the possession of

material non-public information, which includes (i) quarterly and annual restrictions surrounding the

dissemination of financial results and (ii) other specific circumstances surrounding developments known to the

Company and not yet publicly disclosed. See "Corporate Governance—Insider Trading Policy" for additional

information.

**EQUITY COMPENSATION PLAN INFORMATION**

The following is information about our equity compensation plans as of December 31, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Plan Category** | **Number of** <br>**securities**<br>**to be issued upon**<br>**exercise of**<br>**outstanding** <br>**options,**<br>**warrants and**<br>**rights (a)** | **Weighted-average**<br>**exercise price of**<br>**outstanding** <br>**options,**<br>**warrants and** <br>**rights (b)** | **Number of** <br>**securities**<br>**remaining** <br>**available for**<br>**future issuance** <br>**under**<br>**equity** <br>**compensation** <br>**plans**<br>**(excluding** <br>**securities**<br>**reflected in** <br>**column**<br>**(a)) (c)**  | **Number of** <br>**securities**<br>**remaining** <br>**available for**<br>**future issuance** <br>**under**<br>**equity** <br>**compensation** <br>**plans**<br>**(excluding** <br>**securities**<br>**reflected in** <br>**column**<br>**(a)) (c)**  |
| Equity compensation plans approved by security holders | (1) | (1) | 5454678 | (2) |
| Equity compensation plans not approved by security <br>holders<br>|  |  |  |  |
| Total | (1) | (1) | 5454678 | (2) |

---

____________________________________

(1)The Company has grants of unvested 458,809 time-based RSUs and 177,920 PSUs (which are reflected

here at maximum of 200%) as of December 31, 2025 under the Third Amended and Restated Cboe Global

Markets, Inc. Long-Term Incentive Plan. The weighted average exercise price of outstanding RSUs and

PSUs is not included at column (b) as such awards do not have an exercise price.

(2)Consists, as of December 31, 2025, of 5,013,538 shares of our common stock available for future issuance

under the Third Amended and Restated Cboe Global Markets, Inc. Long-Term Incentive Plan, assuming

maximum performance for PSUs, and 441,140 shares of our common stock available for future issuance

under the Employee Stock Purchase Plan, including an estimated 15,547 shares of our common stock

potentially subject to purchase as of December 31, 2025, with respect to the offering period that ran from

September 16, 2025 through March 15, 2026. The estimated shares of our common stock subject to

purchase under the Employee Stock Purchase Plan were calculated by dividing participant withholdings as

of December 31, 2025 by a purchase price equal to the closing share price of our common stock on

September 16, 2025 less the applicable program discount.

---

| | |
|:---|:---|
| 82 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**<u>AUDIT MATTERS</u>**

**PROPOSAL 3—RATIFICATION OF APPOINTMENT OF** 

**INDEPENDENT REGISTERED PUBLIC** 

**ACCOUNTING FIRM**

**General**

KPMG, an independent registered public accounting firm, served as our independent registered public

accounting firm for the year ended December 31, 2025, and our Audit Committee has again selected KPMG to

serve as our independent registered public accounting firm for the 2026 fiscal year. Representative(s) of KPMG

will be present at the Annual Meeting, will have the opportunity to make a statement if they so desire, and will be

available to respond to appropriate questions.

Although stockholder ratification is not required by our Bylaws or otherwise, the Board, as a matter of good

corporate governance, is requesting that stockholders ratify the selection of KPMG as our independent

registered public accounting firm for the 2026 fiscal year. If stockholders do not ratify KPMG, the Audit

Committee will reconsider its appointment.

The Board and the Audit Committee recommend that stockholders vote **FOR** ratification of the appointment of

KPMG as our independent registered public accounting firm for the 2026 fiscal year.

**Independent Registered Public Accounting Firm Fees**

KPMG served as our independent registered public accounting firm for the years ended December 31, 2025

and 2024 and is serving in such capacity for the 2026 fiscal year. The following table presents fees billed, or

expected to be billed, to us by KPMG for the years ended December 31, 2025 and 2024:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Audit Fees | $4936961 | $4529431 |
| Audit-Related Fees | 904646 | 446129 |
| Tax Fees | 76704 |  |
| All Other Fees |  | 100000 |
| Total | $5918311 | $5075560 |

---

Audit Fees consist of the aggregate fees billed, or expected to be billed, for professional services rendered by

KPMG for the integrated audit of our annual consolidated financial statements and internal control over financial

reporting, quarterly reviews of our unaudited condensed consolidated financial statements, and audits of various

domestic and international subsidiaries.

Audit-Related Fees consist of the aggregate fees billed, or expected to be billed, for assurance and related

services rendered by KPMG, including services rendered in connection with certain regulatory requirements of

our subsidiaries.

Tax Fees consist of the aggregate fees billed, or expected to be billed, for tax consulting services rendered by

KPMG in various jurisdictions in which we operate.

All Other Fees relate to professional services not included in the categories above and consist of the aggregate

fees billed, or expected to be billed, for non-financial assessments (including reporting requirement readiness)

rendered by KPMG.

**Pre-Approval Policies and Procedures**

The Audit Committee of the Board has adopted policies and procedures for the pre-approval of services

provided by our independent registered public accounting firm. These services may include audit services,

audit-related services, tax services, and other services. Such policies and procedures require that the Audit

Committee shall pre-approve all auditing and permitted non-audit services (including the fees and terms

thereof).

As permitted under the Sarbanes-Oxley Act of 2002 and its pre-approval policies and procedures, the Audit

Committee has delegated certain pre-approval authority to its Chair and a majority of the Audit Committee

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 83 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

members, one of which must be the Chair. The Audit Committee member or members to whom such authority is

delegated must then report any pre-approval decisions to the Audit Committee at the next scheduled Audit

Committee meeting.

**REPORT OF THE AUDIT COMMITTEE**

The Audit Committee assists the Board in its oversight of the integrity of our consolidated financial statements,

compliance with legal and regulatory requirements and the performance of the internal audit function.

Management is responsible for our internal control over financial reporting and financial reporting process.

KPMG, our independent registered public accounting firm, is responsible for performing an independent audit of

our consolidated financial statements and assertions related to the effectiveness of our internal control over

financial reporting and for issuing reports on these consolidated financial statements and assertions related to

the effectiveness of our internal control over financial reporting.

In this context, the Audit Committee hereby reports as follows:

The Audit Committee has reviewed and discussed with management and KPMG the audited

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

consolidated financial statements and the assertions related to effectiveness of our internal control over

financial reporting.

The Audit Committee has discussed with KPMG the matters required to be discussed by the applicable

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

requirements of the Public Company Accounting Oversight Board (U.S.) ("PCAOB") and the SEC.

The Audit Committee has received the written disclosures and communications from KPMG required by

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

applicable requirements of the PCAOB regarding its communications with the Audit Committee

concerning independence and has discussed with KPMG its independence.

Based on the review and discussions referred to above, the Audit Committee recommended to the Board that

the consolidated financial statements and our assertions related to the effectiveness of our internal control over

financial reporting, along with KPMG's audit opinions thereon, be included in our Annual Report on Form 10-K

for the year ended December 31, 2025 for filing with the SEC.

We selected KPMG as our independent registered public accounting firm for fiscal year 2026. The Board is

recommending that stockholders ratify that selection at the Annual Meeting. See "Proposal 3—Ratification of

Appointment of Independent Registered Public Accounting Firm" for more information.

**Audit Committee**

James E. Parisi (Chair)

William M. Farrow, III

Alexander J. Matturri, Jr.

Jennifer J. McPeek

---

| | |
|:---|:---|
| 84 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**<u>STOCKHOLDER PROPOSAL</u>**

**PROPOSAL 4—STOCKHOLDER PROPOSAL—**

**SHAREHOLDER RIGHT TO ACT BY** 

**WRITTEN CONSENT**

We have received notice of the intention of stockholder John Chevedden to present the following proposal at

the Annual Meeting. Mr. Chevedden has advised us that he owns at least 50 shares of stock in the Company.

We will furnish the address for the proponent upon receipt of a request to the Corporate Secretary for such

information. In accordance with federal securities regulations, the text of the stockholder proposal and

supporting statement appears below exactly as received. The contents of the proposal or supporting statement

are the sole responsibility of the proponent, and we are not responsible for the content of the proposal or any

inaccuracies it may contain.

As explained below, the Board does not support the adoption of this proposal and asks stockholders to consider

the Board's response following the proponent's statement below. If the proposal is properly presented at the

Annual Meeting, the Board recommends you vote **AGAINST** this proposal 4.

**Proposal 4—Shareholder Right to Act by Written Consent**

![Picture1 (1).jpg](cboe-20260401_g64.jpg)

Shareholders request that the board of directors take the necessary steps to permit written consent by the

shareholders entitled to cast the minimum number of votes that would be necessary to authorize an action at a

meeting at which all shareholders entitled to vote thereon were present and voting (without any unnecessary

restriction based on length of stock ownership or the method by which Cboe Global Markets shareholders hold

their CBOE shares). This includes shareholder ability to initiate any appropriate topic for written consent.

Shareholders acting by written consent and calling for a special shareholder meeting are 2 means that

shareholders of a company can use to put forth a proposal on a timely basis without waiting for the annual

shareholder meeting.

CBOE recently adopted a right for 25% of CBOE shares to call for a special shareholder meeting following a

shareholder vote on a CBOE proposal on this topic at the 25% mark. However on the same ballot 44% of CBOE

shareholders approved a proposal on the same topic but at the 10% mark. This 44% approval likely represented

more than 50% approval from the CBOE shares that have access to independent proxy voting advice and who

are the most informed shareholders on matters put to a vote.

Shareholders whose 44% support was unanswered by CBOE may wish to direct their votes to this proposal

because it is another means to put forth a proposal on a timely basis without waiting for the annual shareholder

meeting.

Shareholder proposals obtain good support at CBOE yet is unclear how CBOE will respond to the impressive

vote of 56% support for 2025 Political Spending Disclosure proposal at the CBOE annual shareholder meeting.

As of late 2025 CBOE has not notified the proponent of the 2025 Political Spending Disclosure whether CBOE

will take any action in response to the impressive 56% support that CBOE shareholders gave.

Please vote yes:

**Shareholder Right to Act by Written Consent—Proposal 4**

**BOARD OF DIRECTORS' STATEMENT IN OPPOSITION**

Our Board has carefully considered this stockholder proposal, and it believes that the proposal is not in the best

interests of the Company or its stockholders. The Company routinely monitors and evaluates trends in

corporate governance, reviews them against our current practices and structures and regularly asks for and

receives input from stockholders and other stakeholders. The Nominating and Governance Committee

considers all this input when reviewing proposals to change our practices. Following a comprehensive review of

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 85 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

the Company's governance structures, for the reasons outlined below, our Board recommends a vote **AGAINST** 

this proposal 4.

**Action by written consent is unnecessary given the ability of stockholders to call special meetings**

In addition to stockholders being able to propose and vote on important matters at our annual stockholder

meetings, stockholders holding at least 25% of the Company's voting power may call a special meeting of

stockholders, without any requirement that stockholders have held their shares for any defined period of time.

This right, which was adopted in response to feedback from our stockholders in 2024, permits the Company's

stockholders to bring important matters before all stockholders for consideration in a fully transparent and

equitable manner. Stockholder meetings offer important protections and advantages to all stockholders that are

absent from the written consent process. The protections and advantages of stockholder meetings include the

following:

Meetings are held at a time, date and venue publicly announced in advance, and all stockholders may

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

attend, consider the proposed actions, and vote their shares.

All stockholders have a chance to engage meaningfully in the process, voice their concerns, offer their

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

perspectives, and cast their votes, and also have greater flexibility to change their decisions before the

proposed action becomes effective.

Accurate and complete information about the proposed actions is widely distributed in a proxy

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

statement well in advance of stockholder meetings, thereby encouraging a fully informed discussion

and consideration of the merits of the proposed actions.

The Board can analyze the proposed actions and provide a well-informed recommendation on them

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

before stockholders vote on the proposed action.

These protections ensure that all stockholders, not just those solicited by a particular group, can participate

meaningfully in governance decisions.

**Our extensive stockholder engagement program allows stockholders to provide ongoing and** 

**constructive feedback to our Board and management, and, despite statements to the contrary from the** 

**proponent, we have demonstrated a consistent and meaningful responsiveness to prior stockholder** 

**votes**

We regularly engage with our investors to learn and understand their views and then communicate those views

to the Board or Board committees, as applicable. These engagements routinely cover strategy and

performance, corporate governance, executive compensation, and other current and emerging issues to help

ensure that our Board and management understand and address the issues that are important to our

stockholders. For more information, see "Stockholder Engagement".

The proponent suggests that we were not responsive to stockholders with regard to the 2024 vote on the

special meeting proposals and also indicates that we did not take any action in response to the 2025 vote on

the political spending proposal. In fact, we were responsive to stockholders on both matters.

At the 2024 Annual Meeting of Stockholders, we supported a proposal to give stockholders a special meeting

right at a 25% ownership threshold. At the same meeting, the proponent set forth a competing proposal for a

special meeting right at a 10% ownership threshold. The proposal at a 25% ownership threshold received

60.5% of votes in favor and the proposal at a 10% ownership threshold received 44.8% of votes in favor.

The proponent references the 2024 vote on special meeting thresholds and suggests that the stockholders who

voted in favor of the 10% ownership threshold would favor the current proposal for a written consent right

because their prior "support was unanswered," as stated by the proponent. However, this characterization omits

important context. Following the 2024 Annual Meeting of Stockholders, the Board amended the Company's

Bylaws to provide stockholders with a right to call a special stockholder meeting at a 25% ownership threshold

in response to the stockholder vote and with additional input gathered through stockholder outreach. Such

outreach efforts included conversations with our largest stockholders who indicated support for a 25% threshold

as opposed to a 10% threshold. When stockholders voted on these proposals, a greater proportion voted in

favor of the Board-recommended 25% special meeting threshold management proposal (60.5%) than the 10%

threshold stockholder proposal (44.8%). The Board implemented the threshold that received majority support

and aligns with best practices among peer companies. The Board believes that a 25% threshold strikes the

proper balance between stockholder rights and protecting the Company and its stockholders from potential

abuse of the special meeting right, while providing stockholders with meaningful and timely access to raise

important matters between annual meetings.

---

| | |
|:---|:---|
| 86 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

On political spending disclosure, the Company proactively adopted a Political Contributions Policy in early 2025,

before the 2025 Annual Meeting of Stockholders and before stockholders voted on the proposal, and made it

publicly available on its website. At the 2025 Annual Meeting of Stockholders, the proponent presented a

proposal requesting that the Company issue a report detailing the Company's political contributions. The

proposal passed with 56.1% of votes in favor. Following the vote and additional stockholder engagement, we

revised the Political Contributions Policy in August 2025. The Political Contributions Policy and a list of

contributions made to state and local candidates or political entities is available in the Governance Documents

section of our website. Accordingly, we have demonstrated responsiveness to the stockholder proposal

regarding political spending both before and after the 2025 Annual Meeting of Stockholders. For additional

information regarding our stockholder engagement efforts, see "Stockholder Engagement".

**Our corporate governance practices emphasize Board accountability and provide numerous** 

**opportunities for stockholder action**

In addition to providing for extensive stockholder engagement throughout the year and stockholders' right to call

special meetings, our existing corporate governance practices and policies emphasize Board accountability and

give stockholders ample opportunity to take action at a properly called stockholders' meeting. Significant

examples include the following.

Stockholders can call special meetings;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Proxy access Bylaw provision for director nominations;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Directors are elected annually;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Majority voting standard in director elections;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Majority voting standard for Bylaw and Charter amendments;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

10 of the 12 director nominees are independent;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Independent Audit, Compensation and Human Capital, and Nominating and Governance Committees;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Robust annual Board and committee self-evaluation process;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Split Chairman and CEO roles;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Risk oversight by Board and committees, including a Risk Committee;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Human capital and succession oversight by Board and Compensation and Human Capital Committee;

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Executive sessions of Board and committees; and

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Anti-hedging, anti-pledging, and clawback policies for executive officers.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

For additional information, see "Corporate Governance".

We believe that our corporate governance practices and policies enable stockholders to act in support of their

interests while avoiding the risks associated with stockholder action by written consent.

**Stockholder meetings provide a more transparent, informed, and equitable process for all stockholders** 

**to exercise their rights**

In contrast to the open and transparent forum of a stockholder meeting, stockholder action by written consent,

where there may be limited advance notice, discussion or debate, can result in decisions made with limited

transparency and without the benefit of full deliberation by permitting a bare majority of stockholders to act

alone. Such action would deprive many stockholders of the opportunity to assess, discuss, deliberate and vote

on pending stockholder matters. It would also deprive the Board of the opportunity to carefully discuss the

merits, disadvantages, and overall implications of a stockholder proposal and then to vote on a proposed action.

This could include matters that are significant in nature, such as removing directors or amending the Company's

governance documents, all without a stockholder meeting to consider the merits or consequences of that matter

and without affording all stockholders, including those who may not have been solicited or who need additional

time to evaluate the proposal, the opportunity to participate in the decision. The Board believes that matters of

sufficient importance to warrant action between annual stockholder meetings should not be decided in this

manner.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 87 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**Action by written consent could create confusion and disruption for stockholders and the Company**

The Board also believes that permitting stockholder action by written consent is not appropriate for Cboe, a

large, widely held public company with both institutional and retail investors. If action by written consent is

permitted, multiple stockholder groups could solicit written consents at any time and as frequently as they

choose on a range of insignificant or self-interested issues, or with respect to issues that Company

management and the Board are already contemplating or reviewing. Some of these written consents may be

duplicative or contradictory, which has the potential to create substantial confusion and disruption for

stockholders and a significant burden on the Company's resources, including the time and attention of the

Board, its executives and its employees with no corresponding benefit to our stockholders.

Additionally, we face unique regulatory constraints as an exchange operator. Because we operate national

securities exchanges that have status as self-regulatory organizations, implementing this proposal would

require amendments to the Company's Charter and Bylaws that must be filed with and approved by the SEC as

required by Section 19(b)(1) of the Exchange Act. The SEC may request changes to any proposed

amendments as part of its review process. This regulatory requirement adds complexity and uncertainty to the

implementation of the proposal and represents an additional burden on Company resources.

The Board believes the Company's resources would be better spent on executing its growth strategy to deliver

results for the Company's stockholders.

**The Company's current practice is consistent with market practice.**

The Company's current practice of not permitting stockholder action by written consent is consistent with the

practice of most other large public companies. As of March 20, 2026, a significant majority of S&P 500

companies, approximately 70%, either do not permit stockholders to act by written consent or require that any

stockholder action by written consent be unanimous (which is effectively the same as not permitting action by

written consent for a large public company). As such, the Company believes that the combination of its ongoing

dialogue with stockholders and its current corporate governance practices, including a meaningful special

meeting right and proxy access right, renders the proposal's implementation unnecessary and not aligned with

stockholders' interests.

**Conclusion**

We believe that our existing corporate governance structure is strongly supportive of stockholder rights and

provides stockholders with effective avenues to raise important matters. Accordingly, the adoption of the

proposal permitting action by written consent is unnecessary and not in the best interests of the Company and

its stockholders.

The Board recommends that the stockholders vote **AGAINST** this proposal 4, the stockholder proposal on the

right to act by written consent.

---

| | |
|:---|:---|
| 88 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**<u>OTHER ITEMS</u>**

**BENEFICIAL OWNERSHIP OF MANAGEMENT AND DIRECTORS**

The following table lists the shares of our common stock that were beneficially owned as of March 19, 2026, or

as of the date otherwise indicated below, and the percentage of our common stock beneficially owned, based

on 104,742,273 shares outstanding on March 19, 2026, by each of:

Our directors and nominees,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Our NEOs,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Our directors, nominees, and NEOs and other executive officers in service as of March 19, 2026, as a

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

group, and

Beneficial owners of more than 5% of our common stock.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

---

| | | |
|:---|:---|:---|
| **Name** | **Number of**<br>**Shares of**<br>**Common Stock (1)**<br>| **Percent of** <br>**Voting** <br>**Common Stock** <br>|
| Craig S. Donohue | 2604 | \* |
| Fredric J. Tomczyk  | 34815 | \* |
| Jill M. Griebenow | 17081 | \* |
| Christopher A. Isaacson (2) | 50059 | \* |
| Patrick Sexton | 29575 | \* |
| Timothy Lipscomb | 2638 | \* |
| David Howson (3) | 12635 | \* |
| Catherine R. Clay (4) |  | \* |
| William M. Farrow, III | 12205 | \* |
| Edward J. Fitzpatrick | 12921 | \* |
| Ivan K. Fong | 6911 | \* |
| Janet P. Froetscher | 14500 | \* |
| Jill R. Goodman | 11918 | \* |
| Erin A. Mansfield  | 1911 | \* |
| Cecilia H. Mao  | 1911 | \* |
| Alexander J. Matturri, Jr. (5) | 4761 | \* |
| Jennifer J. McPeek | 5838 | \* |
| Roderick A. Palmore | 27200 | \* |
| James E. Parisi | 9439 | \* |
| All serving directors, nominees, NEOs and other executive officers as a <br>group (24 persons)<br>| 263809 | \* |
| The Vanguard Group (6) | 12688861 | 12.1% |
| BlackRock, Inc. (7) | 9414735 | 9.0% |
| AllianceBernstein L.P. (8) | 6777633 | 6.5% |

---

____________________________________

\*Less than 1%.

(1)Except as described below, the RSUs and PSUs granted to our directors and executives, as applicable,

which do not entitle the holder to voting rights and are described in the "Non-Employee Director

Compensation" and "Executive Compensation—Summary Compensation" sections of this Proxy Statement,

are not included in this table. Beneficial ownership is determined in accordance with Rule 13d-3 under the

Exchange Act, pursuant to which a person or group of persons is deemed to have "beneficial ownership" of

a security if that person has the right to acquire beneficial ownership of such security within 60 days. As

such, amounts also include shares of common stock that the directors, NEOs and the other executive

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 89 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

officers who are not NEOs have or will have the right to acquire pursuant to RSUs and PSUs that will

become vested within 60 days following March 19, 2026. Amounts for non-employee directors (other than

Mr. Tomczyk) include 729 shares of unvested RSUs granted to each non-employee director pursuant to the

Third Amended and Restated Cboe Global Markets, Inc. Long-Term Incentive Plan that will become vested

within 60 days following March 19, 2026. The number of shares of unvested RSUs that will become vested

within 60 days following March 19, 2026 held by applicable directors as a group is 8,019.

(2)Amount is as of March 6, 2026. Mr. Isaacson resigned as Executive Vice President, Chief Operating Officer

at the end of March 6, 2026 and his last day with the Company was March 6, 2026.

(3)Amount is as of March 6, 2026. Mr. Howson resigned as Executive Vice President, Global President, at the

end of August 1, 2025 and his last day with the Company was August 1, 2025. See "Severance, Change in

Control and Employment-Related Agreements—Mr. Howson's Separation Letter Agreement" for a

description of the vesting treatment of Mr. Howson's awards in connection with his resignation.

(4)Amount is as of March 6, 2026. Ms. Clay resigned as Executive Vice President, Global Head of Derivatives,

at the end of September 30, 2025 and her last day with the Company was October 15, 2025. See

"Severance, Change in Control and Employment-Related Agreements—Ms. Clay's Equity Award

Acceleration" for a description of the vesting treatment of Ms. Clay's awards in connection with her

resignation.

(5)Mr. Matturri is not standing for reelection as a director at the Annual Meeting.

(6)Based on information set forth in a Schedule 13G/A filed with the SEC on February 13, 2024. The Schedule

13G/A reports that, as of December 29, 2023, The Vanguard Group, 100 Vanguard Blvd., Malvern, PA

19355, has sole dispositive power with respect to 12,242,338 shares of common stock. In addition, The

Vanguard Group has shared voting power with respect to 135,611 shares of common stock and shared

dispositive power with respect to 446,523 shares of common stock. On March 26, 2026, The Vanguard

Group filed a Schedule 13G/A noting that, following an internal realignment that occurred on January 12,

2026, certain subsidiaries or business divisions of subsidiaries of The Vanguard Group will report beneficial

ownership separately and The Vanguard Group will no longer have beneficial ownership of those shares.

(7)Based on information set forth in a Schedule 13G/A filed with the SEC on October 17, 2025. The Schedule

13G/A reports that, as of September 30, 2025, BlackRock Inc., 50 Hudson Yards, New York, NY 10001, has

sole voting power with respect to 8,747,562 shares of common stock and sole dispositive power with

respect to 9,414,735 shares of common stock.

(8)Based on information set forth in a Schedule 13G/A filed with the SEC on November 14, 2025. The

Schedule 13G/A reports that, as of September 30, 2025, AllianceBernstein L.P., 501 Commerce Street,

Nashville, TN 37203, has sole voting power with respect to 6,367,296 shares of common stock and sole

dispositive power with respect to 6,772,184 shares of common stock. In addition, AllianceBernstein L.P. has

shared dispositive power with respect to 5,449 shares of common stock.

**RELATIONSHIPS AND RELATED PARTY TRANSACTIONS**

Our Audit Committee has responsibility for reviewing and approving all related party transactions. The

Committee has adopted a related-party transactions approval policy. Under this policy, transactions between us

and any executive officer, director or holder of more than 5% of our common stock, or any immediate family

member of such person, must be approved or ratified by the Committee in accordance with the terms of the

policy. Since January 1, 2025, there were no transactions in which Cboe Global Markets or any of its

subsidiaries was a party, in which the amount involved exceeded $120,000 and in which a director, a director

nominee, an executive officer, a security holder known to own more than 5% of our common stock, or an

immediate family member of any of the foregoing had, or will have, a direct or indirect material interest. The

Audit Committee has pre-approved transactions by our directors or director nominees that are due to such

director or nominee being a Trading Permit Holder, Trading Privilege Holder, participant or member, or affiliated

with a Trading Permit Holder, Trading Privilege Holder, participant or member firm, on one of our exchanges;

provided that the amounts paid or received in such transactions are based on a set fee or rebate schedule

applicable to all similarly situated Trading Permit Holders, Trading Privilege Holders, participants or members.

From time to time, we may participate in arms' length transactions with entities formerly affiliated with our

related persons in the ordinary course of business. The Company believes that such transactions involve terms

no less favorable to the Company than those that it believes would have been obtained in the absence of such

former affiliations.

---

| | |
|:---|:---|
| 90 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**INCORPORATION BY REFERENCE**

To the extent that this Proxy Statement is incorporated by reference into any other filing by Cboe Global Markets

with the SEC under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, the

information contained in the sections of this Proxy Statement entitled "Audit Matters—Report of the Audit

Committee" and "Executive Compensation—Pay Versus Performance" (to the extent permitted by the rules of

the SEC) shall not be deemed to be "soliciting material" and will not be deemed incorporated, unless specifically

provided otherwise in such filing. The information contained in the "Executive Compensation—Compensation

and Human Capital Committee Report" shall not be deemed to be "soliciting material" and will not be deemed to

be incorporated by reference into any filing under the Securities Act or the Exchange Act, other than Cboe

Global Markets' Annual Report on Form 10-K, except to the extent specifically provided otherwise in such filing.

**STOCKHOLDER PROPOSALS**

Any stockholder who, in accordance with SEC rules, wishes to present a proposal for inclusion in the proxy

materials to be distributed in connection with next year's annual meeting must timely submit the proposal to the

Corporate Secretary, Cboe Global Markets, Inc., 433 West Van Buren Street, Chicago, Illinois 60607.

Stockholder proposals for inclusion in our proxy statement for the 2027 Annual Meeting of Stockholders must be

received on or before December 3, 2026 and must comply in all other respects with applicable SEC rules.

Our Bylaws allow any stockholder, or a group of up to 20 stockholders, owning at least 3% of our outstanding

shares of common stock continuously for at least 3 years, to nominate and include in our proxy statement for

the 2027 Annual Meeting of Stockholders director nominees constituting up to the greater of 2 individuals and

20% of the total number of directors then in office, provided that the stockholder(s) and nominee(s) satisfy the

requirements specified in our Bylaws. The stockholder(s) must notify the Corporate Secretary of Cboe Global

Markets, Inc. in writing and provide the specified information described in our Bylaws concerning the proposed

nominee(s). The notice must be delivered to the address set forth in the paragraph above and received at our

principal executive offices not less than 120 days nor more than 150 days prior to the first anniversary of the

date that we first distributed this Proxy Statement to stockholders, which is April 2, 2026. As a result, notice of

director nominations submitted under these requirements must be received no earlier than the open of business

on November 3, 2026 and no later than the close of business on December 3, 2026, unless our annual meeting

date occurs more than 30 days before or after May 14, 2027, in which case the stockholder's notice must be

received no earlier than 150 days before such annual meeting and no later than the later of 120 days before

such annual meeting or the 10th day following the day on which public announcement of the date of such

meeting is first made by us. The requirements for such notice are set forth in our Bylaws, a copy of which can

be obtained upon request directed to the Corporate Secretary at the address set forth above.

Any stockholder who wishes to propose any business or nominate a person for election to the Board to be

considered by the stockholders at the 2027 Annual Meeting of Stockholders, which proposal or nomination

would not be included in the Company's proxy statement, must notify the Corporate Secretary of Cboe Global

Markets, Inc. in writing and provide the specified information described in our Bylaws concerning the proposed

business or nominee. The notice must be delivered to or mailed to the address set forth in the paragraph above

and received at our principal executive offices not less than 90 days nor more than 120 days prior to the first

anniversary of the date of the Annual Meeting. As a result, any notice given by a stockholder pursuant to these

provisions of our Bylaws (and not pursuant to the SEC rules relating to stockholder proposals for inclusion in the

proxy materials) must be received no earlier than 5:00 p.m., Eastern time, on January 14, 2027 and no later

than 5:00 p.m., Eastern time, on February 13, 2027, unless our annual meeting date occurs more than 30 days

before or more than 70 days after May 14, 2027, in which case the stockholder's notice must be received not

later than 5:00 p.m., Eastern time, on the tenth day following the day on which public announcement is first

made of the date of the annual meeting. The requirements for such notice are set forth in our Bylaws, a copy of

which can be obtained upon request directed to the Corporate Secretary at the address set forth above.

In addition, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of

director nominees other than the Company's nominees must provide notice that sets forth the information

required by applicable SEC rules, including Rule 14a-19, no later than March 15, 2027. However, we note that

this date does not supersede any of the requirements or timing described above and set forth in our Bylaws, a

copy of which can be obtained upon request directed to the Corporate Secretary at the address set forth above.

If a stockholder that has notified the Company of its intention to present a proposal at the 2027 Annual Meeting

of Stockholders does not appear or send a qualified representative to present their proposal at the 2027 Annual

Meeting of Stockholders, the Company need not present the proposal for a vote at the 2027 Annual Meeting of

Stockholders.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 91 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**VOTING INSTRUCTIONS**

***Why did I receive these proxy materials?***

Our Board is asking for your proxy in connection with the Annual Meeting. By giving us your proxy, you

authorize the proxyholders (Craig S. Donohue and Patrick Sexton) to vote your shares at the Annual Meeting

according to the instructions that you provide. If the Annual Meeting is adjourned or postponed, your proxy will

be used to vote your shares when the meeting reconvenes.

Our 2025 Annual Report to Stockholders, which includes a copy of our Annual Report on Form 10-K for the year

ended December 31, 2025 (excluding exhibits), as filed with the SEC, is being mailed to stockholders with this

Proxy Statement.

***Who can vote at the Annual Meeting?***

You are entitled to vote your shares of our common stock if you were a stockholder at the close of business on

March 19, 2026, the record date for the Annual Meeting. On that date, there were 104,742,273 shares of our

common stock outstanding. Therefore, there are 104,742,273 shares of voting common stock outstanding, each

of which entitles the holder to 1 vote for each matter to be voted on at the Annual Meeting. Our outstanding

common stock is held by approximately 95 stockholders of record as of March 19, 2026. A list of stockholders of

record will be open for examination by any stockholder for any purpose germane to the Annual Meeting for a

period of 10 days prior to the Annual Meeting at our principal executive offices at 433 West Van Buren Street,

Chicago, Illinois 60607.

***Who is and is not a stockholder of record?***

If you hold shares of common stock registered in your name at our transfer agent, Broadridge Corporate Issuer

Solutions, Inc. ("Broadridge"), you are a stockholder of record.

If you hold shares of common stock indirectly through a broker, bank, or similar institution, or are an employee

or director who holds shares of restricted stock at Fidelity, you are not a stockholder of record, but instead hold

in "street name". Please see the information under the heading ***"If I hold my shares in "street name" and do***

***not provide voting instructions, can my broker still vote my shares?"*** for important information.

If you are a stockholder of record, Broadridge is sending these proxy materials to you directly. If you hold shares

in street name, these materials are being provided to you by the broker, bank, or similar institution through

which you hold your shares.

***What do I need to do to attend the Annual Meeting?***

The Annual Meeting will be a completely virtual meeting of stockholders, which will be conducted via live audio

webcast. The live audio webcast of the Annual Meeting will also be available for listening to the general public,

but participation in the Annual Meeting, including voting shares and submitting questions, will be limited to

stockholders. You are entitled to participate in the Annual Meeting only if you were a stockholder at the close of

business on March 19, 2026, the record date for the Annual Meeting, or if you hold a valid proxy to vote at the

Annual Meeting.

If you were a stockholder of record as of the close of business on March 19, 2026, or you hold a valid proxy for

the Annual Meeting, you will be able to attend the Annual Meeting via live audio webcast, vote your shares, and

submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/CBOE2026. To

participate, you will need your 16-digit control number included in your proxy materials, on your proxy card, or

on the instructions that accompanied your proxy materials.

If you were not a stockholder of record, but you hold shares in street name and you want to attend the Annual

Meeting via live audio webcast, vote your shares, and submit your questions during the meeting by visiting

www.virtualshareholdermeeting.com/CBOE2026, you must obtain, from the broker, bank, or other organization

that holds your shares, the information required, including a 16-digit control number, and you may be required to

provide proof of beneficial ownership, such as your most recent account statement as of the record date, a copy

of the voting instruction form provided by your broker, bank, trustee, or nominee, or other similar evidence of

ownership.

If you are not a stockholder or if you have lost your 16-digit control number, you will be able to listen to the live

audio webcast of the Annual Meeting by visiting www.virtualshareholdermeeting.com/CBOE2026, but you will

not be able to vote or submit your questions during the meeting.

---

| | |
|:---|:---|
| 92 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

The Annual Meeting will begin promptly at 8:00 a.m., Central time. We encourage you to access the meeting

prior to the start time. Online access will open at 7:45 a.m., Central time, and you should allow ample time to log

in to the meeting live audio webcast and test your computer audio system.

We recommend that you carefully review the procedures needed to gain admission in advance. If you do not

comply with the procedures described here for attending the Annual Meeting via live audio webcast, you will not

be able to participate online.

Please contact Investor Relations at investorrelations@Cboe.com or (312) 786-7559 in advance of the Annual

Meeting if you have questions about attending the Annual Meeting.

***If I am unable to attend the live audio webcast of the Annual Meeting, may I listen at a later date?***

Yes, an audio replay of the Annual Meeting will be posted and publicly available on the Events and

Presentations page of our Investor Relations website at http://ir.Cboe.com. This audio replay will cover the

entire Annual Meeting, including each stockholder question addressed during the Annual Meeting.

***What if during the check-in period or during the Annual Meeting I have technical difficulties or trouble***

***accessing the virtual meeting live audio webcast?***

During online check-in and continuing through the length of the virtual Annual Meeting, we will have technicians

standing by to assist you with any technical difficulties you may have accessing the live audio webcast. If you

encounter any difficulties accessing the Annual Meeting during the check-in or at meeting time, please call (844) 986-0822 (U.S.) or (303) 562-9302 (International).

***Why is the Annual Meeting being conducted as a virtual meeting via live audio webcast?***

We believe a virtual meeting format for the Annual Meeting may facilitate stockholder attendance, dialogue, and

participation by enabling stockholders to participate fully, and equally, from any location around the world, at no

cost. We will be able to engage with all stockholders as opposed to just those who can afford to travel to an in-

person meeting. The virtual format will also allow stockholders to submit questions and comments during the

meeting.

We are utilizing technology from Broadridge, a leading virtual meeting solution. The platform is expected to

accommodate most, if not all, stockholders. Both we and Broadridge will test the platform technology before

going "live" for the Annual Meeting.

***How do I submit questions or comments for the Annual Meeting?***

Stockholders can submit questions or comments online during the Annual Meeting via live audio webcast by

visiting www.virtualshareholdermeeting.com/CBOE2026. We will answer timely submitted questions or

comments on a matter to be voted on at the Annual Meeting before voting is closed on the matter. Then, we will

address appropriate general questions or comments from stockholders regarding the Company. Questions or

comments received during the Annual Meeting will be presented as submitted, uncensored and unedited,

except that we may omit certain personal details for data protection issues or we may edit profanity or other

inappropriate language. Questions or comments regarding general economic, political, or other views that are

not directly related to the business of the meeting, that are of an individual concern to a stockholder or that are

not an appropriate subject matter for general discussion, are not pertinent to the meeting and therefore will not

be presented. If we receive substantially similar questions, we may group those questions together and provide

a single response to avoid repetition.

***How do I vote?***

You may cast your vote in one of four ways:

***By Internet <u>before</u> the Annual Meeting.*** The web address for Internet voting is www.proxyvote.com

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

and is also on the enclosed proxy card. Internet voting is available 24 hours a day.

***By Internet <u>during</u> the Annual Meeting*.** You may vote online during the Annual Meeting (see ***"What***

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

***do I need to do to attend the Annual Meeting?"***). However, even if you plan to participate in the

Annual Meeting via live audio webcast, we recommend that you also vote by Internet as described

above so that your votes will be counted if you later decide not to participate in the Annual Meeting.

***By Telephone.*** The number for telephone voting is 1-800-690-6903 and is also on the enclosed proxy

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

card. Telephone voting is available 24 hours a day.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 93 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***By Mail.*** Mark the enclosed proxy card, sign and date it, and return it in the pre-paid envelope we have

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

provided.

If you choose to vote by Internet before or during the Annual Meeting or by telephone, then you do not need to

return the proxy card. To be valid, your vote by Internet before the Annual Meeting or telephone must be

received by 11:59 p.m., Eastern time, on May 13, 2026 for shares held directly, the deadline specified on the

proxy card. If you vote by Internet before the Annual Meeting or telephone and subsequently obtain a legal

proxy from your account representative, then your prior vote will be revoked regardless of whether you vote that

legal proxy.

The Internet and telephone voting procedures are designed to authenticate stockholders' identities, allow

stockholders to give their voting instructions, and confirm that stockholders' instructions have been recorded

properly. Stockholders voting by Internet or telephone should understand that, while we do not charge any fees

for voting by Internet or telephone, there may nevertheless be costs that must be borne by you.

***May I change my vote?***

If you are a stockholder of record, you may revoke your proxy or change your vote at any time before it is voted

at the Annual Meeting by:

Submitting a new proxy by telephone or through the Internet, after the date of the earlier voted proxy,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Returning a signed proxy card dated later than your last proxy,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Submitting a written revocation to the Corporate Secretary of Cboe Global Markets, Inc. at 433 West

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

Van Buren Street, Chicago, Illinois 60607, or

Voting online during the Annual Meeting.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

If you are a stockholder of record and need a new proxy card, to change your vote or otherwise, please contact

the Corporate Secretary at the address above or via email at CorporateSecretary@Cboe.com.

If your bank, broker, or other nominee holds your shares in "street name", you may revoke your proxy or change

your vote only by following the separate instructions provided by your bank, broker, or nominee.

***If I submit a proxy by Internet, telephone or mail, how will my shares be voted?***

If you properly submit your proxy by one of these methods, and you do not subsequently revoke your proxy,

your shares of common stock will be voted in accordance with your instructions.

If you sign, date, and return your proxy card but do not give voting instructions, your shares of common stock

will be voted as follows:

FOR the election of each of our director nominees,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

FOR the advisory vote to approve the compensation paid to our executive officers,

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

FOR the ratification of the appointment of KPMG as our independent registered public accounting firm

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

for our 2026 fiscal year, and

AGAINST the stockholder proposal regarding the shareholder right to act by written consent.

![cboe-20240516xdef14a_a004.jpg](cboe-20260401_g9.jpg)

In addition, if you properly submit your proxy by one of these methods, and you do not subsequently revoke

your proxy, and any other matters are properly presented at the Annual Meeting, your shares of common stock

will be voted in accordance with the judgment of the persons voting the proxy on such matters. We are not

aware of any other matters that will be considered at the Annual Meeting.

***If I hold my shares in "street name" and do not provide voting instructions, can my broker still vote my***

***shares?***

Under the rules of various securities exchanges, brokers that have not received voting instructions from their

customers 10 days prior to the meeting date may vote their customers' shares in the brokers' discretion on the

proposal regarding the ratification of the appointment of KPMG as our independent registered public accounting

firm for our 2026 fiscal year, because the rules of the exchanges currently deem this a "discretionary" matter.

Absent instruction, brokers will not be able to vote on any of the other matters included in this Proxy Statement.

If brokers exercise their discretion in voting on the proposal regarding the ratification of KPMG, a "broker non-

vote" will occur as to the other matters presented for a vote at the Annual Meeting, unless you provide voting

instructions.

---

| | |
|:---|:---|
| 94 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

***What vote is required for adoption or approval of each matter?***

***Election of Directors.*** You may vote FOR or AGAINST each of the director nominees or you may ABSTAIN.

Each nominee must receive the affirmative vote of a majority of the votes properly cast with respect to his or her

election in order to be elected. Each nominee has tendered his or her resignation, contingent on failing to

receive a majority of the votes cast in this election and acceptance by the Board. In the event any director fails

to receive a majority of votes cast, the Nominating and Governance Committee will consider and make a

recommendation to the Board as to whether to accept the resignation.

***Advisory Vote to Approve Executive Compensation.*** You may vote FOR or AGAINST the advisory proposal

to approve our executive compensation or you may ABSTAIN. A majority of the shares of common stock

properly cast upon this proposal must be voted FOR approval of this advisory proposal for it to pass. Votes cast

FOR or AGAINST with respect to the proposal will be counted as shares cast on the proposal.

***Ratification of the Appointment of our Independent Registered Public Accounting Firm.*** You may vote

FOR or AGAINST the ratification of the appointment of our independent registered public accounting firm or you

may ABSTAIN. A majority of the shares of common stock properly cast upon this proposal must be voted FOR

ratification for it to pass. Votes cast FOR or AGAINST with respect to this matter will be counted as shares cast

on the matter.

***Stockholder Proposal Regarding the Shareholder Right to Act by Written Consent.*** You may vote FOR or

AGAINST the stockholder proposal regarding the shareholder right to act by written consent or you may

ABSTAIN. A majority of the shares of common stock properly cast upon this proposal must be voted FOR

approval of this proposal for it to pass. Votes cast FOR or AGAINST with respect to the proposal will be counted

as shares cast on the proposal.

***Abstentions and Broker Non-Votes.*** Abstentions and broker non-votes will not be considered a vote cast

either for or against any of the matters being presented in this Proxy Statement and will not impact the voting

results. If you do not provide your broker with voting instructions, the broker cannot vote your shares on any

matter other than the ratification of the appointment of our independent registered public accounting firm. A

"broker non-vote" occurs when your broker submits a proxy for the meeting with respect to discretionary

matters, but does not vote on non-discretionary matters because you did not provide voting instructions on

these matters. In the case of a discretionary matter (*i.e.*, the ratification of the appointment of our independent

registered public accounting firm), your broker is permitted to vote your shares of common stock even when you

have not given voting instructions (as described above under ***"If I hold my shares in "street name" and do***

***not provide voting instructions, can my broker still vote my shares?"***).

***How many votes are required to transact business at the Annual Meeting?***

A quorum is required to transact business at the Annual Meeting. The holders of a majority of the outstanding

shares of our common stock as of March 19, 2026, present or represented by proxy and entitled to vote, will

constitute a quorum for the transaction of business at the Annual Meeting. Abstentions and broker non-votes are

treated as present for quorum purposes.

***What happens if the meeting is postponed or adjourned or encounters technical difficulties?***

Your proxy will remain valid and may be voted at the postponed or adjourned meeting. You will be able to

change or revoke your proxy until it is voted. If there are any technical issues in convening or hosting the

meeting, we will promptly post information to our Investor Relations website, including information on when the

meeting will be reconvened.

***How do I obtain more information about Cboe Global Markets, Inc.?***

A copy of our 2025 Annual Report to Stockholders, which includes our Annual Report on Form 10-K, is enclosed

with this Proxy Statement. The 2025 Annual Report, our Annual Report on Form 10-K for the fiscal year ended

December 31, 2025 filed with the SEC, our Corporate Governance Guidelines, our Code of Business Conduct

and Ethics, and the charters for our Audit, Compensation and Human Capital, and Nominating and Governance

Committees are available on our website at http://ir.Cboe.com. In addition, we intend to disclose any future

amendments to certain provisions of our Code of Business Conduct and Ethics, or any waivers of such

provisions, applicable to any principal executive officer, principal financial officer, principal accounting officer or

controller, or persons performing similar functions on our website at http://ir.Cboe.com.

These documents may also be obtained, free of charge, by writing to: Cboe Global Markets, Inc., 433 West Van

Buren Street, Chicago, Illinois 60607, Attn: Investor Relations; or by sending an e-mail to:

investorrelations@Cboe.com.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 95 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

These documents, as well as other information about us, are also available on our website at http://ir.Cboe.com.

Information on our website does not form a part of this Proxy Statement.

***How do I sign up for electronic delivery of proxy materials?***

This Proxy Statement and our 2025 Annual Report to Stockholders are available on our website at http://

ir.Cboe.com. If you would like to help reduce our costs of printing and mailing future materials, you can consent

to access these documents in the future over the Internet rather than receiving printed copies in the mail.

If you are a stockholder of record, you may sign up for this service by contacting our transfer agent in writing at

Broadridge, 51 Mercedes Way, Edgewood, NY 11717 or calling (866) 301-8223. If you hold shares of common

stock in "street name", you can contact your account representative at the broker, bank, or similar institution

through which you hold your shares for information regarding electronic delivery of future materials. Your

consent to electronic delivery will remain in effect until you revoke it.

***Who pays the expenses of this proxy solicitation?***

The Company will pay the expenses of the preparation of our proxy materials and the solicitation of proxies by

the Company for the Annual Meeting. Certain of our directors, officers or employees may make solicitations in

person, telephonically, electronically, or by other means of communication. We have also engaged Sodali & Co

(formerly Morrow Sodali LLC) to assist in the solicitation and distribution of proxies. Our directors, officers, and

employees will receive no additional compensation for any such solicitation, and we will pay Sodali & Co a fee

of $10,500 for its services, as well as reimbursements for certain expenses. We will request that banks,

brokerage houses, and other custodians, nominees, and fiduciaries forward all of our solicitation materials to the

beneficial owners of the shares that they hold of record. We will reimburse these record holders for customary

clerical and mailing expenses incurred by them in forwarding these materials to customers.

If you have any questions about the Annual Meeting or need additional copies of this Proxy Statement or

additional proxy cards, please contact Sodali & Co at 333 Ludlow St, 5th Floor, South Tower, Stamford,

Connecticut 06902. Banks and brokerage firms may call (203) 658-9400 and stockholders may call toll-free at

(800) 662-5200 or by sending an e-mail to: CBOE.info@sodali.com.

***Who will count the vote?***

The Company has engaged Broadridge to serve as the inspector of elections for the Annual Meeting. As

inspector of elections, Broadridge will tabulate the voting results.

***What does it mean if I get more than one proxy or voting instruction card?***

If your shares are registered in more than one name or in more than one account, you will receive more than

one card. This may occur if you hold common stock in multiple accounts, such as with different brokers in street

name and as the record holder with Broadridge. Please complete and return all of the proxy or voting instruction

cards that you receive (or vote by telephone or through the Internet all of the shares on all of the proxy or voting

instruction cards received) to ensure that all of your shares are voted.

---

| | |
|:---|:---|
| 96 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

**<u>APPENDIX A—RECONCILIATION OF NON-GAAP</u>**

**<u>FINANCIAL MEASURES TO GAAP</u>**

**<u>MEASURES</u>** 

In addition to disclosing results determined in accordance with GAAP, Cboe Global Markets, Inc. has disclosed

certain non-GAAP measures of operating performance in this Proxy Statement. These measures are not in

accordance with, or a substitute for, GAAP, and may be different from or inconsistent with non-GAAP financial

measures used by other companies. The non-GAAP measures provided in this Proxy Statement are corporate-

wide EBITDA and adjusted EBITDA and 3-year adjusted EPS. Management believes that the non-GAAP

financial measures presented in this Proxy Statement provide the appropriate means to determine

compensation payouts under our annual incentive plan. The Company also believes that providing a discussion

of these metrics provides management and investors an additional perspective on the Company's financial and

operational performance and trends.

---

| | |
|:---|:---|
| **(in millions)** | **Twelve Months** <br>**Ended**<br>**December 31,** <br>**2025**<br>|
| **Reconciliation of Net Income Allocated to Common Stockholders to EBITDA and** <br>**Adjusted EBITDA** <br>|  |
| Net income allocated to common stockholders | $1094.8 |
| Interest expense, net | 2.9 |
| Income tax provision | 466.6 |
| Depreciation and amortization | 122.4 |
| **EBITDA** | $1686.7 |
| Non-GAAP adjustments not included in above line items |  |
| Acquisition-related expenses | 0.3 |
| Business realignment costs | 7.0 |
| Non-operating investment adjustments, net | (96.8) |
| Executive compensation adjustment | 1.6 |
| Impairment of assets | 46.7 |
| **Adjusted EBITDA, including minority investments** | $1645.5 |
| Minority investments (1) | 9.3 |
| **Adjusted EBITDA, excluding minority investments** | $1654.8 |

---

_____________________________________

(1)Impact from minority investments are removed for purposes of annual incentive plan achievement

calculations.

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 97 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **(in millions)** | **Twelve Months** <br>**Ended**<br>**December 31,** <br>**2024**<br>|
| **Reconciliation of Net Income Allocated to Common Stockholders to EBITDA and** <br>**Adjusted EBITDA** <br>|  |
| Net income allocated to common stockholders | $761.0 |
| Interest expense, net | 24.2 |
| Income tax provision | 318.9 |
| Depreciation and amortization | 133.0 |
| **EBITDA** | $1237.1 |
| Non-GAAP adjustments not included in above line items |  |
| Acquisition-related expenses | 1.3 |
| Loss on investments | 31.4 |
| Gain on sale of property held for sale  | (1.0) |
| Cboe Digital syndication wind down  | (1.0) |
| Gain on Cboe Digital non-recourse notes and warrants wind down  | (1.4) |
| Costs related to Cboe Digital wind down  | 2.1 |
| Change in contingent consideration | 2.1 |
| Impairment of intangible assets | 81.0 |
| **Adjusted EBITDA, including minority investments** | $1351.6 |
| Minority investments (1) | 11.2 |
| **Adjusted EBITDA, excluding minority investments** | $1362.8 |

---

_____________________________________

(1)Impact from minority investments are removed for purposes of annual incentive plan achievement

calculations.

---

| | |
|:---|:---|
| 98 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **(in millions)** | **Twelve Months** <br>**Ended**<br>**December 31,** <br>**2023**<br>|
| **Reconciliation of Net Income Allocated to Common Stockholders to EBITDA and** <br>**Adjusted EBITDA** <br>|  |
| Net income allocated to common stockholders | $757.5 |
| Interest expense, net | 50.4 |
| Income tax provision | 286.2 |
| Depreciation and amortization | 158.0 |
| **EBITDA** | $1252.1 |
| Non-GAAP adjustments not included in above line items |  |
| Acquisition-related expenses | 7.4 |
| Income from investment | (2.1) |
| Change in contingent consideration | (14.4) |
| Impairment of investment | 1.8 |
| **Adjusted EBITDA, including minority investments** | $1244.8 |
| Minority investments (1) | (3.5) |
| **Adjusted EBITDA, excluding minority investments** | $1241.3 |

---

_____________________________________

(1)Impact from minority investments are removed for purposes of annual incentive plan achievement

calculations.

---

| | |
|:---|:---|
| **(in millions)** | **Twelve Months** <br>**Ended**<br>**December 31,** <br>**2022**<br>|
| **Reconciliation of Net Income Allocated to Common Stockholders to EBITDA and** <br>**Adjusted EBITDA** <br>|  |
| Net income allocated to common stockholders | $234.1 |
| Interest expense, net | 56.4 |
| Income tax provision | 197.9 |
| Depreciation and amortization | 166.8 |
| **EBITDA** | $655.2 |
| Non-GAAP adjustments not included in above line items |  |
| Acquisition-related expenses | 19.9 |
| Impairment of investment | 10.6 |
| Loan forgiveness | (1.3) |
| Gain on investment | (7.5) |
| Goodwill impairment | 460.9 |
| Investment establishment costs | 3.0 |
| Change in contingent consideration | (5.2) |
| **Adjusted EBITDA** | $1135.6 |

---

---

| | |
|:---|:---|
| **Cboe Global Markets 2026 Proxy Statement** | 99 |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **(in millions)** | **Twelve Months** <br>**Ended**<br>**December 31,** <br>**2021**<br>|
| **Reconciliation of Net Income Allocated to Common Stockholders to EBITDA and** <br>**Adjusted EBITDA** <br>|  |
| Net income allocated to common stockholders | $527.3 |
| Interest expense, net | 47.4 |
| Income tax provision | 227.1 |
| Depreciation and amortization | 167.4 |
| **EBITDA** | $969.2 |
| Non-GAAP adjustments not included in above line items |  |
| Acquisition-related expenses | 15.6 |
| Impairment of investment | 5.0 |
| Change in contingent consideration | (2.7) |
| **Adjusted EBITDA** | $987.1 |

---

---

| | |
|:---|:---|
| 100 | **Cboe Global Markets 2026 Proxy Statement** |

---

<u>[**Table of Contents**](#i6fe99c16e7ba4527ada2d89600dfba88_16)</u>

---

| | |
|:---|:---|
| **(in millions, except per share amounts)** | **Thirty-Six Months** <br>**Ended**<br>**December 31,** <br>**2025**<br>|
| **Reconciliation of 3-Year Net Income Allocated to Common Stockholders to Non-GAAP**  |  |
| Net income allocated to common stockholders | $2613.3 |
| Non-GAAP adjustments |  |
| Acquisition-related expenses (1) | 9.0 |
| Amortization of acquired intangible assets (2) | 275.2 |
| Non-operating investment adjustments, net | (65.7) |
| Change in contingent consideration | (12.3) |
| Executive compensation adjustment | 1.6 |
| Business realignment costs | 9.1 |
| Gain on Cboe Digital non-recourse notes and warrants wind down | (1.4) |
| Cboe Digital syndication wind down | (1.0) |
| Gain on property held for sale | (1.0) |
| Impairment of assets | 127.7 |
| Total Non-GAAP adjustments | $341.2 |
| Income tax expense related to the items above | (91.1) |
| Tax reserves | (20.7) |
| Deferred tax re-measurements | 14.4 |
| Valuation allowances | 2.3 |
| Net income allocated to participating securities - effect on reconciling items | (1.6) |
| **Adjusted 3-year net income allocated to common stockholders** | $2857.8 |
| **Reconciliation of 3-Year Diluted EPS to Non-GAAP** |  |
| Diluted earnings per common share | 24.76 |
| Per share impact of non-GAAP adjustments noted above | 2.32 |
| **3-year Adjusted diluted earnings per common share** | $27.08 |

---

_____________________________________

(1)This amount includes professional fees and outside services, severance, facilities expenses, impairment

charges and other costs related to the Company's acquisitions.

(2)This amount represents the amortization of acquired intangible assets related to the Company's

acquisitions.

![2026 Proxy Card Page 1 Final.jpg](cboe-20260401_g65.jpg)

![2026 Proxy Card Page 2 Final.jpg](cboe-20260401_g66.jpg)